Graduate Theses, Dissertations, and Problem Reports
1998

Cellular mechanisms of altered neuronal sensitivity in the
genetically epilepsy-prone rat
Lance Russell Molnar
West Virginia University

Follow this and additional works at: https://researchrepository.wvu.edu/etd

Recommended Citation
Molnar, Lance Russell, "Cellular mechanisms of altered neuronal sensitivity in the genetically epilepsyprone rat" (1998). Graduate Theses, Dissertations, and Problem Reports. 3150.
https://researchrepository.wvu.edu/etd/3150

This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

Cellular Mechanisms of Altered Neuronal Sensitivity in the Genetically
Epilepsy-Prone Rat

Dissertation

Submitted to the School of Medicine
West Virginia University
Morgantown, WV

In Partial Fulfillment of the Requirements
for the degree of
Doctor of Philosophy
in Pharmacology and Toxicology
by
Lance R. Molnar
September, 1998

Contents
TOPIC

PAGE

TABLE OF CONTENTS........................................................................................

i

LIST OF TABLES...................................................................................................

iv

LIST OF FIGURES.................................................................................................

vi

ABSTRACT.............................................................................................................

x

I. CELLULAR RESPONSIVENESS......................................................................

1

A. Adaptive Changes in Sensitivity

2

B. Plastic Changes in Sensitivity

8

II. EPILEPSY...........................................................................................................

12

A. Animal Models of Epilepsy

14

B. The Genetically Epilepsy-Prone Rat (GEPR)

16

III. THE CEREBELLUM.......................................................................................

22

A. Basic Features

24

B. Neuronal Elements

26

C. Functional Divisions

29

D. Circuitry

36

E. Development

41

IV. THE GABAA-RECEPTOR...............................................................................

50

A. GABAA-Receptor Structure and Composition

50

B. Activation and Modulation of the GABAA-Receptor

52

C. The Benzodiazepine Binding Sites

57

D. Subunit-Specific Interactions of Various Modulators

58

E. In Vivo Regulation of the GABAA-Receptor

60

F. Cerebellar Purkinje Neurons and the GABAA-Receptor

63

ii

TOPIC

PAGE

V. EXPERIMENTAL DESIGN.............................................................................

65

VI. METHODS........................................................................................................

68

A. Brain Slices

70

B. Electrophysiological Recording I: Intracellular Recording

71

C. Statistical Analysis of Intracellular Data

78

D. Electrophysiological Recording II: Whole-Cell and Single-Channel Patch
Clamp

79

VII. RESULTS.........................................................................................................

84

A. Basic Electrical Membrane Properties

85

B. The Effects of Ouabain in Sprague-Dawley Rats

92

C. Intracellular Comparison of Sprague-Dawley and GEPR-NE Purkinje
Neurons

96

D. Intracellular Comparison of Sprague-Dawley and GEPR-9 Purkinje
Neurons

106

E. Intracellular Comparison of Sprague-Dawley and GEPR-3 Purkinje
Neurons

118

F. Comparison of GABA Responses using the Whole-Cell Patch-Clamp
Technique

128

G. Comparison of GABA Responses in Single-Channel Outside-Out Patches

135

VIII. DISCUSSION.................................................................................................

140

A. Purkinje Neurons in Cerebellar Slices Obtained from Sprague-Dawley,
GEPR-NE, GEPR-3, and GEPR-9 Animals have Equivalent Basic
Electrical Membrane Properties

144

B. Developmental Changes in Cellular Responsiveness of Purkinje Neurons

146

C. Cellular Responsiveness of Sprague-Dawley Purkinje Neurons to Various
Agonists

150

D. Comparison of the Responsiveness of Purkinje Neurons from GEPR-NE,
GEPR-3, and GEPR-9 Animals with that of Sprague-Dawley Purkinje
Neurons

153

iii

TOPIC

PAGE

E. Comparison of GEPR-9, GEPR-3, and Sprague-Dawley Purkinje Neuron
Whole-Cell and Single-Channel Conductance Responses

157

F. Conclusions

159

IX. REFERENCES..................................................................................................

iv

161

LIST OF TABLES
TABLE 1.

ARS scoring system for seizure severity in GEPRs exposed to audiogenic...........17
stimulation

TABLE 2.

Timeline of major developmental events for the rat cerebellum focusing...........48-49
upon the Purkinje neurons and those events which directly impact upon the.

TABLE 3.

Various compounds which interact with the GABAA-receptor complex and..........56
their effects.

TABLE 4.

Resting membrane potential (mV) of Purkinje neurons in cerebellar....................88
slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats at various
postnatal ages.

TABLE 5.

Input resistance (M ) of Purkinje neurons in cerebellar slices from................90
Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats at various postnatal ages.

TABLE 6.

Effects of superfusing ouabain (1 mM) on the resting membrane potential........95
(RMP) of Purkinje neurons in cerebellar slices from Sprague-Dawley rats of various
postnatal ages determined using intracellular recording techniques.

TABLE 7.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............98
slices from Sprague-Dawley and GEPR-NE rats induced by various GABA-receptor
agonists and antagonists as determined using intracellular recording techniques.

TABLE 8.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............100
slices from Sprague-Dawley and GEPR-NE rats induced by excitatory agonists as
determined using intracellular recording techniques.

TABLE 9.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............107
slices from Sprague-Dawley and GEPR-9 rats induced by various GABA-receptor
agonists and antagonists as determined using intracellular recording techniques.

TABLE 10.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............109
slices from Sprague-Dawley and GEPR-9 rats induced by excitatory agonists as
determined using intracellular recording techniques.

(continued)

v

TABLE 11.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............117
slices from Sprague-Dawley and GEPR-9 rats induced by GABA and/or modulators
of the GABAA-receptor as determined using intracellular recording techniques.

TABLE 12.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............119
slices from Sprague-Dawley and GEPR-3 rats induced by various GABA-receptor
agonists and antagonists as determined using intracellular recording techniques.

TABLE 13.

Changes in membrane potential of Purkinje neurons in vermal cerebellar............121
slices from Sprague-Dawley and GEPR-3 rats induced by excitatory agonists as
determined using intracellular recording techniques.

TABLE 14.

Geometric mean EC50 values ± S.E.M. (in µM) determined from...........127
concentration-response curves for membrane polarization effects of various agonist
using intracellular recording techniques in Purkinje neurons.

TABLE 15.

Resting membrane potential (mV) and input resistance (M ) of Purkinje........129
neurons in cerebellar slices immediately following attainment of whole cell
configuration of the patch-clamp technique.

TABLE 16.

Mean open durations (msec) and closed durations (msec) obtained from..........136
single-channel recordings of Purkinje neurons from Sprague-Dawley, GEPR-3, and
GEPR-9 animals.

vi

LIST OF FIGURES
FIGURE 1.

Drawing of the external rat cerebellum, a sagittal section, and a folium..................23

FIGURE 2.

Depictions of the vestibulocerebellar (A), cerebrocerebellar (B), and..............32-35
spinocerebellar (C) pathways.

FIGURE 3.

Diagramatic illustration of cerebellar neuronal connections and the major.......39-40
transmitters involved in these connections.

FIGURE 4.

Schematic illustrating the postnatal development of the rat cerebellum..................47

FIGURE 5.

Intracellular recording of a Purkinje neuron in a cerebellar slice showing..........73
antidromic action potential invasion of the soma following white matter stimulation.

FIGURE 6.

Representative voltage responses (A) and current injection (B) traces as...............74
used for the formation of current-voltage (I/V) curves.

FIGURE 7.

Current-voltage (I/V) plots for Purkinje neurons in cerebellar slices from..............75
a 10 day (P10) and a 27 day (P27) old Sprague-Dawley rat as determined using
intracellular recording techniques.

FIGURE 8.

Response of a Purkinje neuron in a cerebellar slice from a Sprague-Dawley...........77
rat to 1 µM muscimol application via superfusion.

FIGURE 9.

Representative whole-cell (A) and single-channel current (B) traces from..........82
Purkinje neurons of Sprague-Dawley rats.

FIGURE 10. Bar graph comparing the resting membrane potential of Purkinje neurons...........87
in cerebellar slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats
measured using intracellular recording techniques.
FIGURE 11. Bar graph comparing the input resistance of Purkinje neurons in cerebellar..........89
slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats measured using
intracellular recording techniques.
FIGURE 12. Plots of the resting membrane potential (~) and input resistance (>) for...........91
Purkinje neurons in cerebellar slices from Sprague-Dawley rats at various postnatal
ages as determined using intracellular recording techniques.
(continued)

vii

FIGURE 13. A trace of the membrane response of a Purkinje neuron in a cerebellar slice.........93
from a P22 Sprague-Dawley rat to ouabain superfusion illustrates the depolarizing
effects of ouabain on the membrane potential.
FIGURE 14. Plot of the depolarizing effects of superfusing ouabain (1 mM) on the...............94
resting membrane potential of Purkinje neurons in cerebellar slices from SpragueDawley rats as determined using intracellular recording techniques.
FIGURE 15. Concentration-response curves of Purkinje neurons to superfusion of GABA........102
for Sprague-Dawley and GEPR-NE animals.
FIGURE 16. Concentration-response curves of Purkinje neurons to superfusion of...............103
muscimol for Sprague-Dawley and GEPR-NE animals.
FIGURE 17. Concentration-response curves of Purkinje neurons to superfusion of ..............104
glutamate for Sprague-Dawley and GEPR-NE animals.
FIGURE 18. Concentration-response curves of Purkinje neurons to
aspartate.....105 for Sprague-Dawley and GEPR-NE animals.

superfusion of

FIGURE 19. Concentration-response curves of Purkinje neurons to superfusion of GABA........111
for Sprague-Dawley and GEPR-9 animals.
FIGURE 20. Concentration-response curves of Purkinje neurons to superfusion of...............112
muscimol for Sprague-Dawley and GEPR-9 animals.
FIGURE 21. Concentration-response curves of Purkinje neurons to superfusion of..............114
glutamate for Sprague-Dawley and GEPR-9 animals.
FIGURE 22. Concentration-response curves of Purkinje neurons
aspartate.....115 for Sprague-Dawley and GEPR-9 animals.

to

superfusion of

FIGURE 23. Concentration-response curves of Purkinje neurons to superfusion of GABA........122
for Sprague-Dawley and GEPR-3 animals.
FIGURE 24. Concentration-response curves of Purkinje neurons to superfusion of.........123
muscimol for Sprague-Dawley and GEPR-3 animals.
FIGURE 25. Concentration-response curves of Purkinje neurons to superfusion of...............125
glutamate for Sprague-Dawley and GEPR-3 animals.

(continued)
viii

FIGURE 26. Concentration-response curves of Purkinje neurons
aspartate.....126 for Sprague-Dawley and GEPR-3 animals.

to superfusion of

FIGURE 27. Concentration-response curves of the mean neuron peak current.......................131
amplitudes of Purkinje neurons to superfusion of GABA.
FIGURE 28. Mean concentration-response curves of Purkinje neurons to superfusion of........132
higher concentrations of GABA depicting the steady-state current.
FIGURE 29. Mean I/V curves of Purkinje neurons exposed to 1 mM GABA held at.............134
various membrane potentials.
FIGURE 30. Histogram plot of the amplitude of detected open events for GEPR-9................138
Purkinje neurons.
FIGURE 31. Histogram plots of open durations for Sprague-Dawley, GEPR-3, and...............139
GEPR-9 Purkinje neurons upon application of 100 µM GABA.

ix

ABSTRACT
The genetically epilepsy-prone rat (GEPR) is an animal model of epilepsy which exhibits
deficits in GABAergic neurotransmission in a variety of brain regions. However, the underlying
cause for this deficit has yet to be described. The present studies were therefore performed in order
to elucidate the mechanism(s) underlying this GABAergic deficit. To accomplish this task,
electrophysiological recordings of Purkinje neurons in sagittal slices of the cerebellar vermis were
performed. The initial aim was to compare the basic electrical membrane characteristics of Purkinje
neurons from GEPR and control animals using standard intracellular recording techniques. These
studies indicated that there is no significant difference in resting membrane potential or input
resistance between GEPRs and control. To compare GEPR and control neurons pharmacologically,
full concentration response curves were constructed for membrane polarization responses to GABA,
muscimol, glutamate, and aspartate. While there was an approximate 4-fold increase in the GABA
and muscimol EC50s for GEPR Purkinje neurons compared to control animals without a change in
maximal response, EC50s generated for glutamate and aspartate were not significantly different
between animal strains, indicating a specific subsensitivity to GABAA-receptor activation for GEPR
Purkinje neurons. In order to further investigate the underlying cause of this specific subsensitivity,
whole and single-channel patch recording techniques were used to compare conductance properties
of GABAA-receptors from Purkinje neurons from GEPR and control animals. These studies
indicated that GEPR Purkinje neuron GABAA-receptors display a decreased level of maximal
chloride conductance upon activation by ligand as well an increased rate of desensitization. This
provides further evidence that GEPR Purkinje neurons display a specific subsensitivity to GABAAreceptor activation which is due to the chloride gating characteristics of this receptor complex.
x

I. CELLULAR RESPONSIVENESS
The basic functional units of the nervous system are neurons, which, along with muscle cells
and pancreatic -cells, are unique in that they respond to stimuli by generating electrical impulses,
that is, they are excitable. The function of an individual neuron is dependent upon both its innate
electrical properties in conjunction with its interaction with afferent input and efferent target(s),
such that, for any neuronal circuit to operate properly, each neuron along the pathway must correctly
respond to the input it is receiving and then appropriately convey this information to its postsynaptic
effector(s). In this way, the maintenance and regulation of cellular responsiveness is fundamentally
important to the proper functioning of neuronal circuits.

Abnormal responsiveness can,

consequently, lead to the misinterpretation of ongoing activity and thus yield undesirable
communication between neurons.
Historically, most of our understanding of how cells regulate their responsiveness has been
obtained by investigating experimentally induced changes in responsiveness. Through a variety of
procedures (see review by Fleming and Westfall, 1988), it is possible to produce alterations in
responsiveness by which cells attempt to adapt to changes in their microenvironment to maintain
a proper flow of information. In general, such induced changes have fallen into one of two
categories, deviation or adaptive changes in sensitivity. More recently, the closely related but
somewhat different concept of neuronal, or synaptic, plasticity has garnered significant attention
as an adaptive phenomenon. This plasticity can be defined as modifications in synaptic strength
that follow specific patterns of neuronal activity (Abraham and Tate, 1997). The most common uses
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of this term are for describing changes in neuronal communication that occur during processes such
as long-term potentiation and long-term depression, and to describe the capacity of the nervous
system to undergo major and relatively rapid reorganization after input manipulation. Thus, some
forms of synaptic plasticity and certain types of altered sensitivity, as described below, may have
a similar fundamental basis. In either case, neurons regulate their activity by altering their cellular
responsiveness to better accommodate to the microenvironment with which they are presented.

A. Adaptive Changes in Sensitivity
Adaptive changes in sensitivity, by definition, involve alterations in the cellular
responsiveness to an agonist or agonists that occur in response to a chronic modification in the level
of cellular activity. This is in contrast to deviation supersensitivity which is the result of acute
inhibition or loss of either metabolism or uptake of neurotransmitters resulting in an elevated level
of transmitter in the biophase (Fleming and Westfall, 1988). Since the research presented here is
relevant specifically to adaptive changes in sensitivity, further discussion will be limited to that
subject.
Adaptive supersensitivity is characterized by a leftward shift of the agonist dose-response
curve. Coincident with this shift, there may also be an increase in the maximal response and/or a
change in the slope of the dose-response curve (Fleming et al., 1973). Similarly, adaptive
subsensitivity is evidenced by a rightward shift of the dose-response curve with or without decreases
in the slope and maximal response. Thus, for either subsensitivity or supersensitivity, there is an
alteration in the quantitative relationship between the stimulus and the cellular response evoked by
that stimulus. There is, however, no single mechanism that accounts for all adaptive changes in
-2-

responsiveness. Mechanisms that have been firmly supported by experimental evidence include
alterations in receptor number (or density), alterations in signal transduction mechanisms, and
alterations in electrophysiological membrane properties, such as the resting membrane potential
(Fleming and Taylor, 1995). The mechanism(s) involved depend(s) on the type of cell or species
of animal. Furthermore, a given adaptive response may employ more than one of these mechanisms
to produce an overall change in responsiveness (see below).
The fact that altering the number of functional receptors in turn alters the responsiveness of
a cell to an agonist can be demonstrated by the law of mass action. This law dictates that, at
equilibrium, the following relationship exists for the reaction R + A W RA :
KD = [R][A]/[RA]
where [R], [A], and [RA] represent the concentrations of free receptors, free agonist, and agonistreceptor complexes, respectively, and KD is the dissociation constant for the agonist-receptor
complex. If [Rt] is then used to represent the total concentration of receptors (i.e., [Rt] = [R] +
[RA]), the following relationship can be derived:
(KD/[A]) + 1 = [Rt]/[RA]
Thus, when [A] is unchanged, and since KD is a constant, as the concentration of total receptors
changes ([Rt]), the concentration of agonist-receptor complexes ([RA]) must also change
proportionally. Therefore, if the ability of the agonist to activate the receptor has not changed (i.e.,
affinity and efficacy remain the same), the effect of a given concentration of agonist ([A]) will
change according to the magnitude and direction of the alteration in receptor population. An
increase in receptor population would produce a leftward shift in the agonist dose-response curve
(supersensitivity), whereas a decrease in receptor population would yield a rightward shift
-3-

(subsensitivity). Importantly, this shift in responsiveness is specific for A, the agonist(s) which
activate the receptor, R.
The first documented evidence of changes in responsiveness due to alterations in receptor
levels was in denervated skeletal muscle (Thesleff, 1960). With chronic denervation, skeletal
muscle becomes supersensitive to nicotinic agonists (Thesleff, 1960). Furthermore, evidence
suggests that a large part of this increased sensitivity is due to the spread of cholinoceptors beyond
the neuromuscular endplate which renders the entire muscle responsive to nicotinic agonists
(Axelson and Thesleff, 1959; Miledi, 1960). Evidence for such receptor regulation in the nervous
system also exists. One such example is in a classical rodent model of Parkinson’s disease in which
the dopaminergic nigrostriatal pathway is lesioned with 6-hydroxydopamine (6-OHDA). Chronic
depression of dopaminergic transmission to the striatum in this manner leads to an up-regulation
of dopamine receptors in the striatum (Seeman, 1980). In each of these examples, denervated
skeletal muscle and experimental parkinsonism, it should be noted that changes in the total number
of receptors do not fully account for the adaptive changes which are expressed (Fleming and
Westfall, 1988). However, in both cases there is firm evidence that receptor levels are altered and
that these alterations contribute significantly to shifts in the sensitivity of these receptors to agonists.
Furthermore, the fact that a single neuron or muscle cell may employ multiple methods for adjusting
its responsiveness emphasizes the flexibility which neurons have when accomplishing this task.
As mentioned above, another mechanism by which cells can alter their responsiveness is
through changes in electrophysiological characteristics. The membrane potential (E m) of excitable
cells is determined for the most part by the permeability to, and electrochemical gradients of, ions
across the cellular membrane. A fundamental component of creating and maintaining much of these
-4-

gradients is the Na+-K+ pump (or Na+,K+-ATPase). The pump, which exchanges sodium and
potassium ions across the cellular membrane, may be either electroneutral (one for one ionic
exchange) or electrogenic (unequal exchange of charge). It is important to note that the pump may,
in fact, be electroneutral in some instances and electrogenic in others within a given tissue
depending on the experimental conditions (Thomas, 1972; Fleming, 1980).
When the pump is electrogenic, it creates a positive outward current that contributes to the
membrane potential. Thomas (1972) estimated this contribution of the pump (Ep) to the membrane
potential to be:

where r is the coupling ratio of the pump (i.e., r = 1.5 when 3 Na+ are exchanged for 2 K+), b is the
ratio of the sodium and potassium ionic permeabilities, KO is the external potassium ion
concentration, NaO is the external sodium ion concentration, and R, T, and F are the gas constant,
temperature, and Faraday’s constant, respectively. Though the contribution of this ATPase to the
membrane potential will vary from tissue to tissue and from cell to cell, estimations of its
contribution in a variety of cells have tended to be in the 10 to 30 millivolt (mV) range (Fleming,
1980). One such estimation of this contribution was put forth by Urquilla et al. (1978) for cells of
the guinea pig vas deferens.

Using procedures to inhibit the electrogenic pump potential

(application of 10-5 M ouabain or decreased extracellular K+), they were able to depolarize the cells
by approximately 10 mV. Since the pump may be responsible for quite a significant portion of the
membrane potential in some cases, the regulation of its activity represents a potential target by
which neurons may nonspecifically shift their responsiveness to neurotransmitters, essentially by
changing their state of excitability. The nonspecificity of this shift, which arises since changes in
-5-

RMP will alter responsiveness to any agonist that acts via altering the membrane potential (see
below), serves as an important diagnostic tool when investigating changes in sensitivity.
A classic example of the relationship between the membrane potential and the
responsiveness of cells is the adaptive supersensitivity of the guinea pig vas deferens which can be
induced by chronic reserpine treatment, decentralization (preganglionic denervation of
autonomically innervated cells), or denervation of the smooth muscle (Westfall, 1970a; Westfall et
al., 1972). Such procedures induce an approximate 10 mV depolarization of the smooth muscle
cells (Fleming and Westfall, 1975), similar to the level of depolarization attainable by inhibiting the
pump (above; Urquilla et al., 1978). Furthermore, there is evidence that a reduction in the amount
of [3H] ouabain binding to the pump (Wong et al., 1981) as well as a reduction in enzyme activity
(Gerthoffer et al., 1979) exist and that these reductions are due specifically to a decrease in the
amount of the

-subunit of the pump (Hershman et al., 1993). Furthermore, the -subunit is the

2

subunit responsible for both the enzymatic activity and cardiac glycoside (ouabain) binding
(Sweadner, 1989). Concomitant with these changes are increased sensitivities to -adrenoceptor
agonists, muscarinic agonists, histamine, and potassium ions that follow similar time courses to the
depolarization (Westfall, 1970a; Fleming and Westfall, 1975) and the reduction in pump protein
(Hershman et al., 1995). Since the threshold potential at which action potentials are elicited
remains unchanged in the supersensitive muscle (Goto et al., 1978) and a given amount of
transmitter produces relatively equal amounts of depolarization in both control and supersensitive
cells, less transmitter is needed to reach the threshold for firing. Thus, for a variety of unrelated
agonists which function by depolarizing the cells to the threshold of action potential firing,
supersensitive cells require less of these agonists to produce firing.
-6-

A third mechanism which has been shown to account for adaptive changes in sensitivity
is a change in cellular signaling transduction process(es). Altering sensitivity by changes in the
amount, availability, or effectiveness of mediators of activity presents, in some cases, quite a
different picture than those mechanisms described above. Whereas changes in receptor number or
density clearly yield highly specific changes in cellular responsiveness and alterations of the
membrane potential changes responsiveness nonspecifically via either decreased or increased
excitability, the impact of changes in signal transduction processes on the specificity of changes is
not as clear cut. Such changes may lead to specific alterations in responsiveness. An example of
this would be a change in the gating of a ligand-operated ion channel. By altering the conductance
characteristics of such a receptor-gated channel, a neuron could potentially alter its responsiveness
specifically to transmitters that mediate the activity of that channel. Such receptor modification has
been observed for the GABAA-receptor via protein kinase A (Porter et al., 1990), protein kinase C
(Lin et al., 1994), or tyrosine kinase (Moss et al., 1995) mediated receptor phosphorylation.
On the other hand, with certain changes in signal transduction mechanisms, most notably
with intracellular signaling pathways and second messengers, neuronal responsiveness can
potentially be altered to a wide array of transmitters which interact with such messengers via their
signal transduction cascade. One such example of this sort of adaptational process occurs in
cultured dorsal root ganglia neurons which are chronically exposed to etorphine, a non-selective
opioid agonist. Attali and Vogel (1989) have shown that such chronic exposure to etorphine leads
to a specific reduction in the amount of the -subunit of the G-protein, Gi, but no changes in
adenylyl cyclase activity. As would be predicted, they were also able to show that these cultured
neurons displayed marked subsensitivity to the activation of receptor systems which rely upon Gi
-7-

to mediate their signaling, including -opioid receptor activation (U50488H), 2-adrenergic receptor
activation (clonidine), and muscarinic cholinoceptor activation (carbachol).
As has been described, adaptive sensitivity changes represent mechanisms by which cells
alter their responsiveness. Such adaptive changes are, however, merely a subset of the mechanisms
by which cellular responsiveness can be regulated, namely, those changes induced either
experimentally, pharmacologically, or pathologically via deprivation or elevation of input. Thus,
they represent ways in which cells attempt to return to a “normal” level of activity subsequent to
physiologically abnormal input. Such homeostatic responses allow individual cells to compensate
for perturbations of their microenvironment. Plasticity, on the other hand, is somewhat different
in that the trigger for changes in responsiveness is not necessarily abnormal input. In these
instances, rather than acting to regain homeostasis after receiving abnormal input, cells essentially
become able to recognize patterns of input, alter their responsiveness according to this pattern, and
then convey a predictable output to their efferent targets based on such particular patterns of input.

B. Plastic Changes in Sensitivity
Since the original description of long-term potentiation in the dentate gyrus (Bliss and
Lømo, 1973) twenty five years ago, the study of plasticity and the description of phenomena which
it encompasses has dramatically evolved. Plasticity is now being used to describe a number of
different events which involve altered cellular communication, and thus an important distinction
should be made. There are forms of plasticity, as alluded to earlier, that involve structural
reorganization within the nervous system leading to changes in cellular communication rather than
changes in responsiveness. Examples of such processes include reorganization of sensory systems
-8-

after peripheral nerve injury (Kaas and Florence, 1997) and neural overgrowth after limb restriction
(Schallert et al., 1997). Though the discovery of such processes is both important and exciting, it
is, in fact, changes in cellular responsiveness which are the emphasis of the present studies. For this
reason, further discussion will focus on those instances where neural plasticity involves changes in
cellular responsiveness. Thus, the term plasticity in this discussion can appropriately be defined
as changes in synaptic efficacy or function which are induced by prior activity or modifications in
activity and which persist across time.
Many such forms of use-dependent enhancement of synaptic transmission have been
identified in the mammalian nervous system (Artola and Singer, 1993; Malenka and Nicoll, 1993;
Abraham and Tate, 1997). The underlying theme to these alterations is that relatively brief patterns
of synaptic activity can lead to longer term changes in synaptic strength. The terms used for these
persisting changes are long-term potentiation (LTP) and long-term depression (LTD). LTP, in
general, is considered to be homosynaptic and associative (Artola and Singer, 1993). The term
homosynaptic is used to illustrate that alterations in synaptic efficacy are specific to the afferent
fibers stimulated (i.e., they are input-specific). Thus, high-frequency (>100 Hz) tetanic stimulation
of an afferent pathway leads to a prolonged increase in the synaptic efficacy at that synapse alone
(Madison et al., 1991; Tsien and Malinow, 1991). LTP is associative since it is induced in synapses
only during those times when they are active while at the same time other, distinct inputs are also
active. This accounts for the fact that periodic, low-frequency (<5Hz) stimulation of one pathway
which is in phase with periodic, high-frequency (>100 Hz) stimulation of another conditioning
pathway, will result in LTP of both pathways (Linden, 1994).
In contrast to LTP, LTD has been found to occur at inactive synapses as well as active ones
-9-

(Artola and Singer, 1993).

Thus, LTD may be homosynaptic or heterosynaptic.

Briefly,

homosynaptic LTD occurs at inputs whose activation directly contributes to inducing the
modification, whereas heterosynaptic LTD describes modifications which occur to inputs which
were inactive during induction (Artola and Singer, 1993). For example, homosynaptic LTD
describes the process by which low-frequency (<1 Hz) stimulation results in a persistent decrease
in the efficacy of that synapse (Sejnowski, 1991; Artola and Singer, 1993; Linden, 1994). On the
other hand, heterosynaptic LTD describes a situation which occurs concurrent with homosynaptic
LTP. That is, tetanic stimulation of one afferent pathway results in both homosynaptic LTP of that
pathway and LTD in an unstimulated pathway(s) to the same neuron. Like LTP, LTD may also be
associative. Periodic, low-frequency stimulation of an afferent pathway out of phase with a
periodic, high-frequency stimulation of another pathway results in an associative LTD of the lowfrequency pathway (Artola and Singer, 1993; Linden, 1994).
Having described these processes, one important issue becomes the manner by which they
occur. Though many factors are important in the overall induction of plasticity, there are a few
critical events which appear to be a common theme among such plastic changes. These include a
change in membrane potential which is typically a postsynaptic depolarization, elevations in
intracellular Ca++ concentration ([Ca++]I), and modifications of intracellular protein content
(Abraham and Tate, 1997). Changes in protein content fall into one of two classes. Shorter term
forms of plasticity are typically dependent on post-translational modification of existing proteins
whereas longer term forms of plasticity are usually dependent upon gene expression and de novo
protein synthesis. As well as having factors of induction in common, it has also become apparent
that these plastic changes also share similar features for the maintenance of these changes. Such
-10-

maintenance is typically via the activation of protein kinase A and various isoforms of the adenylyl
cyclases (Abraham and Tate, 1997). Among these modifications, the step which appears to
determine whether LTD or LTP will be witnessed is the rise in [Ca++]I. LTD requires an initial surge
of [Ca++]I above resting levels (Linden et al., 1991) as buffering of intracellular Ca++ blocks the
induction of LTD (Sakurai, 1990; Bröcher et al., 1992; Hirsch and Crépel, 1992; Mulkey and
Malenka, 1992). Though this mechanism is also evident in LTP, the induction of LTP requires a
stronger depolarization of the postsynaptic membrane and a greater subsequent rise of [Ca++]I
(Artola et al., 1990; Bliss and Collinridge, 1993; Abraham and Tate, 1997).
As described above, adaptive sensitivity changes are typically studied to help better
understand how normal cells adjust certain aspects of their responsiveness in order to compensate
for abnormal changes in their microenvironment.

Similarly, plastic changes are typically

investigated to determine how cells “learn” to interpret certain patterns of signals and then reinforce
those signals during subsequent presentations of them. However, often overlooked aspects of these
phenomena are the consequences of deficiencies in these processes or instances where such
phenomena occur without proper provocation, in other words, those situations in which cells do not
alter their responsiveness in an appropriate manner or inherently maintain an inappropriate level of
responsiveness. Thus, it is important to recognize that such abnormal regulation of responsiveness
can, in and of itself, represent a pathological condition. One group of pathological conditions which
appear to be likely candidates for such a problem are the epilepsies. Inherent to many of these
disorders, as will be described in section II, is abnormal excitability of neurons in the central
nervous system.
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II. Epilepsy
The epilepsies are a group of neurological disorders which manifest themselves as seizures
characterized by paroxysmal neuronal discharge. This abnormal neuronal discharge results from
the recruitment of neurons throughout the brain into synchronous activity. The result of this
discharge in large ensembles of neurons is an epileptic seizure which produces involuntary,
stereotyped alterations in behavior. Epileptic seizure disorders afflict approximately two million
individuals in the United States (Shin and McNamara, 1994; French, 1994) and as many as forty
million people throughout the world (Delgado-Escueta et al., 1986), making epilepsies the second
most common neurological disease in man (Martin, 1991). Though there are numerous types and
manifestations of such seizure disorders (for comprehensive review see Delgado-Escueta et al.,
1986), they can be characterized as types of a few basic forms of seizures. Based upon the
mechanism of onset and propagation, seizures can be categorized as being partial, partial with
secondary generalization, or generalized (Hopkins and Appleton, 1996).
If the abnormal discharge arises and then remains localized within a specific region of the
brain, it is termed a partial (or focal) seizure. The perception of the seizure by the individual and/or
the external manifestations depend primarily upon the site of origin. For example, if such a seizure
were to originate in the large toe region of the motor cortex, initial manifestation would be the
contraction of muscles in the contralateral big toe. The extent of the motor cortex over which the
discharge spread would subsequently determine which other muscles would contract, with muscles
represented in directly neighboring regions of the motor cortex being the next to be afflicted (e.g.,
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the rest of the toes, the foot, the ankle and so forth). When such a seizure occurs without a
disturbance in consciousness, it is called a simple partial seizure.
If such a discharge continues to spread throughout the entire brain, it is said to be a partial
seizure with secondary generalization (to a convulsive seizure). These are known as tonic-clonic
or grand-mal seizures due to their symptomology. The first phase of such a seizure is characterized
by widespread contraction (tonic) of muscles throughout the body making it very rigid. The rate
at which different muscles are incorporated into these contractions depends upon the rate at which
the discharge spreads in the central nervous system. After a few minutes in the tonic phase, the
seizure will progress to the clonic (convulsive) phase characterized by rhythmic movements of limb
and trunk muscles. Furthermore, these seizures, like any seizure which spreads throughout the
entire brain, are accompanied by the loss of consciousness.
The third possibility is that a seizure is generalized at the onset such that neuronal discharge
is generated and subsequently spreads to all areas of the brain almost simultaneously. Typical
absence (or petit-mal) seizures are of this type. The onset and termination of such seizures are very
abrupt, as might be expected from the rapid rate of transmission which is required. They are often
just brief interruptions in the normal stream of consciousness and may occur as frequently as 50
times a day (Hopkins and Appleton, 1996). Absence seizures are also frequently associated with
myoclonic jerks of the musculature which are of similarly short duration.
The causes of the many different forms of epilepsy (see review by Delgado-Escueta et al.,
1986) include genetic inheritance, trauma, infectious diseases, degenerative disorders and a host of
others. Even with the various precipitating causes, each type results in a seizure disorder that is due
to the same underlying cause, namely, neuronal hyperexcitability. Proposed mechanisms for this
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hyperexcitability are based on the premise that there is a shift in the excitatory/inhibitory balance
of neurotransmission in the brain (Meldrum, 1990; Tasker and Dudek, 1991) which could be
attributed to:
1) Altered sensitivity to excitatory neurotransmitter(s),
2) Altered sensitivity to inhibitory neurotransmitter(s),
3) Alterations in the release and/or metabolism of neurotransmitter(s), or
4) Some combination of the above

A. Animal Models of Epilepsy
In most cases of human epilepsy, it has proven very difficult to pinpoint a cellular basis for
this hyperexcitability. Most studies of human epilepsy rely upon techniques such as brain imaging
analysis, electroencephalogram (EEG) recordings, or postmortem analysis of brain chemicals.
Because of the variety of forms of epilepsy, it is difficult to correlate alterations of these parameters
with the disease, and often the findings appear to be contradictory (Glass and Dragunow, 1995).
Furthermore, one must use caution in interpreting the results of such analyses since one rarely
knows whether the observed changes actually contribute to the cause of the disease state or perhaps
represent a consequence of the disease state. It should be remembered that the epilepsies are a
variety of diseases which happen to share a common basis (neuronal hyperexcitability) and a
common symptom (seizure), rather than a single disease with a single cause. Consequently, animal
models of seizures and epilepsy serve as invaluable tools in deciphering the mechanisms of the
epilepsies and developing therapeutic strategies for managing them.
Animal models of epilepsy are relatively abundant. Many of the original animal models of
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epilepsy relied upon inducing seizures, by some means, in otherwise normal animals. Most
prominent among these approaches were the use of chemical convulsants (De Dyn et al., 1992) and
the use of both chemical and electrical kindling (McNamara, 1986). Chemical convulsants, those
substances which induce seizures in vivo, come in a variety of forms. Typically they are substances
which either produce lesions of the brain (e.g., metal compounds), enhance excitatory transmission
(e.g., excitatory amino acids), or decrease inhibitory transmission (e.g., bicuculline or
mercaptoproprionic acid). Kindling refers to the phenomenon by which repeated exposure of the
brain to subconvulsive levels of an electrical or chemical stimulus results in the intensification of
seizure activity which typically culminates in a generalized seizure (McNamara, 1986). Both of
these models have served valuable functions in identifying the ways by which seizures are initiated
and spread. Furthermore, they have proven to be valuable resources in the development of
anticonvulsant compounds (Shin and McNamara, 1994). In some cases, they may closely
approximate a subset of epilepsies which affect certain individuals (e.g., lesion studies compared
to trauma). However, such methods do not adequately represent the types of epilepsy which are not
the result of some form of an external insult to the brain.
The genetic models of epilepsy, of which there are now many, possess an inherent advantage
for investigating the mechanisms of epilepsy.

Namely, these animal models result from

inadequacies of the brain itself rather than relying upon external manipulation of the central nervous
system. Such models have been bred in a variety of different species and include examples such
as the DBA/2 mouse, the tottering mouse (C57BL/6j tg/tg), the genetically epilepsy-prone rat
(GEPR), the genetic absence epilepsy rat (GAER), the Mongolian gerbil, and the Senegalese
(photoepileptic) baboon (Jobe et al., 1991). Models such as these have all been well characterized
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relative to their seizure development, predisposition, and characteristics. Therefore, these animals
serve as valuable tools in which to investigate the mechanisms by which neuronal hyperexcitability
develops in animals predisposed to seizures. It should be emphasized that no single model is likely
to provide all the answers in understanding the epilepsies, whether it be a genetic, kindling, or
chemical model. Instead, it is the information accumulated from a variety of these models which
will provide the insights to better understand the origin of the pathology as well as to develop better
strategies for treatment of the epilepsies.

B. The Genetically Epilepsy-Prone Rat (GEPR)
The GEPR model of epilepsy consists of two separately derived strains of seizure-prone rats,
GEPR-3s and GEPR-9s, and a genetic non-epileptic control strain, GEPR-NEs (originally called
GEPR-0s). These animals were selectively bred from Sprague-Dawley stock based upon their
seizure predisposition (Jobe et al., 1991). The seizure-prone strains have characteristic and
reproducible convulsive patterns in response to audiogenic stimulation which are phenotypic
markers by which these animals are bred and categorized. The numeric identifiers of these animals
are based upon a system of audiogenic response scores (ARS) developed by Jobe et al. (1973) for
the evaluation of convulsive intensity such that GEPR-3s display an ARS of 3 and GEPR-9s an
ARS of 9. These ARS scores correlate to convulsive properties as indicated in Table 1.
The GEPR is an animal model that inherits the propensity for seizures as a polygenetic and
autosomal trait (Ribak et al., 1988a) and shares a number of important features with some human
forms of epilepsy. Other than a convulsive predisposition, the GEPRs exhibit no gross evidence
of neurological dysfunction such that eating, sleeping, ambulation, and breeding habits are not
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Table 1. ARS scoring system for seizure severity in GEPRs exposed to audiogenic stimulation
(Dailey and Jobe, 1985).
ARS Score

Early Response

0

No response

1

Running Fit

2

Two running fits

3

One running fit

4

Two running fits

5

One running fit

6

Two running fits

7

One running fit

8

Two running fits

9

One running fit

Convulsive Posture
No convulsion

Clonic convulsion (generalized clonus)
Tonus of the neck, trunk, and forelimbs;
hindlimb clonus
Nearly complete tonic extension, except
hindfeet
Complete tonic extension (full tonic-clonic
convulsion)

characteristically different from those of normal animals (Jobe et al., 1993a,b). Perhaps the most
important trait shared with many human epilepsies is the genetic component. Both humans with
epilepsy and GEPRs exhibit seizures which are precipitated by events which do not give rise to
seizures in normal counterparts. In addition to being susceptible to audiogenic seizures, GEPRs are
susceptible to seizures induced by hyperthermia (a characteristic retained into adulthood) and a
significant incidence of spontaneous seizures (Jobe et al., 1986; Dailey et al., 1989). The GEPRs
also exhibit an increased sensitivity to a variety of seizure-evoking stimuli including electroshock
(Browning et al., 1990), pentylenetetrazol (Browning et al., 1990), kindling (Savage et al.,
1986a,b), convulsant drugs (Dailey et al., 1989), and hyperbaric oxygen (Laird and Jobe, 1987;
Millan et al., 1991). Moreover, clinically useful antiepileptic drugs for the management of
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generalized tonic-clonic seizures in humans also inhibit audiogenic seizures in GEPRs, though the
most effective agents are not the same for both the GEPR-3s and GEPR-9s (Dailey and Jobe, 1985;
Dailey et al., 1989, 1992).
Numerous deficits in the GEPR central nervous system have been described which could
contribute to the seizure predisposition of these animals. However, whether any or all of these
represent the exact cause has yet to be determined. Two problems complicate the determination of
the true precipitating factor for the seizure-prone state, similar to the problems with investigating
human epilepsy. One of these is in determining which deficits are inherent and which are the result
of compensatory responses by the animal to other deficits. This is, of course, very difficult to
determine. However, as more data have accumulated from various brain regions concerning many
neurotransmitter systems, greater confidence in discriminating between precipitating and
compensatory factors has been gained.
The other complication concerns the impact of prior seizure history on the deficits seen. In
order to minimize the possibility that prior seizures are the precipitating factor for a given deficit,
more recent studies have begun to take advantage of an, as of yet unmentioned, aspect of seizure
predisposition in these animals. Though the precise reason is not yet known, these animals do not
exhibit the predisposition to seizures prior to postnatal day 15 (Jobe et al., 1980). Thus, by using
animals which are very young, it is possible to ensure that the animals have never displayed seizure
activity (e.g., < 15 days old) or that such activity has been minimal.
A vast majority of the available literature on GEPRs discusses evidence of altered
noradrenergic and serotonergic transmission. Presynaptic norepinephrine and serotonin content in
most areas of the CNS appears to be reduced equally in seizure naive GEPR-9s and GEPR-3s
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compared to controls (Dailey et al., 1991). In addition to reduced presynaptic norepinephrine and
serotonin content, the GEPRs also exhibit a reduced norepinephrine and serotonin turnover (Jobe
et al., 1984), reduced norepinephrine synthetic enzymatic activity, i.e., tyrosine hydroxylase (Dailey
and Jobe, 1986) and dopamine- -hydroxylase (Browning et al., 1989a; Lauterborn and Ribak,
1989), reduced serotonin synthetic enzymatic activity, i.e., tryptophan hydroxylase (Statnick et al.,
1996), and a reduced capacity for norepinephrine (Browning et al., 1989b) and serotonin uptake
(Statnick et al., 1996) in many areas of the CNS.
Though not as thoroughly investigated at this point, there are a number of regions in the
brain which also exhibit deficits in GABAergic neurotransmission. Electrophysiological studies
in the inferior colliculus (Faingold et al., 1986a,b), cerebral cortex (Waterhouse., 1986), cerebellum
(Gould et al., 1991, 1995), striatum (Lasley et al., 1989), and the hippocampus (Browning et al.,
1986) have consistently reported reductions in sensitivity to GABA. In each case, a two- to fivefold reduction in sensitivity has been reported. Importantly, this is a feature which the GEPRs share
with a number of other epilepsy models (Gale, 1989, 1992; DeDyn et al., 1990; Houser, 1991; Jobe
et al., 1991; Snodgrass, 1992). Furthermore, there is evidence for reduced effectiveness of
GABAergic transmission in a large variety of human epilepsies (Delgado-Escueda et al., 1986;
Houser, 1991; Richens, 1992) and many of the therapeutic agents currently being employed to treat
the epilepsies function to facilitate GABAergic transmission (Richens, 1992).
Due to a number of factors, the cerebellum is a very attractive area of the brain in which to
further investigate the possible presence and mechanism of deficits in GABAergic transmission in
the GEPR. First, the fundamentals of physiological GABAergic transmission in the cerebellum
have been well characterized. The characteristics of the postjunctional receptors for this transmitter
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in normal rats have been intensely investigated and have provided a sound basis from which
hypotheses can be formed and conclusions can be made regarding the role of GABA in neuronal
function. The reason that the GABAergic system has been so well characterized in the cerebellum
is due, primarily, to the other factors which make the cerebellum a desirable region of the brain to
study. The cerebellum is an evolutionarily conserved structure in which the anatomy, physiology,
and pharmacology have been extensively characterized (see section III). In addition, it is an
attractive region of the brain in which to study development since most of the development of the
rat cerebellum occurs postnatally.
To this point, the study of the GEPR cerebellum has been mostly via extracellular recordings
obtained in situ. In these studies (Gould et al., 1991, 1995), Purkinje neurons were shown to be
subsensitive to the effects of GABA and muscimol (a GABAA-receptor selective agonist) but not
to baclofen (a GABAB-selective agonist), norepinephrine, or glutamate, indicating that the
subsensitivity is at least relatively specific for GABAA-receptor activation. Radioligand binding
studies in cerebellar homogenates, however, provided no evidence of a change in the cerebellar
binding characteristics of [3H]-muscimol or [3H]-flunitrazepam (Gould et al., 1995), each of which
targets different sites on the GABAA-receptor complex (see section IV).
One inherent disadvantage of using the cerebellum as a brain region of investigation in the
study of epilepsy is its highly inhibitory nature. The vastly inhibitory architecture of the cerebellum,
which will be more thoroughly described in the following section (section III), prohibits its direct
participation in seizure activity. That is, though the cerebellum may have altered discharge patterns,
it does not display the characteristic synchronous, paroxysmal discharge typical of cerebral cortical
neurons during seizure activity. Thus, evidence of factors which might contribute to seizure
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predisposition obtained via investigation of the cerebellum is somewhat indirect evidence.
However, it should be remembered that in order for an animal to be inherently prone to a
generalized seizure, many populations of neurons are presumably deficient in their ability to inhibit
seizure activity. Therefore, the wide spread change(s) which affect cortical neurons are likely to be
present in neurons of the cerebellum as well. Furthermore, in an animal which has no other
apparent abnormalities, cellular changes evident in the cerebellum could quite likely be
representative of alterations that exist in various other brain regions.
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III. THE CEREBELLUM
In an attempt to paint a precise and accurate picture of the cerebellum which can be readily
followed by those of various backgrounds, general features of the cerebellum will first be described,
followed by more specific discussion of the pertinent features of the cellular anatomy, physiology,
and pharmacology. Many of the general features of the cerebellum, except where referenced, come
from textbook type sources including Adelman (1987), Carpenter (1991), Cooper et al. (1991), Ito
(1984), and Kandel et al. (1991). Once this general overview of the cerebellum has been presented,
a relatively detailed description of the postnatal development of this structure will be developed.
This discussion will be broken down into subtopics to facilitate easier reference to specific points
of interest. Though, as will be discussed later, this study deals primarily with the development and
responsiveness of only the Purkinje neurons of the cerebellum, it will prove useful to have a solid
understanding of all the major constituents of the cerebellum as they have important interactions
and play integral roles in regulation of both the development and responsiveness of Purkinje
neurons. Lastly, it should be reiterated that references to the size and number of structures, timing
of developmental events, and other such features will be descriptive of the rat cerebellum unless
otherwise noted as this is the animal model which has been employed for these studies.
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A. Drawing of one half of a rat cerebellum depicted
from a caudal to rostral perspective. The numbers
indicate: (1) vermis; (2) colliculus caudalis; (3)
lateral cerebellar hemisphere; (4) flocculus; (5)
paraflocculus.

B. Drawing of a mid-saggital section of the
cerebellum. The white area approximates the white
matter and the Roman numerals indicate lobules
with each small fold representing numerous folia.

C. Drawing of a single folium of the cerebellum,
illustrating the three layers of the cerebellar cortex
as well as the white matter. Abbreviations indicate:
(ML) molecular layer; (PcL) Purkinje cell layer;
(GcL) granule cell layer; (WM) white matter.

FIGURE 1. Series of three drawings depicting the external structure of the rat cerebellum
(A), a mid-saggital section of the cerebellum (B), and a folium from within the cerebellum (C).
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A. Basic Features
The cerebellum occupies the majority of the posterior cranial fossa, overlying the posterior
aspects of the pons and medulla, and extending laterally beneath the tentorium cerebelli. It
constitutes only about 14% of the total volume of the human brain (Inukai, 1928) yet contains more
than half of its total number of neurons. Its main function is to indirectly regulate movement and
posture by acting as a type of comparator which compensates for errors in movement by comparing
intention with performance and then adjusting the output of the major descending motor systems
of the brain. Though the relative size of the cerebellum has increased dramatically through
evolution, the basic structure and wiring have been remarkably preserved (Eccles et al., 1967a,b;
Larsell, 1967; Palay and Chan-Palay, 1974; Ito, 1984). Structurally, the cerebellum consists of a
superficial gray mantle (the cerebellar cortex), an internal white mass (the medullary substance), and
four pairs of intrinsic nuclei (fastigial, globose, emboliform, dentate) which are embedded in the
white matter.
As seen in Figure 1A, the cerebellum is divided into three main portions, a medial part (the
vermis) and two lateral lobes (the hemispheres) as well as the flocculonodular lobe and the
colliculus caudalis. These are connected to the lower segments of the brainstem by three pairs of
cerebellar peduncles, the inferior, superior, and middle cerebellar peduncles, which contain all
efferent and afferent fibers passing to and from the cerebellum. The inferior cerebellar peduncles
connect the cerebellum to the medulla and contain two divisions, the restiform body and the
juxtarestiform body.

The restiform body is primarily composed of dorsal- and rostral-

spinocerebellar tracts, the cuneocerebellar tract, as well as the olivocerebellar tract.

The

juxtarestiform body contains primarily vestibulocerebellar and cerebellovestibular fibers. The
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middle cerebellar peduncles, which connect the cerebellum to the pons, are also known as the
brachium pontis and contain the pontocerebellar fibers. The superior cerebellar peduncles contain
the majority of the cerebellar output pathways and are also called brachium conjunctivum. The
tracts which they contain include the dentatorubral, dentatothalamic, ventral spinocerebellar,
interpositorubrothalamic, fastigiothalamic, and fastigiovestibular tracts as well as the
trigeminocerebellar and ceruleocerebellar fibers.
The entire cerebellar cortex is a uniform, laminated structure throughout and is composed
of three transversely oriented layers which are folded into a large number of narrow leaf-like
laminae known as folia (see Figures 1B and 1C). The outermost layer, known as the molecular
layer, contains two major cell types: basket cells and stellate cells. Other major components of the
molecular layer include the beautiful, fan-like dendritic arborizations of the Purkinje neurons, the
axons of granule cells (termed parallel fibers), and the dendrites of Golgi type II cells. The middle,
Purkinje cell layer of the cortex is named after its primary constituents, the somata of Purkinje
neurons. The innermost layer, or granular layer, contains an abundance of small, tightly packed
granule cells along with Golgi type II cells, cerebellar glomeruli, and sparse numbers of other cells
such as unipolar brush cells and Lugaro cells (Mugnaini et al., 1997; Slater et al., 1997).
The essential functional design of the cerebellum comes in the form of an interaction
between the neurons of the cerebellar cortex and the cerebellar nuclei. Major afferent fibers to the
cortex come in two varieties, climbing fibers and mossy fibers, and the sole efferent output of the
cerebellar cortex is the axons of the Purkinje neurons which primarily target the cerebellar nuclei.
These cerebellar nuclei, which also receive collateral inputs from the incoming climbing and mossy
fibers, then project to other brain regions. In general, the deep cerebellar nuclei maintain a tonic,
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high-frequency, excitatory discharge which is inhibited by the GABAergic projections of the
Purkinje neurons.

B. Neuronal Elements
As mentioned, cerebellar afferents are of two types, climbing fibers and mossy fibers. In
mammals, all climbing fibers originate from a single nucleus of the brainstem, the inferior olivary
nucleus (Desclin, 1974, 1976; Courville and Farco-Cantin, 1978; Campbell, 1980; Montarolo et al.,
1980; Campbell and Armstrong, 1983a,b). Projections to the inferior olive originate in the spinal
cord, motor cortex, brainstem, and cerebellar nuclei. The climbing fibers are only thinly myelinated
with a diameter of 1-3 µm. As they enter the innermost granular layer of the cerebellar cortex, these
fibers lose their myelin and then arborize into long branches which ascend through the cerebellar
cortex giving off numerous collaterals (Scheibel and Scheibel, 1954). Though some of these
collaterals terminate in the granular layer, the vast majority eventually terminate on the trunk and
smooth dendrites of Purkinje neurons in the molecular layer (O’Leary et al., 1971; Palay and ChanPalay, 1974). While the branching of these fibers is very expansive across a folium, or convolution,
it is quite minimal along an individual folium, thus restricting these branches to a single plane.
Mossy fibers, on the other hand, are both larger and more numerous than the climbing fibers and
constitute the major afferent input to the cerebellum. Unlike climbing fibers, mossy fibers originate
from neurons located in a variety of regions within the central nervous system, including, the
pontine nuclei, the spinal cord, the reticular formation, the cerebellar nuclei, and the vestibular
nuclei. Mossy fibers also branch repeatedly along both planes of the cerebellum so that an
individual fiber may terminate extensively within an individual folium as well as across many folia.
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As these fibers enter the granular layer, they too lose their myelination, branch, and subsequently
terminate in as many as 44 large, mossy-like arborizations, or rosettes, from which their name was
derived.
Purkinje neurons, the sole output neurons of the cerebellar cortex, are arranged with their
cell bodies lying in a single folded sheet. Each of these cell bodies, with a diameter of 20-40 µm
(Inukai, 1928; Mugnaini, 1972), gives rise to a single, large (.10 µm) dendritic trunk directed
toward the pial surface. This dendrite subsequently gives rise to numerous primary, secondary, and
tertiary branches. Though the primary and secondary branches are typically smooth, the small
tertiary branches are richly invested with spines, with a single Purkinje cell having approximately
100,000 such spines in the molecular layer. The axons of Purkinje cells proceed centrally through
the granular layer, give off numerous recurrent collaterals which are typically restricted to the folium
of origin, become myelinated, course through the cerebellar white matter, and terminate in the
cerebellar nuclei (McCrea et al., 1976).
There are four such cerebellar nuclei on each side of the midline. From medial to lateral
these are termed the fastigial, globose, emboliform, and dentate nuclei. The fastigial nuclei, which
lie near the midline in the roof of the fourth ventricle, receive input from Purkinje cells in the vermis
of the cerebellar cortex. The fastigial nuclei send projections to the pons, the spinal cord, the
vestibular nuclei, and the ventral thalamic nuclei. Appearing continuous in lower mammals, the
globose and emboliform nuclei are collectively termed the interposed nuclei and receive their
afferents from Purkinje cells in the paravermis of the cerebellar cortex, which is that portion of the
cortex immediately adjacent and just lateral to the vermis. The largest of the cerebellar nuclei, the
dentate nuclei, receive the axons of Purkinje neurons in the lateral portion of the cerebellar
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hemispheres. These hemispheres are the large, lateral regions of the cerebellar cortex (see Figure
1A). The dentate and interposed nuclei project primarily to the ventral thalamic nuclei and the red
nucleus.
Intrinsic neuronal elements of the cerebellum other than the deep cerebellar nuclei and
Purkinje neurons include granule cells, Golgi cells, basket cells, and stellate cells. Granule cells,
located in the granular layer, have relatively small cell bodies (5-8 µm) and give rise to
approximately 3-5 dendrites which are no more than 30 µm in length before terminating in a
clawlike expansion (Palkovits et al., 1971). It has been estimated that there are as many as 1011
granule cells in the human cerebellum, more cells than are found in the entire cerebral cortex
(Jacobsen, 1991). The thin (#1 µm) axon of each of these granule cells ascends several hundred
micrometers, past the Purkinje cell layer, into the molecular layer where it bifurcates in a T-shaped
fashion. This bifurcation yields two branches that run horizontally in opposite directions through
the length of the molecular layer. Running parallel to the long axis of the folium, these axonal
branches are termed parallel fibers. This particular orientation in the folium situates these fibers
perpendicular to the large dendritic arborizations of the Purkinje cells, allowing each granule cell
to interact with the spiny processes of numerous such dendritic trees along their course as well as
allowing each Purkinje cell to receive synapses from hundreds of thousands of granule cells
(Larramendi and Victor, 1967; Chan-Palay and Palay, 1970).
The Golgi cells of the rat cerebellum come in two varieties, large and small, with somal
diameters of 9-16 µm and 6-11 µm, respectively (Jakob, 1928; Palay and Chan-Palay, 1974). The
larger cells are located primarily in the upper portion of the granular layer, directly adjacent to the
Purkinje cell layer, whereas the smaller cells tend to occupy the lower half of the granular layer.
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Regardless of the type of Golgi cell, the large dendrites of these cells are scattered throughout the
cerebellar cortex, accepting input from parallel fibers, mossy fibers, and climbing fibers. For the
most part, the axons of Golgi cells extend only slightly into the granular layer, branch repeatedly,
and subsequently terminate upon granule cell dendrites in clusters called cerebellar glomeruli.
These glomeruli are a complex synaptic structure with three primary participants, the dendritic
terminals of as many as twenty granule cells, one mossy fiber terminal rosette, and the terminals of
Golgi cell axons. Thus, two types of presynaptic fibers (from Golgi cells and mossy fibers) enter
into a complex with one postsynaptic element (granule cell dendrites). This configuration of
synapses allows the Golgi cell to function as a negative feedback control of mossy fiber to granule
cell signaling.
The basket and stellate cells are the primary interneurons of the cerebellum. Both are located
in the molecular layer, with basket cells residing in the deeper third of this layer (closest to the
Purkinje cell layer) and stellate cells tending to occupy the outermost two-thirds of the molecular
layer. In the molecular layer both receive input from the parallel fibers of granule cells. Basket cells
have branching dendrites which are oriented parallel to the Purkinje dendritic trees, thus
perpendicular to the parallel fibers, and give rise to an axon which, during its course, gives off
numerous branches. Each of these axonal branches, as many as ten per basket cell, entwines around
the soma of neighboring Purkinje neurons in a basket-like form which gives them their name.
Stellate cells, on the other hand, tend to be larger as one moves from the outermost granular layer
toward the Purkinje cell layer, typically have a few radial dendrites, and possess a short axon
parallel to the dendritic fields of the Purkinje neurons.
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C. Functional Divisions
Functionally, the cerebellum is broken down into three divisions, including the
vestibulocerebellum, spinocerebellum, and the cerebrocerebellum (see Figure 2).

The

vestibulocerebellum, so named by Angaut and Brodal (1967), is made up of the flocculonodular
lobes of the cerebellum. The flocculonodular lobe (or flocculus) is a small part of the cerebellum
which is separated from the larger main body (see Figure 1A), containing the vermis and
hemispheres, by the posterolateral fissure. The vestibulocerebellum receives its name from the main
source of its direct input, the vestibular nuclei. The vestibular nuclei relay information concerning
head position from the semicircular canals and the orientation of the head from the otolith organs.
Through its reciprocal connections back to the vestibular nuclei, the flocculonodular lobe
participates in the control of equilibrium, the control of axial and proximal limb muscles which are
used to maintain balance, and the coordination of movements of the head and eyes. To further aid
in the regulation of these functions, visual information from the lateral geniculate nucleus, superior
colliculus, and striate cortex is relayed via the pontine nuclei to the vestibulocerebellum.
The spinocerebellum is composed of the vermis and the intermediate, most medial portions
of the hemispheres. As can be deduced from its name, the primary input to this region is from the
spinal cord via the spinocerebellar tracts, though afferents from the auditory, visual, and vestibular
systems also converge upon Purkinje neurons in these portions of the cerebellar cortex. The
spinocerebellar tracts are mossy fiber pathways which convey somatic sensory information to the
cerebellar cortex directly from the spinal cord, resulting in two complete somatosensory maps of the
body in the cerebellum. Whereas the dorsal- and ventral-spinocerebellar tracts project information
for the trunk and lower extremities, the cuneo- and rostral-spinocerebellar tracts present the
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cerebellum with information regarding the upper extremities and neck. This information is then
relayed, processed and affects Purkinje neurons, that project to the fastigial and interposed nuclei.
The fastigial nucleus then projects bilaterally to the brainstem reticular formation and the lateral
vestibular nuclei which subsequently send efferents back to the spinal cord. There are also
projections from the fastigial nucleus to the primary motor cortex via the contralateral ventrolateral
nucleus of the thalamus. Through these projections, the fastigial nucleus is able to regulate the
ongoing movements of axial and proximal musculature. The interposed (i.e., globose and
emboliform) nuclei, on the other hand, aid in the coordination of distal limb movement via
projections to the magnocellular portion of the contralateral red nucleus. The red nucleus relays this
information to the ventrolateral nucleus of the thalamus and then on to the limb areas of the motor
cortex.
The remaining lateral portions of the cerebellar hemispheres collectively make up the
cerebrocerebellum. The cerebrocerebellum indirectly receives information from sensory, motor,
premotor, and posterior parietal cortices via contralateral projections from the pontine nuclei.
Purkinje neurons of the lateral hemispheres then project to the dentate nucleus which sends its
efferent fibers to the contralateral ventrolateral nucleus of the thalamus. Projections from the
ventrolateral nucleus of the thalamus to the motor and premotor regions of the cerebral cortex enable
the dentate nuclei to be involved with the planning and initiation of limb movements. The dentate
nuclei also project to the parvocellular portion of the red nucleus which relays this information back
to the cerebellum, primarily via the ipsilateral inferior olivary nucleus.
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FIGURE 2. Depictions of the vestibulocerebellar (A), cerebrocerebellar (B), and
spinocerebellar (C) pathways. Abbreviations: (CL) Contralateral; (BL) Bilateral; (ICP)
Inferior cerebellar peduncle; (MCP) Middle cerebellar peduncle; (SCP) Superior cerebellar
peduncle; (CBT) Corticobulbar tract; (RST) Rubrospinal tract; (LCST) Lateral corticospinal
tract; (VCST) Ventral corticospinal tract; (VSTs) Vestibulospinal tracts; (SCTs)
Spinocerebellar tracts. An X indicates that the pathway decussates during its course from one
structure to the other.
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D. Circuitry
Although a more thorough description and discussion of the pharmacology will be
considered later in this manuscript, it is prudent at this point to describe some of the basic
neuropharmacology of the cerebellum in order to aid the understanding of cerebellar circuitry and
the transmitters which are involved in information processing. One easy way to think about the
transmitter function of the cerebellum is that it is intrinsically composed of inhibitory cells, except
for the granule cells. Purkinje neurons, Golgi cells, basket cells, and stellate cells all possess
inhibitory actions mediated by GABAergic projections. Granule cells, on the other hand, are
excitatory and employ glutamate as their transmitter. Similarly, both main afferent pathways to the
cerebellum are excitatory. The majority of mossy fibers use glutamate, whereas aspartate is the
primary neurotransmitter of climbing fibers, though there are relatively minor numbers of both
mossy fibers and climbing fibers which utilize serotonin or monoamines. Finally, the cerebellar
nuclei are also excitatory, using either glutamate or aspartate as their transmitter.
The basic circuitries of the cerebellar cortex may be described as two input circuits, via
mossy fibers and climbing fibers, and a sole output circuit, via Purkinje neurons (see Figure 3). The
mossy fiber circuit is best understood by breaking it down into smaller units. Upon stimulation of
a small group of excitatory mossy fibers, granule cells are activated. The granule cells subsequently
excite all other neuronal types in the cerebellum. Via their parallel fibers, granule cell axons
activate Purkinje
neurons, stellate cells, and basket cells. Additionally, in the cerebellar glomeruli, Golgi cells are
activated via the dendrites of granule cells. It is the location and temporal relationships of these
interactions which produce the interesting array of effects that follow mossy fiber stimulation. The
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activation of Purkinje neurons via the parallel fibers is quickly inhibited to some extent by
neighboring basket and stellate cells which are simultaneously activated by the same fibers.
However, because of the axonal orientation of these inhibitory interneurons, adjacent Purkinje
neurons which are not activated by the parallel fibers are strongly inhibited by the newly active
interneurons. Such “off-beam” inhibition functions to strengthen the signal by sharpening the
distinction between those Purkinje neurons which have been activated and those which have not.
At the same time, there is a negative feedback loop, via the activation of Golgi cells, which limits
the effect of granule cell activation. Thus, the overall outcome of mossy fiber stimulation tends to
be a brief, but relatively large and sharply defined, activation of firing from a discrete population
of Purkinje neurons.
Compared to the mossy fiber circuitry, the climbing fiber circuit is much simpler. In mature
mammals, a single Purkinje neuron is contacted by only one climbing fiber, though a single
climbing fiber may contact up to ten Purkinje neurons. Furthermore, this connection is one of the
most powerful excitatory contacts in the mammalian nervous system (Eccles et al., 1966) and acts
as an all-or-none excitatory connection. Climbing fibers also activate Golgi cells which function
to inhibit input from mossy fibers, as described above. Thus, upon stimulation of a group of
climbing fibers, Purkinje cells are dominated by the climbing fiber input and produce prolonged
bursts of high-frequency activity known as complex spikes (Thach, 1968, 1970). Thus, in either
case, stimulation of climbing fibers or of mossy fibers, an increase in Purkinje neuron activity is
observed.
This brings us to the third circuit of the cerebellum, the output circuit. Afferents which
activate Purkinje neurons also activate cells of the deep nuclei since collaterals of both climbing
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fibers and mossy fibers extend to these areas. This excitation of the deep cerebellar nuclei is then
followed, after a brief delay, by a rather powerful inhibition via the Purkinje neurons activated by
the same signal. Though there are also some interneuronal connections which come into play, the
basic depiction of a brief excitation, followed by a powerful inhibition still holds true for the output
of Purkinje neurons to the deep cerebellar nuclei.
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FIGURE 3. Diagramatic illustration of cerebellar neuronal connections and the major
transmitters involved in these connections. (+) and (-) signs indicate excitatory and inhibitory
transmission, respectively. The deep cerebellar nuclei represent the primary efferent target
of Purkinje neurons and the sole output pathway from the cerebellum. Abbreviation: (pf)
Parallel fibers.
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E. Development
This section on cerebellar development will be concerned mainly with highlighting those
events in the development process which may impact upon the responsiveness of Purkinje neurons.
However, some additional details which are, in general, important steps in cerebellar development,
will be included if they provide a benefit in developing an overall understanding of the processes
which are occurring at different stages during cerebellar development. Many of the manuscripts
referenced in this section provide far more detail than will be presented here and are recommended
reading if a more in depth understanding of this process is desired. In addition, the book by Masao
Ito (1984) entitled The Cerebellum and Neural Control is a particularly useful source for a general
understanding of all the development processes in the cerebellum. Finally, as a reminder, the time
frames depicted for developmental events to occur in the following discussion are described for the
rat unless otherwise indicated. However, it should be noted that the development of the cerebellar
cortex proceeds in a similar manner, though at somewhat different rates, among various vertebrates,
including man. Postnatal ages will be indicated with a ‘P’ and embryonic ages with an ‘E’ such that
P0 will represent the day of birth, P7 will represent the seventh postnatal day of life, and E7 will
represent the seventh embryonic day. A basic summary of the following descriptions are pictured
in Figure 4 and listed as a timeline in Table 2 at the end of this section.
In general, the stage of development of the cerebellum at birth can be correlated with the
animal’s powers of locomotion and motor coordination such that precocial animals tend to have a
more developed cerebellum at birth than do altricial animals (Jacobsen, 1991). Furthermore, the
birth process itself plays no part in triggering the postnatal events of cerebellar neurogenesis and
morphogenesis such that artificially shortening or prolonging the gestational period does not appear
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to affect the time at which these events occur (Zagon, 1975). The histogenesis of the cerebellar
cortex occurs from well defined germinal zones which give rise to the different types of neurons in
a predictable manner.
For Purkinje neurons, development occurs in essentially three phases. The initial, embryonic
stage of this development occurs as the rhombic lip of the fourth ventricle gives rise to the deep
cerebellar nuclei, Purkinje neurons, and Golgi cells during the second and third weeks of gestation,
with Purkinje neurons originating between E12 and E17 (Das and Nornes, 1972; Altman and Bayer,
1978). This is followed by the formation of granule cells, stellate cells, basket cells, and some glial
cells from another germinal zone, the external granular layer, which is found immediately beneath
the pia covering the cerebellar plate. By E24 the Purkinje neurons complete their migration to what
then becomes the Purkinje cell layer (Addison, 1911; Daduone, 1966). Initially, however, the cell
bodies stack in an immature pattern of up to twelve cells deep. Even before the Purkinje neurons
attain their adult alignment of a single row pattern, the earliest synaptic contacts to these newly
formed Purkinje neurons occur in the form of climbing fiber axons. This synaptic contact first
becomes anatomically apparent on E27 (O’Leary et al., 1971) though functional climbing fiber
activation of Purkinje neurons has been found no earlier than P3 (Woodward et al., 1971; Crepel,
1972; Shimono et al., 1997). Just prior to P0, the Purkinje neurons enter the second stage of their
development.
The second stage of Purkinje neuron ontogenesis is the process by which the cell bodies
become aligned into a monolayer and subsequently sprout the axons which ultimately form synaptic
connections with the deep cerebellar nuclei. This process is completed by P4 (Addison, 1911;
Altman 1972a,b; Altman and Winfree, 1977) though few functional synapses with the Purkinje
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neurons have yet formed (Altman, 1972a,b). At birth (P0), the cytological organization of the
inferior olivary nucleus, which gives rise to the climbing fibers, is well established (Altman and
Bayer, 1978), but the level of spontaneous activity of these cells is very low (Mariani and Changeux,
1981b). However, just hours after birth, extracellular recording of Purkinje neurons reveals that
spontaneous action potentials can already be observed (Woodward et al., 1969), and by P1
antidromic activation of Purkinje cells is observed upon white matter stimulation (Shimono et al.,
1997). During P1-P2, Purkinje neurons also develop regular, sustained activity (Woodward et al.,
1969) and become sensitive to iontophoretically applied GABA, norepinephrine (Woodward et al.,
1969, 1971), glutamate, aspartate, and quisqualate (Dupont et al., 1987).
Also during this period (P0 to P5), a small portion of granule cells begin their migration
from their original position in the external granular layer (Hager et al., 1995), though most will not
begin this process for another week. The external granular layer is a germinal zone lying beyond
the molecular layer (see above) which disappears as the granule cells migrate toward their mature
position in the (internal) granular layer. Such a migration requires that the granule cells traverse
both the molecular and Purkinje cell layers. They do so in radial pathways as their newly forming
axons, which will later become parallel fibers, trail behind them, occupying the full length of
distance through which these cells migrate. Finally, during the first five postnatal days, climbing
fiber afferents begin to wrap profusely around Purkinje neuron somata. Unlike the mature pattern
where each Purkinje neuron receives afferents from only one climbing fiber, neonatal Purkinje
neurons may receive afferents from three to four climbing fibers beginning on P3 (Crepel et al.,
1976; Mariani and Changeux, 1981a).
The third period of ontogenesis, when a single apical dendrite first emerges from the
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Purkinje neuron soma, extends toward the pial surface, and branches repeatedly, occurs from P5 to
P30. During this period, there are numerous developmental events which occur as the Purkinje cells
mature, many over similarly protracted periods of time. For this reason, these events will be
organized and discussed based upon the day which they occur, or start to occur. On P5 mossy fibers
start to enter the cerebellum (Altman, 1972b), redundant innervation of Purkinje neurons by
climbing fibers reaches a maximum of approximately 3.57 climbing fibers per Purkinje neuron
(Mariani and Changeux, 1981a,b), and Purkinje neurons extend abundant, temporary perisomatic
processes (Altman, 1972a). From P5-P8, these perisomatic processes are contacted by climbing
fibers (Altman, 1972a), and a substantial number of granule cell axons begin to extend horizontally
along the long axis of the folium from their outermost tip to form the parallel fibers (Hager et al.,
1995).
The next few days of postnatal development likewise bring numerous changes. On days P6
and P7 the vast majority of inhibitory basket cells form, though synaptic contacts between them and
neighboring cells have yet to develop (Altman, 1972a). On P7, spontaneous climbing fiber bursts
appear, as well as coincident high-frequency discharges of Purkinje cells (Woodward et al., 1969).
Furthermore, from P7 to P10, the cellular mechanisms necessary for the rhythmical and
synchronized discharge of inferior olivary neurons, which give rise to the climbing fibers, is
established (Mariani and Changeux, 1981b). Also on P7, glial processes begin to ensheath parts
of the Purkinje cell soma (Altman, 1972a), increasing numbers of climbing fiber synapses onto
Purkinje perisomatic processes are seen (Altman, 1972a), and action potentials in the parallel fibers
of granule cells appear (Shimono et al., 1997). From P8 to P11, stellate cells will originate, though
synapses will not begin to occur for a few more days (Altman, 1972a). At the same time, parallel
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fiber synapses begin to form with the previously formed basket cells (Altman, 1972a). From P8 to
P14, the majority of granule cells will have begun their radial descent through the molecular and
Purkinje cell layers (as described above) with the peak in this movement occurring on P10 to P11
(Altman, 1972b). During this same period (P8-14), the temporary perisomatic processes of Purkinje
somata start to disappear (Altman, 1972a; Berry and Bradley, 1976) and the number of redundant
innervations of Purkinje neurons by climbing fibers begins to decline (Mariani and Changeux,
1981b).
The next six days, P10 to P15, are days during which many of the neuronal and synaptic
elements of the cerebellum begin to rapidly mature. During this period, the Purkinje neurons begin
showing an increase in spontaneous firing rates (Crepel, 1972), a decrease in spike duration, and
a shift from regular to irregular discharge patterns (Woodward et al., 1969). The development of
this mature pattern of spontaneous activity (Crepel, 1972) results from both endogenous properties
of autorhythmicity (Llinas and Sugimori, 1980a,b) and synaptic activation of the Purkinje cells
through their main afferents (Puro and Woodward, 1977). Concomitantly, the Purkinje neuron
dendrites grow almost exclusively in the lateral domain, reaching their mature width on P15 (Berry
and Bradley, 1976). On P10 immature basket cell axon terminals are first seen to establish synapses
on Purkinje cell soma (Altman, 1972a), the mossy fiber-granule cell synapses become functional
(Larramendi, 1969; Mugnaini, 1969; Altman, 1972b; Shimono et al., 1997), and Golgi cell
inhibition of granule cells is observed (Shimono et al., 1997). By P12, nearly all of the Purkinje
soma is ensheathed by glial processes (except at synaptic boutons) and the perisomatic processes
are greatly reduced (Altman, 1972a). One point of discrepancy in the literature during this period
of development concerns the formation of parallel fiber synapses with Purkinje dendritic spines.
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Although it appears in anatomical studies that these synapses do not occur until P15 (Altman,
1972a), electrophysiological evidence indicates that such synapses are functional as early as P10
(Woodward et al., 1969; Shimono et al., 1997).
On P15 more of the mature, adult characteristics of Purkinje neurons become evident. The
somata has both an adult appearance (Altman, 1972a) and size (Jacobsen, 1991), the redundant
innervation by climbing fibers is absent (Mariani and Changeux, 1981a,b; Jacobsen, 1991), and the
glial sheathing has extended to secondary and tertiary dendrites in the lower molecular layer
(Altman, 1972a). Also on P15, lower stellate cells begin forming their inhibitory contacts with
outgrowing Purkinje cell dendrites (Altman, 1972a), Golgi cells have matured (Altman, 1972b),
Purkinje cell dendrites begin growing primarily in the vertical domain toward the pial surface (Berry
and Bradley, 1976), and the development of cerebellar glomeruli begins to increase (Altman,
1972b,c) as the bulk of the granule cells are formed (Altman, 1969). On P21 the inferior olivary
nucleus reaches an adult level of activity (Mariani and Changeux, 1981b), which represents a tenfold increase over that observed at birth, as the formation of Purkinje dendritic spines has spread
upward to about the middle of the molecular layer. Finally, the Purkinje cell dendritic tree reaches
its maximum vertical height on P30 (Berry and Bradley, 1976) though the dendrites will continue
to increase in size through P110 (Jacobsen, 1991).
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P3

P7

P10

P15

P21

FIGURE 4. Schematic illustrating the postnatal development of the rat cerebellum. The stage of
development is indicated below each section (in postnatal days). Letters represent: Purkinje neuron
(P); climbing fiber (CF); basket cell (bc); granule cell (Gc); parallel fiber (Pf); stellate cell (Sc);
Golgi cell (G); mossy fiber (MF).
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TABLE 2. Timeline of major developmental events for the rat cerebellum focusing upon the
Purkinje neurons and those events which directly impact upon them. References for specific events
are indicated in the text (IIIE).
DAY(S)
E12-17

Developmental Event
-Purkinje neurons are formed

P0

-Cytological organization of the inferior olivary nucleus is well established but the
level of spontaneous activity is low
-Purkinje neuron extracellular action potentials are observed as early as several hours
after birth

P1

-Antidromic action potentials in Purkinje neurons following white matter stimulation
is observed
-Regular, sustained activity of Purkinje neurons first seen
-Purkinje neurons are sensitive to iontophoretically applied GABA and
norepinephrine

P3

-Climbing fiber excitation of Purkinje neurons observed

P4

-Purkinje neurons have formed a monolayer with few or no synapses

P5

-Mossy fibers are seen
-Multiple innervation of Purkinje neurons by climbing fibers first observed at P3 is
maximal, approximately 3.5 climbing fibers per Purkinje neuron
-Purkinje neurons have abundant transient perisomatic processes with occasional
climbing fiber synapses

P6-7

-Origination of basket cells

P7

-Glial processes begin to ensheath Purkinje neuron soma
-Increase in the number of climbing fiber synapses on Purkinje neuron perisomatic
processes
-Action potentials in parallel fibers appear
-High frequency climbing fiber burst discharges of Purkinje neurons arise
-The rhythmical and synchronized discharge of inferior olive neurons begins to be
established

P8

-65% of Purkinje neurons are multiply innervated by climbing fibers
-Commencement of synaptogenesis and stellate cell formation in the lower molecular
layer

P9

-46% of Purkinje neurons are multiply innervated by climbing fibers with a mean
number of 1.46 climbing fiber collaterals per Purkinje neuron
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P10

-29% of Purkinje neurons are multiply innervated by climbing fibers
-Activation of Purkinje neurons by parallel fiber stimulation observed
-Functional mossy fiber-granule cell synapses
-Golgi cell inhibition of granule cells appears
-Disappearance of Purkinje neuron perisomatic processes
-Basket cell synapses with Purkinje neuron soma begin to form and continues for a
few days

P10-15

-Increase in spontaneous firing rates, a decrease in spike duration (P12-14), and a
shift from regular to irregular discharge patterns in Purkinje neurons

P12

-Essentially the entire Purkinje neuron soma not covered with boutons is ensheathed
with glia
-Mossy fiber terminals are seen in small numbers but are immature with few
synapses formed
-Cerebellar glomeruli first seen and formation continues for more than 30 days

P15

-Purkinje neuron soma have an adult-like appearance
-Parallel fibers form synapses with the outgrowing dendritic spines of Purkinje
neurons and lower stellate cells
-Redundant innervation of Purkinje neurons by climbing fibers disappears
-Glial sheathing has extended to the secondary and tertiary dendrites in the lower
molecular layer
-Golgi cells are mature in appearance
-Granule cells extend dendrites
-Cerebellar glomeruli are small and few in number
-Purkinje neuron dendritic tree growth shifts from the lateral to the vertical plane

P15-21

-Purkinje neuron dendrites arborize with outgrowth of secondary and tertiary
branches coupled to the formation of parallel fiber synapses with them

P21

-Inferior olive neurons reach adult level of activity (ten-fold increase since birth)
-Purkinje neuron dendritic spines spread upward to the middle of the molecular layer

P30

-Height of the Purkinje neuron dendritic tree has reached adult level

P110

-Entire growth of Purkinje neurons is complete
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IV. THE GABAA-RECEPTOR
-Amino butyric acid (GABA), the most abundant neurotransmitter in the mammalian brain,
exerts its actions via three subsets of GABA receptors termed GABAA-, GABAB-, and GABACreceptors. Whereas GABAA- and GABAC-receptors are ligand-gated ion channel receptors, the
GABAB-receptor is of the seven transmembrane, G-protein coupled receptor family. Of these three
receptor subtypes, it is the GABAA-receptor which mediates the principal fast synaptic inhibitory
transmission and is of particular interest here. For this reason, the following discussion will focus
primarily upon this group of receptors.

A. GABAA-Receptor Structure and Composition
As stated above, the GABAA-receptor is a member of the superfamily of ligand-gated ion
channel receptors and consequently shares many structural and functional similarities with the other
members of this superfamily which also includes the nicotinic acetylcholine receptors, the
strychnine-sensitive glycine receptors, and the serotonergic 5-HT3 receptor (Boulter et al., 1987;
Grenningloh et al., 1987; Schofield et al., 1987). The basic structure of these receptors is that of
a pentameric pseudosymmetrical transmembrane structure surrounding a central pore (Seeburg et
al., 1990; Nayeem et al., 1994). Each of the five subunits is composed of a large N-terminal
extracellular domain thought to mediate ligand interactions, four transmembrane spanning domains
(M1-M4) with a large intracellular loop containing consensus sites for phosphorylation (in some
subunits) between transmembrane segments M3 and M4, and an extracellular C-terminal domain
(Betz, 1990; Galzi and Changeux, 1994; Macdonald and Olsen, 1994; Barnard, 1995; Möhler et
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al., 1995). The M2 transmembrane regions (second from the N-terminus) of each subunit form the
lining of a central chloride channel pore, providing the environment needed for the passage of select
ions, namely Cl- and HCO3- (Unwin, 1993).
To date, at least fifteen different GABAA-receptor subunit isoforms from five distinct
families have been cloned from the mammalian central nervous system, including
and
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(Whiting et al., 1990; Bateson et al., 1991; Kofuji et al., 1991; Harvey et al., 1994; Korpi et al.,
1994). Of these subunit isoforms, only the two subunits are found predominantly outside of the
brain. These subunits, primarily located in the retina (Cutting et al., 1991), combine only with other
subunits in vivo and thus form a subset of GABAA-receptors with unique enough characteristics
to be classified as separate receptors termed GABAC-receptors. These GABAC-receptors, however,
share only two basic traits with GABAA-receptors, binding GABA and conducting chloride ions
(Sieghart, 1995).
With such a large number of subunit isoforms, it quickly becomes obvious that there are a
vast multitude of possible receptor subunit compositions.

However, with all the possible

compositions, it appears that relatively few of these possible combinations are employed in vivo.
Although the true number of physiologically relevant GABAA-receptors and their subunit
stoichiometries are still far from being determined, in vivo, the majority of GABAA-receptors are
formed by subunit combinations consisting of, 1) 2 , 2 , and 1 , 2) 2 , 1 , and 2 , or 3) 2 , 1 , 1 ,
and 1 with the -subunit typically being of the 2-subtype in each case (Benke et al., 1991, 1994;
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Duggan et al., 1991; Pollard et al., 1991; Backus et al., 1993; Mertens et al., 1993; Barnard, 1995;
Fritschy and Möhler, 1995; Stephenson, 1995; Bohlhalter et al., 1996; Wisden et al., 1996).
Although this is by no means true for all of the GABAA-receptors, it does provide some guidelines
by which to predict which receptors might most prominently be formed when the subunit
constituents are known. This is, in turn, important based upon the fact that many aspects of
GABAA-receptor function are critically dependent on subunit composition, as will become evident
in the subsequent discussion.

B. Activation and Modulation of the GABAA-Receptor
GABAA-receptors, which require the binding of at least two GABA molecules for full
activation (Sakmann et al., 1993), have multiple conductance levels which vary slightly depending
on the subunit composition. The main conductance level of between 27 and 30 picoSiemens (pS;
Hamill et al., 1983; Sakmann et al., 1983; Macdonald and Olsen, 1994) is responsible for 95% of
the total current which flows through the chloride channel (Macdonald, 1994). Other conductance
levels of 11-12 pS, 17-19 pS, and 44 pS have also been observed with low frequency (Sakmann et
al., 1983; Macdonald and Olsen, 1994). Upon activation, the GABAA-receptor opens in a burst-like
fashion which is evidenced by openings or groups of openings separated by relatively long closed
periods (Colquhuon and Sigworth, 1983). With each of these bursts, chloride ions flow down their
electrochemical gradient through the pore of the channel. The rate of ion transport is, however,
limited by the binding of anions at one of two sites inside the channel (Sakmann et al., 1983).
Studies in mammalian brain tissue utilizing [3H]GABA initially revealed the existence of
high and low affinity states for GABA binding with KD values in the low and high nanomolar range,
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respectively (Olsen et al., 1981). However, more recent studies have revealed an additional very
low affinity binding site which requires micromolar concentrations of GABA to open the chloride
channel and modulate other binding sites on the GABAA-receptor complex (see below), and it is this
site at which GABA is now generally considered to exert its physiological effects (Olsen et al.,
1982; Squires et al., 1983; Segal and Barker, 1984; Kardos and Cash, 1990). The actual location
of binding sites for GABA have yet to be fully determined. Some studies have indicated that the
GABA binding sites may reside at the interface between

and

subunits, since this was the

minimal composition required for completely effective GABA-dependent chloride gating (Smith
and Olsen, 1995). However, recombinant studies employing homoligomeric channels consisting
of , , , or subunits revealed that these receptors display multiple conductance states in response
to activation by GABA (Sieghart, 1995). The results of these latter studies have been interpreted
to indicate that each subunit contains a GABA binding site, allowing for up to five such binding
sites on any given receptor (Sieghart, 1995).
In addition to being activated by GABA and GABAA-receptor selective agonists such as
muscimol, the GABAA-receptor is modulated and antagonized at numerous sites on the receptor
complex. In order to fully describe the activity of such modulators and antagonists, it is important
to understand what their “typical” action on ion conductance is, and this information will be
followed by a summary of how these “typical” actions are affected by the presence or absence of
individual subunit isoforms.
Benzodiazepines, barbiturates, and neurosteroids (and neuroactive steroids) form the major
modulatory classes of agents that interact with the GABAA-receptor. Although all of these
compounds enhance GABAA-receptor-activated chloride currents (Choi et al., 1977; Macdonald
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and Barker, 1978a,b; Callachan et al., 1987a,b), they do so via distinct mechanisms and by acting
at separate allosteric regulatory sites on the receptor complex (Study and Barker, 1981; Olsen, 1981,
1987; Twyman et al., 1989). Benzodiazepines increase GABAA-mediated current by increasing
opening frequency via an increase in receptor-ion channel coupling without altering single channel
conductance or open duration (Study and Barker, 1981; Vicini et al., 1987; Edgar and Schwarz,
1992). These ligands, which act at the appropriately named benzodiazepine site (or receptor) on
the GABAA-receptor complex, do not gate the chloride channel in the absence of GABA or GABAAreceptor agonists (Macdonald, 1994).
Barbiturates have a different modulatory effect on the channel. These compounds increase
the average open duration without altering single channel conductance amplitude (Barker and
McBurney, 1979; Study and Barker, 1981), and at higher concentrations (>50 µM) can directly gate
the GABAA-receptor chloride channel even in the absence of GABA (Bormann, 1988; Inomata et
al., 1988), indicating the existence of at least two sites of interactions for barbiturates with the
receptor complex (Sieghart, 1995). Neurosteroids and neuroactive steroids (the distinction being
that neurosteroids are endogenously synthesized de novo, primarily by glia), acting at still other sites
distinct from those mentioned above (Callachan et al., 1987b; Gee et al., 1988; Turner et al., 1989;
Morrow et al., 1990), increase both the opening frequency (Peters et al., 1988) and the average open
channel duration (Twyman and Macdonald, 1992). Like barbiturates, neurosteroids may also
produce direct opening of the channel, an effect which can be inhibited by the plant alkaloid and
GABAA-receptor antagonist, bicuculline (Callachan et al., 1987a,b). However, compared to
barbiturates, neurosteroids are much more potent as allosteric regulators of GABA A-receptor
activation (Woodward et al., 1992; Belelli et al., 1996).
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For each of these previously described sites, the GABAA-receptor, benzodiazepine,
barbiturate, and neurosteroid sites, there are also numerous synthetic ligands which act as
antagonists, partial agonists, and inverse agonists (modulatory sites only). The inverse agonists of
modulatory sites are, in simplest terms, ligands which bind to these sites but act in an opposite
manner to that of the “native” agonist. For example, a benzodiazepine inverse agonist such as Ro
15-4513 has the effect of decreasing GABAA-receptor mediated current by decreasing opening
frequency without altering single channel conductance. An identification and characterization of
many of the numerous compounds which act as agonists, antagonists, or as modulators of the
GABAA-receptor via an action at various sites on the receptor complex is summarized in Table 3.
For many of these compounds their interaction with the GABA A-receptor complex is critically
dependent upon the subunit composition of the receptor. The most well defined and characterized
of these isoform-dependent interactions for will be briefly described below.

-55-

TABLE 3. Various compounds which interact with the GABAA-receptor complex and their effects.
Effect

Compounds

References

Antagonism

Picrotoxin, Pentylenetetrazol,
Bicuculline, Bicyclic cage
compounds, Insecticides,
Zn++, Antidepressants
(amoxapine, mianserin),
Penicillin G

Yoon et al., 1993; Olsen, 1982; Bormann,
1988; Caseda, 1993; Nagata and
Narahashi, 1994; Celentano et al., 1991;
Smart, 1992; Smart and Constanti, 1990;
Squires and Saederup, 1988; Raichle et al.,
1971

Negative
modulators

Avermectin B1a, butyrolactones, Ro 5-4864
Antidepressants (amoxapine,
mianserin), Quinolones,
Arachadonic acid,
Unsaturated fatty acids

Payne and Soderlund, 1993; Holland et al.,
1993; Sieghart, 1995; Squires and
Saederup, 1988; Akaike et al., 1991;
Woodward et al., 1994; Schwartz et al.,
1988; Schwartz and Yu, 1992

Positive
modulators

Avermectin B1a, La3+,
Lanthanides, Cl-,
Chlormethiazole, Propofol,
Inhalation anesthetics,
Ethanol, Loreclezole,
Melatonin, -butyrolactones,
Dihydrogenated ergot
compounds, Substituted
pyrazinones,
Dihydroimidazoquinoxalines,
Quinolones

Payne and Soderlund, 1993; Ma and
Narahashi, 1993a,b; Olsen, 1982; Squires
et al., 1983; Drexler and Sieghart,
1984a,b; Sieghart, 1995; Schumacher and
McEwen, 1989; Moody and Skolnick,
1989; Hales and Lambert, 1991, 1992;
Concas et al., 1991; Wingrove et al., 1994;
Coloma and Niles, 1988; Holland et al.,
1993; Tvrdeic and Pericic, 1991, 1992; Im
et al., 1993; Dillon et al., 1993; Akaike et
al., 1991

Unknown
interaction

Polyamines, 1-aryl-3(aminoalkylidene)oxindoles

Sarges et al., 1989; Gilad et al., 1992
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C. The Benzodiazepine Binding Sites
Ligands acting as agonists at the benzodiazepine binding (or receptor) site allosterically
enhance GABAA-receptor function, clinically producing anxiolytic, sedative-hypnotic, and
anticonvulsant effects. In general, there are three “subtypes” of benzodiazepine sites that may be
formed within the GABAA-receptor complex. These subtypes have been termed BzI, BzII, and BzIII
sites. The BzI (or 1) pharmacological profile is considered the classical benzodiazepine receptor
and constitutes the major population of benzodiazepine binding sites in most rodent brain structures
with a particular predominance in the cerebellum (Upton and Blackburn, 1998). The BzII (or 2)
sites are prominent in only a few areas of the brain, including the hippocampus and striatum
(Benavides et al., 1993), whereas the even rarer BZIII (or diazepam-insensitive) receptor is
primarily located in cerebellar granule neurons.
For the most part, the heterogeneity of the benzodiazepine binding sites is due to the
existence of the various -subunit isoforms, although the presence of the 2-subunit is also required
for the formation of a fully functional benzodiazepine receptor site (below; Pritchett et al., 1989a,
b; Angelotti and Macdonald, 1993). In accordance with this, photoaffinity labeling experiments
indicate that the benzodiazepine binding site is located on the -subunit or at the interface between
- and -subunits (Fuchs et al., 1988; Stephenson et al., 1990). In recombinant pharmacological
and electrophysiological experiments, the

-subunit (in combination with

1

- and

x

-subunits)

2

confers the BZI receptor profile whereas the BZII receptor profile is conferred by these same - and
-subunits in combination with the

-,

2

-, or

3

-subunit isoform (Pritchett et al., 1989; Pritchett

5

and Seeburg, 1990, 1991; Wieland et al., 1992). The BZII receptors may also be further classified
according to their differential affinity for zolpidem, with
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- and

2

-containing receptors displaying

3

an intermediate affinity (compared to the high affinity of

-containing BZI receptors) and

1

-

5

containing receptors possessing a very low affinity for zolpidem (Upton and Blackburn, 1998).
Furthermore, the BzI and BzII receptors may be differentiated by their affinity for the compounds
Cl 218,872, a triazolpyridine, and the 1,4-benzodiazepine 2-oxo-quazepam as well as zolpidem,
each of which has a greater affinity for the BzI subtype than the BzII subtype (Lüddens et al., 1995).
Finally, the diazepam insensitive BZIII receptors are those consisting of either the

4

subunit,

which is present only in very low quantities throughout the mammalian brain, or the

6

isoform

(Sieghart, 1995), which also confers ethanol insensitivity (Korpi et al., 1993) and is localized to
cerebellar and cochlear granule cells (Lüddens et al., 1990; Laurie et al., 1992a; Wisden et al.,
1992; Drescher et al., 1993; Varecka et al., 1994). Both the

- and

4

-subunits confer this

6

insensitivity to benzodiazepine due to a common single amino acid substitution (arginine for
histidine) in their large extracellular domain (Lüddens et al., 1990; Wisden et al., 1991; Wieland
et al., 1992; Gammill and Carter, 1993). In addition to these BZIII, benzodiazepine insensitive
receptors, there are benzodiazepine receptors which have only a weak sensitivity to agonist binding.
This weak sensitivity is imparted by the presence of the relatively rare 1- or 3-subunits in place of
the almost ubiquitous

-subunit (Togel et al., 1994).

2

D. Subunit-Specific Interactions of Various Modulators
As noted in the preceding section, the -subunit plays a very prominent role in determining
the sensitivity to benzodiazepine receptor agonists. However, this prominent role does not appear
to extend to most other modulators of GABAA-receptor function. Although the

subunit

composition also plays a minor role in the modulatory effects of neurosteroids, it appears to have
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no impact upon the effects of barbiturates, picrotoxin, or bicuculline (Macdonald and Olsen, 1994).
The subunits, which are required for full activation of channel conductance by GABAA-agonists,
appear to play an even less vital role in the interactions of modulatory agents with the receptor
complex. However, the presence of different -subunit isoforms do influence the affinity and
efficacies of benzodiazepines, barbiturates, and neurosteroids (Bureau and Olsen, 1990, 1993; von
Blankenfeld et al., 1990; Sigel et al., 1990).
The nature of the subunit(s) present in the receptor/channel complex affects the affinity
and efficacy of benzodiazepine receptor agonists and is also an important determinant in the
sensitivity of receptors to Zn++, ethanol, and zolpidem (Draguhn et al., 1990; von Blankenfeld et
al., 1990; Knoflach et al., 1991; Puia et al., 1991; Smart et al., 1991; Pritchett et al. 1992; Lüddens
et al., 1994; Wafford et al., 1994). However, the

2

isoform is present in far greater abundance in

all areas of the brain compared to any of the other isoforms such that most receptors tend to have
predominantly a

2

isoform profile which confers sensitivity of the receptor to ethanol,

benzodiazepines, and zolpidem-mediated modulation but low sensitivity to Zn ++ (Macdonald and
Olsen, 1994; Lüddens et al., 1995; Sieghart, 1995).
The subunit is the least well characterized of the subunit isoforms and, consequently, little
relevant pharmacological importance of this subunit has been identified (Sieghart, 1995; Wisden
et al., 1996). However, electrophysiological analysis has implied that receptors containing this
subunit display an enhanced response to GABAA-agonists (Saxena and Macdonald, 1994) as well
as a particularly high affinity for diazepam. Interestingly though, the primary location of -subunit
expression is in cerebellar granule cells (Fritschy and Möhler, 1995). This is, as noted above, also
the primary location of the 6-subunit, which imparts benzodiazepine insensitivity to the receptor.
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E. In Vivo Regulation of the GABAA-Receptor
As emphasized in the initial section of this document (section I), the ability of neurons to
adapt or alter their responsiveness to neurotransmission is a vital component in the proper
functioning of neuronal circuitry. Specific alterations in GABAergic responsiveness via GABA Areceptors have, to this point, been found to occur by four different mechanisms, including changes
in receptor number, subunit composition, receptor phosphorylation, and receptor conformation. It
should be noted that there are also non-receptor mediated ways to alter GABAergic function, such
as alterations in membrane potential or chloride concentration gradients, which will not be included
in this discussion. It should, however, be noted that such changes are known to occur, especially
during development where changes in intracellular chloride concentration allow GABA A-receptors
to function in an excitatory role in a number of CNS structures (Conner et al., 1987; Janigro and
Schwartzkroin, 1988; Ben-Ari et al., 1989; Cherubini et al., 1990; Yuste and Katz, 1991; Wu et al.,
1992).
The regulation of GABAA-receptor number has been observed in a number of experimental
systems including stress paradigms, chronic alcohol treatment, and sensory deprivation of the visual
system, which is perhaps the best studied system for such regulation (Kang et al., 1991; Montpied
et al., 1991; Primus and Gallager, 1992; Tietz et al., 1993; Hendry et al., 1994; Huntsman et al.,
1994; Mhatre and Ticku, 1994; We et al., 1994). Transcriptional control of GABAA-receptor
subunit expression has been shown to occur at both the mRNA and protein levels in experiments
studying visual deprivation (Hendry et al., 1994; Huntsman et al., 1994). In these studies,
intraocular injection of TTX (tetrodotoxin) led to an adaptational down-regulation of 1, 2, and 2subunits in the primary visual cortex of adult monkeys.
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The regulation of receptor subunit composition has been most notable in the study of
embryonic and early postnatal development. One clear example of such regulation is in the rat
forebrain. The embryonic rat forebrain GABAA-receptors are characterized by the presence of the
-subunit isoform and absence of the

2

1

isoform. However, late in embryonic development the

adult population of GABAA-receptor subunits begins to emerge with the 1-subunit existing in most
receptors and only a minor population of

2

isoforms (Fritschy et al., 1994). Furthermore, these

authors were able to show that this subunit switch occurred in individual neurons rather than the
shift in expression simply being up-regulation by one group of cells concomitant with downregulation in another group of cells.
Regulation of GABAA-receptors by subunit phosphorylation is still a topic of debate.
Although the fact that these receptors are regulated by intracellular phosphorylation is well accepted,
reports on the consequences of such phosphorylations are still contradictory. Several subunit
isoforms contain consensus kinase substrate sequences in the cytoplasmic loop between the third
and fourth transmembrane regions (M3 and M4) for PKA (protein kinase A), PKC (Ca++-dependent
protein kinase C), and tyrosine protein kinase (Macdonald and Olsen, 1994). In a number of
experiments, phosphorylation of these sites appears to enhance GABAA-receptor currents by either
decreasing desensitization of the receptor, enhancing assembly of subunits, and/or decreasing the
degradation of receptors (Cheun and Yeh, 1993; Macdonald and Olsen, 1994). Thus, for example,
endogenously released norepinephrine via locus coeruleus stimulation or exogenously applied
norepinephrine (acting via -adrenoceptors), cAMP analogs, or PKA, can potentiate GABAmediated currents in cerebellar Purkinje cells (Siggins et al. 1971; Moises and Woodward, 1980;
Waterhouse et al., 1982; Yeh and Woodward, 1983; Sessler et al, 1989; Cheun and Yeh, 1993,
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1996).
However, in some instances, phosphorylation of the GABAA-receptor has apparently
produced the opposite effect of reducing GABAergic current. For example, injection of the PKA
catalytic subunit into mouse spinal cord neurons reduced GABA-evoked currents (Porter et al.,
1990). Similarly, studies in HEK 293 cells revealed that PKA and PKC phosphorylation of a
specific serine residue of the

1

-subunit decreased GABAA-receptor function (Moss et al., 1992).

Thus, it appears that there are a number of factors which govern the ultimate effects of receptor
phosphorylation. Though these factors have yet to be precisely determined, it can be clearly stated
that such phosphorylation does regulate GABAergic function.
In addition, the significance and value of the different subunits in mediating such effects is
that only certain subunit isoforms contain the putative phosphorylation sites with and subunits
serving as the primary targets of these phosphorylations (Macdonald and Olsen, 1994). For
example, the

2L

splice variant contains an 8 amino acid insert (compared to the

2S

splice variant)

with a consensus substrate sequence for an additional PKC phosphorylation site (Whiting et al.,
1990) which may be necessary for the modulation of certain GABA A-receptors by ethanol (Wafford
et al., 1991).
Similar to other allosteric proteins, GABAA-receptors have multiple conformational states
which may influence the effectiveness of receptor activation (Galzi and Changeux, 1994). This has
been demonstrated via the analysis of single channel kinetics, allosteric interactions between ligand
binding sites, and the just noted functional alterations induced by receptor phosphorylation
(Sieghart, 1992; Macdonald and Olsen, 1994; Möhler et al., 1995). To this point, changes in
receptor conformation have been observed to primarily influence desensitization properties of the
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receptor.

For example, following chronic benzodiazepine exposure, recombinant receptors

displayed changes in protein conformation which led to a decrease in allosteric coupling that was
unaccompanied by changes in receptor number or affinity but did lead to a reversible decrease in
agonist efficacy (Klein et al., 1994).

F. Cerebellar Purkinje Neurons and the GABAA-Receptor
There are a number of different pharmacological profiles created by the assembly of
receptors containing different subunit isoforms. However, it appears that the impact of some of
these complicating factors which different subunit combinations introduce is reduced by the fact
that certain discrete brain regions, and in some cases discrete cell populations, tend to express only
a few isoforms abundantly (Laurie et al., 1992a,b; Fritschy and Möhler, 1995; Sieghart, 1995). The
cerebellum is an ideal example of such localization and is one of the reasons that it is considered
such an opportune area of the brain in which to study GABAA-receptor pharmacology (Wisden et
al., 1996). Although the subunit isoform profile of nearly all of the cells of the rat cerebellum is
relatively well characterized (Fritschy and Möhler, 1995; Sieghart, 1995; Wisden et al., 1996) only
the neurons of interest to this study, the Purkinje neurons, will be described in detail here. The
reader is directed to Sieghart (1995) or Wisden et al. (1996) for a more in depth discussion of the
composition of other cerebellar cell types.
For all of the GABAergic input the Purkinje neurons receive, their subunit isoform profile
in normal rats is surprisingly simple. In situ hybridization studies to localize subunit mRNAs show
strong expression of the

,

1

,

2

3

, and

2

genes with

et al., 1992a; Persohn et al., 1992). A rat

2

levels being greater than those of

3

(Laurie

-specific antibody, however, is only weakly reactive

2
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with Purkinje cells (Benke et al., 1994), suggesting that very low levels of this subunit isoform are
expressed. For the splice variants of the

2

isoform, in situ hybridization studies indicate that adult

rat Purkinje neurons contain more of the long version (

2L

Immunocytochemical studies reveal that the

(the

1

and

2/3

) than the short (
2

and

3

; Miralles et al., 1994).

2S

isoforms could not at that time

be distinguished immunocytochemically) combination is present on both Purkinje neuron spines
and dendritic shafts (Somogyi et al., 1989), and it appears that the

2

isoform is colocalized with

these subunits (Benke et al., 1991a,b; Gutiérrez et al., 1994).
Developmentally, each of these subunit isoform mRNAs is present in Purkinje neurons at
birth and their levels accumulate over the first few weeks of postnatal life, reaching their adult levels
by P21 (Zdilar et al., 1991, 1992; Laurie et al., 1992b; Luntz-Leybman et al., 1993). In addition,
Purkinje cells of immature animals transiently stain with antibodies to the subunit (Müller et al.,
1994). This staining, which occurs through P14 (Müller et al., 1994), has not been confirmed by
in situ hybridization analysis (Laurie et al., 1992b). Thus, throughout the postnatal development
of the Purkinje neurons, there is little if any change in the isoform profile. However, it should be
noted that the studies just described had no means of determining the exact composition of the
assembled receptors that were present in the Purkinje neurons or, for that matter, the relative levels
of the different combinations that were present. However, based upon the general guidelines
described above, the most likely subunit compositions of GABA A-receptors for adult Purkinje
neurons are ( 1,

,

1

2/3

,

2/3

,

) and ( 1,

2

,

1

2/3

,

isoforms.
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,

2

) with the

2

2L

representing most of the

2

V. EXPERIMENTAL DESIGN
The present studies employed in vitro cerebellar slices and the electrophysiological
techniques of intracellular recording, whole-cell patch-clamp recording, and single channel
recording in excised outside-out patches to examine the cellular mechanism(s) of a previously
identified specific subsensitivity of GEPR-9 Purkinje neurons to GABAA-receptor activation (Gould
et al., 1991, 1995). In addition, these studies also investigated the cellular responsiveness of
Purkinje neurons from both GEPR-NE and GEPR-3 rats. The initial aims of these studies were to
employ intracellular recording techniques, investigating animals of various postnatal ages, to:
1.) Determine if the Purkinje neuron membrane properties, namely resting membrane
potential (RMP) and input resistance (IR), were the same for Sprague-Dawley, GEPR-NE, GEPR3, and GEPR-9 animals,
2.) Determine whether the cellular responsiveness of Purkinje neurons from GEPR-NE
animals, the genetic control strain for GEPR-3 and GEPR-9 rats, were equivalent to that of normal
Sprague-Dawley rats, and
3.) Determine if the specific subsensitivity to GABAA-receptor activation observed in situ
(Gould et al., 1991, 1995) was also demonstrable in the in vitro slice model for the GEPR-9.
As expected based upon the specific nature of the subsensitivity previously observed in the
GEPR-9 (Gould et al., 1991, 1995), the neuronal membrane properties of GEPR-9 rats were
statistically equivalent to those of Sprague-Dawley, GEPR-NE, and GEPR-3 animals (see Results,
section VII).

Furthermore, the data revealed that around postnatal day 15, which coincided with

the onset of seizure development in the GEPR, Purkinje neurons from all four animal strains
exhibited a significant hyperpolarization which was associated with a significant decrease in their
input resistance. In addition, during this early age at which the cerebellum is still maturing,
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differing responses to glutamate, aspartate, NMDA, GABA, and muscimol were revealed in each
animal strain. Although these universal (i.e., occurring in each animal strain) changes in
responsiveness were not investigated further, studies were conducted to determine the mechanism
for the change in RMP and to see if it played a role in the development of seizure predisposition in
the GEPR.
If the subsensitivity of GEPR-9 Purkinje neurons to GABAA-receptor activation is involved
in the seizure-susceptibility of these animals, it would also be presumed that the GEPR-NE would
fail to display such a subsensitivity, as they are not seizure-prone. In accordance with this, the
GEPR-NE Purkinje neurons displayed equivalent membrane polarization responses to SpragueDawley Purkinje neurons when various inhibitory (including GABA) and excitatory ligands were
applied via superfusion (see Results, section VII).
The third of these tasks was performed in order to assure that the model system chosen
would still be applicable for studying the characteristics of these neurons. These studies employed
superfusion of a variety of ligands onto cerebellar slices while recording intracellularly from
individual neurons. The results (see section VII) indicated that a GEPR-9 Purkinje neuron
subsensitivity to GABA and muscimol, the effects of which could be blocked by both bicuculline
and picrotoxin, did exist without a change in sensitivity of these neurons to glutamate, aspartate,
or norepinephrine.

Thus, the specific subsensitivity to GABAA-receptor activation was

demonstrable in this preparation, and was of approximately of the same magnitude as observed in
the in situ model (Gould et al., 1991, 1995).
The next objective of the present studies was to investigate the cellular responsiveness of
GEPR-3 Purkinje neurons using techniques similar to those employed with Sprague-Dawley, GEPR-66-

NE, and GEPR-9 animals. Since these animals display both a different level and different severity
of seizure-susceptibility, it was expected that they would be identical neither to GEPR-9 nor to
Sprague-Dawley and GEPR-NE animals with respect to their cellular responsiveness. Due to the
lack of much prior information, however, the nature of their responsiveness could not be confidently
predicted.

Via the intracellular recordings and the superfusion of various drugs and

neurotransmitters (as described above), it was found that GEPR-3 Purkinje neurons displayed an
altered cellular responsiveness to GABAA-receptor activation compared to Sprague-Dawley animals
which was of a different nature than that of the GEPR-9s. Whereas the GEPR-9 Purkinje neurons
displayed a parallel rightward shift of the GABA and muscimol concentration-response curves
without a significant change in maximal response, GEPR-3 Purkinje neurons displayed a decrease
in maximal response to these agonists without a significant shift of the concentration-response
curve.
As a final step to investigate the cellular mechanism(s) of these altered responses in GEPR-3
and GEPR-9 Purkinje neurons, whole-cell and single-channel patch-clamp techniques were
employed. The primary aims of these experiments were to determine:
1.) If Purkinje neurons of the GEPR-9 and/or GEPR-3 also displayed decreased levels of
whole cell chloride conductance upon GABA receptor activation and
2.) If GEPR-9 and/or GEPR-3 Purkinje neurons (compared to Sprague-Dawley Purkinje
neurons) displayed decreased single-channel conductance amplitudes in response to GABA.
The findings of the whole-cell experiments were that, similar to the membrane polarization
responses, whole cell conductances were altered for both GEPR-3 and GEPR-9 Purkinje neurons,
though in a different manner (see Results, section VII). However, single-channel analysis of GABA
responses did not reveal differences in conductance amplitude among the three animal strains.
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VI. METHODS
The methods used for these studies involve intracellular microelectrode, whole-cell patch
clamp, and excised outside-out patch clamp recording from slices of the rat cerebellar vermis
maintained in vitro. The brain slice preparation, in its original form, was first developed in the
1930’s by Quastel and Elliot (see Elliot and Wolfe, 1962). Prior to the 1970’s, most of this work
focused on cellular metabolism (McIlwain and Bachelard, 1971). The subsequent development of
olfactory bulb and hippocampal slice preparations (Yamamoto and Kurokawa, 1970; Skrede and
Westgaard, 1971) led to more sophisticated studies of neuronal activity permitting more refined
electrophysiological and pharmacological analysis. As with most techniques, performing such
recordings in slices has both advantages and disadvantages. Compared to recording in situ, in
acutely dissociated cells, or from cells maintained in culture, the in vitro slice preparation was the
best choice for the purposes of these experiments, for the reasons detailed below.
Foremost among these advantages over whole animal recordings is the precision with which
drug applications can be made. Neuron(s) of interest are identifiable visually and/or by electrical
stimulation of fiber tracts which give rise to characteristic responses in such neurons. Compared
to acutely dissociated cells, and in many cases, cells in culture, the slice preparation allows the
investigator to maintain more of the in vivo characteristics of the neuron(s) of interest by invoking
less trauma in these cells. The ability to simulate the in vivo environment in slices is greater since
the loss of synaptic connections and intrinsic neuronal structure can be minimized though it does
limit one to studying only local circuits contained within a given slice. Along with dissociated cells,
slices have the advantage of allowing one to investigate the properties of neurons in an environment
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in which variables such as temperature, pH, cellular energy source, oxygen tension, ionic
composition, and osmolarity can be maintained precisely and at levels similar to those found in vivo.
In order for the in vitro slice technique to retain such advantages, however, the long term
maintenance of the slices must be conducted in such a way that it preserves viability and function
for a period long enough to obtain successful recordings. Thus, there are certain precautions which
must be taken to avoid problems experienced with many brain slice preparations which may
interfere with the integrity of neurons to be studied. Such problems include tissue damage due to
the slicing process, postdecapitation ischemia/hypoxia, and slice anoxia. To reduce the possible
effects of postdecapitation ischemia/hypoxia, the speed of slice preparation is critical. The shorter
the amount of time from decapitation to removal of the desired brain region, the better. Ideally,
removal of the brain tissue in less than 1 minute after decapitation should be obtained (Kano and
Konnerth, 1992). However, even in slice preparations taking as long as 2-6 minutes to prepare, no
such lasting postdecapitation effects appear to be present following 90 minutes of postpreparation
incubation (Lust et al., 1982). Furthermore, Nicholson and Hounsgard (1983) have shown that for
300-400 µm slices, the cellular microenvironment is similar to that reported in the intact brain.
The mechanical damage of the slicing process itself cannot be entirely avoided. During the
procedure a region on either edge of the slice will be disrupted as the cutting blade passes through
the tissue block. If care is taken during this procedure, however, this damage can be reduced to an
area 40-50 µm deep at each cut site (Garthwaite et al., 1979; Misgeld and Frotscher, 1982). Thus,
in a 300 µm slice, there is essentially a 200-220 µm zone of viable, “normal” tissue with which to
work. Avoiding the possible development of an “anoxic core” in the slice preparation is dependent
upon slice thickness. Studies utilizing relatively slow superfusion rates (0.6 ml/min) revealed that
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such an area of anoxia did not occur in slices up to 430 µm in thickness (Fujii et al., 1982). Thus
thinner slices and higher superfusion rates are the most valuable tools in counteracting the
possibility of producing an anoxic core.

A. Brain Slices
Cerebellar slices were prepared according to the methods described by Llinas and Sugimori
(1980a,b), Crepel et al. (1981), Dupont et al. (1987), and Kano and Konnerth (1992) with some
modifications. Animals were anesthetized with either 25 mg/kg sodium pentobarbital or CO2 and
subsequently decapitated with a guillotine. The choice of anesthetic did not alter the viability of
the slices obtained. Following decapitation, the skull and dura mater overlying the cerebellum were
removed, the cerebellar peduncles were severed using a sterile scalpel, and the cerebellum was
removed. Immediately after removal, the cerebellum was placed into aerated (95% O2 /5% CO2)
artificial cerebrospinal fluid (aCSF; composition below) kept on ice at approximately 4 oC. This
process never required longer than 45 seconds to complete. The cerebellum, still in iced aCSF, was
then blocked by sagittal cuts at each vermian vein and one of the cut ends was glued to a teflon
chuck using cyanoacrylate adhesive. The cerebellum was supported on the chuck by a notched agar
block previously prepared and glued to the chuck. Agar cutting blocks were prepared by pouring
molten agar (5% by weight in 150 mM NaCl) into 10cc plastic syringes cut off at one end, cooled,
then cut to an appropriate size as needed.
Using a Vibroslice oscillating tissue slicer (World Precision Instruments), 300 µm thick
sagittal sections of the cerebellar vermis were cut while maintained in aerated, 4 oC aCSF. Upon
obtaining each slice, it was immediately transferred, using a wide mouthed, fire-polished glass
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pipette, to a plastic-mesh basket submerged in a plastic beaker containing continuously aerated
aCSF and kept on ice. All slices used were cut and transferred to the incubation beaker within 10
minutes after decapitation. The incubation beaker was kept on ice until 15 minutes postdecapitation, then removed from ice and allowed to slowly (over a two hour period) warm to room
temperature (20-22oC) prior to initial recordings.

B. Electrophysiological Recording I: Intracellular Recording
Following the recovery period, slices were individually transferred to a holding apparatus
made of nylon mesh glued to a glass micropipette which had been heated and formed into a Ushape. The holding apparatus with the brain slice was then placed in a 1.5 ml laminar flow
recording chamber continuously superfused with aerated aCSF maintained at 22-25oC. Originally,
slices were superfused and recordings obtained at 37oC. However, the lower temperature allowed
for greater slice viability during recording and preliminary studies indicated that the
electrophysiological parameters were not significantly altered by recording at the lower temperature.
Temperature was monitored using a Yellow Springs Instruments thermoprobe placed in the
recording chamber. Perfusion of aCSF was maintained at 3 ml/min via a pressure assisted gravity
feed system. The slice was then viewed under a dissecting microscope (Nikon SMZ-2T) utilizing
a Dolan-Jenner Fiber-Lite fiber optic light source and a bipolar stimulating electrode (teflon coated
platinum wire) for antidromic identification of neurons was placed on the white matter (see Figure
5). Artificial cerebrospinal fluid contained (in mM): NaCl (126); KCl (5); MgSO4 (1.3); NaH2PO4
(1.2); NaHCO3 (26); CaCl2 (2.4); glucose (10).
Standard intracellular recording was performed using single-barreled borosilicate glass
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microelectrodes filled with 3M potassium acetate (KAc) with resistances of 80-110 M . The
electrical activity and cellular currents generated were then amplified and monitored under the
bridge recording configuration using an AXOCLAMP-2A amplifier (Axon Instruments).
Electrophysiological signals were monitored on an oscilloscope (Tektronix 5110, 5111A) and led
to a computer following A/D conversion through a TL-1 DMA interface (Axon Instruments) for data
acquisition, real time analysis, and/or storage for subsequent off-line analysis using Axotape 2.0
(Axon Instruments).
Cells at least 50 µm, but no greater than 250 µm, from the surface of the slice were impaled
with the assistance of a Narishige hydraulic micromanipulator and were identified as Purkinje
neurons based upon the antidromic invasion of the soma following electrical stimulation of the axon
(white matter). An example of such an antidromic action potential is illustrated in Figure 5.
Criteria for inclusion of a given neuron in the population for statistical analysis included the
establishment of a stable resting membrane potential (RMP) between -35 and -75 mV and the
production of an antidromic action potential following white matter stimulation. Cellular input
resistance was determined by regularly (2-5 second intervals) passing several steps of depolarizing
and hyperpolarizing currents through the recording electrode. The voltage change induced by each
electrotonic potential was later quantified, used to assess input resistance based upon Ohm’s law
(V=IR), and used to construct I/V curves. The duration of the electrotonic potential used was
individualized for each neuron so that the membrane capacitance was fully charged for that neuron
(typically 150-250 msec). An example of I/V curve construction is illustrated in Figures 6 and 7,
with Figure 6 showing the actual voltage responses used to construct the I/V curve shown in Figure
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FIGURE 5. Intracellular recording of a Purkinje neuron in a cerebellar slice showing antidromic
action potential invasion of the soma following white matter stimulation. Potential amplitudes were
typically in the 65 to 85 mV range with durations near 1 msec. The pictured potential had an
amplitude of 72 mV and a duration of 1.2 msec.
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A.

B.

FIGURE 6. Representative voltage responses (A) and current injection (B) traces as used for the
formation of current-voltage (I/V) curves (see Figure 7) are depicted. The upper and lower portions
of the inset axis correspond to the upper (A) and lower (B) traces, respectively. Although a time
period long enough for most voltage responses to plateau was used, some voltage responses failed
to plateau as can be seen in (A). Thus, in order to standardize measurements, voltage responses
were measured at 100 msec from the start of current injection as noted by the dashed vertical line
in (A). The large deflections at the beginning and end of the voltage sweeps represent the combined
stimulus artifacts associated with each individual current pulse.
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FIGURE 7. Current-voltage (I/V) plots for Purkinje neurons in cerebellar slices from a 10 day
(P10) and a 27 day (P27) old Sprague-Dawley rat as determined using intracellular recording
techniques. Values were determined from voltage response to injected current as seen in Figure 6.
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7. It should also be noted that even though a large range of values are depicted in Figure 7, nine
smaller current steps between -1.5 and 1.5 nA were used to calculate input resistance (e.g. -1.5, -1.1,
-0.7, -0.3, 0, 0.3, 0.7, 1.1, and 1.5 nA).
Exposure of neurons to drugs was accomplished through the addition of known
concentrations of drug to the superfusing solution. Dead time for drug application was less than
5 seconds. Muscimol, -aminobutyric acid (GABA), glutamate, aspartate, N-methyl-D-aspartate
(NMDA), ouabain, diazepam, bicuculline, picrotoxin, baclofen, and norepinephrine were prepared
as stock solutions in advance in aCSF and stored at -20oC. Aliquots were thawed and diluted to
final concentrations in fresh, aerated aCSF just prior to use. When multiple drugs were applied to
a single neuron, the effects of prior drug applications were allowed to completely wash out before
subsequent exposure to another agent. This was noted by a complete return of the membrane
potential back to RMP (an example for muscimol is depicted in Figure 8). For determining changes
in IR during drug applications, IR was compared before and during drug application by injecting
current at a regular interval during the recording of RMP (see Figure 8). The IR was calculated
from a series of randomly selected electrotonic potential injections (ten before drug application
while at RMP, ten at steady-state maximal effect of drug) and then averaged before comparison.
When ouabain (Na+-K+, ATPase inhibitor), bicuculline, or picrotoxin (GABAA-selective
antagonists) were applied to a slice, no subsequent recordings from that slice were made in order
to avoid residual effects upon other neurons in the same slice. Furthermore, concentration-response
curves were made by applying single increasing concentrations of drug (about 1 minute per
concentration) while allowing time for complete washout of effect between concentrations (noted
by a return to RMP) which varied with the drug used.
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B.

FIGURE 8. Response of a Purkinje neuron in a cerebellar slice from a Sprague-Dawley rat to 1 µM
muscimol application via superfusion. The arrows, 8 and 9, indicate time of drug addition and
removal from the superfusion fluid, respectively. (A) Depicts the hyperpolarization of the
membrane potential noted by the downward movement of the trace and the return to resting
membrane potential (RMP) noted by the upward movement of the trace back to its original level.
(B) Shows portions of this trace on an extended time scale thus illustrating the effects of muscimol
on input resistance (IR) before, during, and after drug application. The downward deflections depict
the voltage responses to injected current (3 nA). The upper half of the inset axis is for trace (A) and
the lower half is for trace (B).
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C. Statistical Analysis of Intracellular Data
Two similar methods were used for statistical analysis of collected data. For parameters
which were assessed across time (e.g., versus age), an analysis of variance (ANOVA) using a nested
design was performed to test for the effect of age. Multiple comparisons were then made using
orthogonal contrast and the -values were adjusted via the method of Bonferroni. Since ten multiple
comparisons were made in each instance where this method was used, a significant p value was
0.005 for these comparisons. For comparing the effects of drugs between animals, for example
Sprague-Dawley vs. GEPR-9, an analysis of variance with nested design was also used. However,
in these instances no multiple comparisons were performed, thus a significant p value was 0.05 for
these comparisons.
An important point which should be made concerning the intracellular concentrationresponse curves for membrane hyperpolarizing responses to both GABA and muscimol presented
in the present manuscript is the saturation of the membrane hyperpolarizing response as the
membrane potential (Vm) approaches the chloride equilibrium potential (ECl). The change in
membrane potential induced solely by the movement of chloride ions is limited by the ECl such that
as Vm increases towards ECl, the driving force for chloride movement into the cell decreases, and the
change in Vm asymtotically approaches ECl in a hyperbolic manner. The non-linearity of this
hyperbolic response makes interpretation of the concentration-response curves more difficult due
to the influence of two hyperbolic functions on the shapes of the curves, namely, the saturable
binding of ligand and receptor and the saturable hyperpolarizing response. For this reason, similar
maximal responses obtained for the hyperpolarization concentration-response curves may be a
function of the saturation of this hyperpolarization and, thus, similar maximal conductances
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between neurons from different animals should not be inferred.

D. Electrophysiological Recording II: Whole-Cell and Single-Channel Patch Clamp
Following the recovery period, slices were individually transferred to a superfusion and
recording chamber (Warner Instrument Corp.), mounted on the stage of an Olympus BX50WIF
microscope equipped for infrared videomicroscopy, and continuously superfused with aerated aCSF
(same composition as for intracellular recording) at room temperature. Superfusion of aCSF was
via a gravity feed system at a rate of 3ml/min. The slice was then viewed under 50-fold (5X
objective, 10X eyepiece) magnification in order to locate the Purkinje cell layer. Once the Purkinje
cell layer was identified based upon its location at the interface between the granule cell and
molecular layers (see section III), an infrared (IR) filter was installed and a 40X water immersion
objective (total magnification = 400X) was used to identify an individual Purkinje cell from which
to record.
Conventional whole-cell patch clamp recording techniques (Hamill et. al., 1981) were used
to record currents from Purkinje neurons in the cerebellar vermis. Patch electrodes were fabricated
from thin-walled borosilicate glass capillaries using a Flaming/Brown micropipette puller (model
P-87, Sutter Instrument Co.) and the shank subsequently coated near the tip with a thin layer of
Sylgard (Dow) to reduce tip capacitance and thus improve background noise (Hamill et al., 1981).
After briefly curing the Sylgard with a hot air gun, electrode tips were fire-polished under
magnification using a microforge (Narishige). The electrode was then filled with an intracellular
solution containing (in mM): CsCl (145); MgCl 2 (1); Mg++-ATP (5); EGTA (5); HEPES (10);
balanced to a pH of 7.2 using CsOH. Mg++-ATP was included in the pipette solution in order to
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prevent run-down of GABA-induced currents (Cheun and Yeh, 1991). Cesium (Cs+) was used as
a replacement for potassium (K+) in order to reduce or eliminate potassium currents. The
extracellular solution (aCSF) was identical to that used for intracellular recordings (see above) with
the exception that tetrodotoxin (TTX; 1 µM) was added to reduce or eliminate sodium currents.
EGTA was present in the electrode solution to buffer calcium which helps prevent spontaneous
increases in the access resistance as the result of partial resealing of the patch membrane (Penner,
1995).
Once a candidate Purkinje neuron was identified with the assistance of a CCD camera
(Dage) and a Sony high-resolution monitor, the patch electrode was brought into the proximity of
the cell with the aid of a Narishige 3D micromanipulator attached to the stage of the microscope.
During the approach, positive pressure was kept on the patch pipette in order to prevent occlusion
of the electrode tip while clearing away tissue debris. Contact with the cell was then noted as an
increase in the electrode resistance (to a 200 µV test pulse) at which point mild negative pressure
was applied to potentiate seal formation while monitoring on a Tektronix oscilloscope. As the
current signal decreased, the test pulse was increased to 20 mV to determine if a giga-ohm seal was
obtained. Further suction was applied until such a seal was obtained and any seal which did not
reach a minimum resistance of 1 G was not used for analysis. Capacitive transients were then
nulled using capacity compensation controls on the amplifier (Dagan, model 8900). The filtering
was then increased from 1 kHz to 10 kHz and residual transients were compensated for.
Further negative pressure was then applied to rupture the membrane which was noted by the
appearance of a large capacity transient and a marked increase in current noise. The resting
membrane potential was noted and the cell was promptly voltage clamped to a membrane potential
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of -60 mV. This membrane potential was chosen based upon intracellular studies which indicated
that this was the approximate resting membrane potential of Purkinje neurons in vermal cerebellar
slices from rats (postnatal age 15 days or older) of each strain used (see Results, Figure 11). At this
point the series resistance was compensated using series resistance controls on the amplifier. For
single-channel recordings, the patch electrode was slowly withdrawn from the cell surface
(following formation of giga-seal and subsequent rupture of the membrane to obtain the whole-cell
configuration) to create an excised outside-out patch with the outer surface of the cellular membrane
in contact with the superfusing fluid.
For determination of the effects of drugs applied via superfusion (e.g., added to the
extracellular perfusate as above), whole cell currents before, during, and after drug application were
recorded at a holding potential (VH) of -60 mV (see Figure 9). Additionally, I/V curves during drug
administration were constructed using a series of voltage ramps from -80 to +20 mV and measuring
the subsequent current. These values were then used to construct I/V plots based upon Ohm’s law
(V=IR; see Results, Figure 29). Agonist-activated membrane currents were amplified using a model
8900 Dagan patch clamp amplifier and led to a computer following digitization (TL1-DMA, Axon
Instruments) for storage and later analysis using pClamp software.
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A.

B.

FIGURE 9. Representative whole-cell (A) and single-channel current (B) traces from Purkinje
neurons of Sprague-Dawley rats. In (A) whole cell currents from before and during step
applications of GABA are superimposed. The numbers next to the individual traces represent the
concentration of GABA (µM) in the superfusing fluid. The > indicates the peak amplitude of the
current for the 10 µM GABA current trace. GABA was applied for approximately 1 minute at 5
minute intervals to allow time for recovery from desensitization (Sigel et al., 1990). For a means
of standardizing measurements, steady-state (ISS) or desensitized currents were measured at 45
seconds after drug application (see text for details). In (B) single-channel currents from a SpragueDawley Purkinje neuron in response to 10 µM GABA are shown for two different time scales as
indicated on the right. The bar above the top trace indicates the portion of the trace seen in the
bottom portion of the figure. The * and # indicate the opening of the channel to two different
conductance levels.
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The analysis of dwell times (open and closed durations) of single-channel currents was
performed using pSTAT (pClamp, Axon Instruments). Open durations were placed into frequency
histograms using linear binning using 0.5 msec bins. Closed durations were placed into frequency
histograms using logarithmic binning and a square-root ordinate transmformation was used
(Sigworth and Sine, 1987). Closed durations were binned using a 10 bins/decade resolution with
a 200 µsec minimum duration. For curve fitting of the binned data, the Simplex method for
maximum likelihood fitting was used. It should also be pointed out that observed open and closed
dwell times were reported. Due to the presence of unresolved openings and closures, the observed
durations will be longer than the true durations (Colquhuon and Sigworth, 1983). No steps were
taken to account for these missed events.
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VII. RESULTS
The initial aim of the present study was to extend the investigations of Gould et al.
(1991,1995) in an experimental preparation which would permit more precise definition of the
deficits in GABAergic transmission in the genetically epilepsy-prone rat (GEPR). As noted, these
previous electrophysiological studies relied primarily upon extracellular single unit recordings
obtained in situ. The results of these experiments indicated that Purkinje neurons of the GEPR-9
cerebellum displayed a specific subsensitivity to GABAA-receptor activation. This conclusion was
based upon the observation that the firing rates of Purkinje neurons from GEPR-9 were equally
responsive to norepinephrine, glutamate, and baclofen but less responsive to GABA and muscimol
compared to control animals. Such specific subsensitivity would not be expected if membrane
properties had been altered (see section IA), but instead, would likely be due to either a decrease in
the number of GABAA-receptors or an alteration in the signal transduction process (Clconductance) for these receptors.
To further elucidate the mechanism(s) responsible for this subsensitivity, these investigations
(Gould et al., 1995) next evaluated GABAA-receptor binding in the cerebellum. This was
accomplished by comparing the binding of [3H]-muscimol and [3H]-flunitrazepam, both of which
bind to the GABAA-receptor complex, in cerebellar homogenates from GEPR-9 and control animals.
These studies indicated that there was no difference in the GABAA-receptor population in the
cerebellum between these two animal strains. This finding suggested that the mechanism
underlying the subsensitivity to GABA in the Purkinje neurons of the GEPR-9 was likely to be due
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to a decreased ability of the GABAA-receptors in the Purkinje neurons of this animal to conduct Clupon activation by a ligand. In order to determine if this is the primary cause of the subsensitivity,
a different, more precise electrophysiological technique needed to be employed. The method we
chose to accomplish this task was to record from Purkinje neurons in slices of the cerebellar vermis
maintained in vitro in order to characterize the electrophysiological properties of these neurons and
to permit more quantitative analysis of the effects of agonist exposure to these neurons.

A. Basic Electrical Membrane Properties
The resting membrane potential (RMP) and input resistance (IR) of Purkinje neurons were
examined using intracellular recording in vermal cerebellar slices from control (Sprague-Dawley
and GEPR-NE) and epileptic (GEPR-3and GEPR-9) animals. Based upon the observations that
indicated a specific subsensitivity to GABAA-receptor activation (Gould et al., 1991, 1995), RMP
and IR were not expected to vary between animal strains. In addition to comparing these electrical
membrane properties between animal strains, they were also compared with respect to animal age.
Since later portions of the present study relied on the ability to perform experiments in relatively
young animals with a minimal seizure history (for GEPR-3 and GEPR-9 rats), and at an age during
which the cerebellum has yet to complete its development (see section III), this analysis with
respect to age was important to ensure that possible developmental events common to each animal
strain were accounted for. Furthermore, possible differences between animal strains with regard
to cerebellar maturation could provide further insight into the development of seizure
predisposition in the epileptic GEPR animals.
Figures 10 and 11 are plots of the RMP and IR, respectively, for control Sprague-Dawley
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and GEPR-NE as well as epileptic GEPR-3 and GEPR-9 rats of various postnatal ages. Tables 4
and 5 provide the means and standard errors plotted in Figures 10 and 11, respectively, as well as
the sample sizes for each group. In order to provide reasonable sample sizes for valid comparisons
between animal strains, the data were grouped according to age groups consisting of five day
periods beginning with postnatal day 10 (P10) and an adult group (P30+) which consisted of
animals 30 days postnatal or older. In addition, this grouping method provided an age group
consisting purely of animals with no prior seizure history (P10-14).
While there were no statistically significant differences between any of the animal strains
for RMP or IR during a given age period (p>0.005), there were differences in both RMP and IR for
each animal strain with respect to age (p<0.005). The RMP became more hyperpolarized and the
IR decreased with increased animal age with the majority of the change occuring between the P1014 and P15-19 aged animals. As such, the RMP and IR from P10-14 animals of each strain were
significantly different from all other age groups (p<0.005). Also included in Figures 10 and 11 as
well as Tables 4 and 5 is a P15+ group, which was also significantly different from the P10-14
group. This is included as a reference for later experiments which employ the use of only animals
15 days postnatal and older which grouped these animals as a single experimental population.
These mean values include values recorded from Purkinje neurons from all animals 15 days or older.
As an example of how these characteristics are altered during cerebellar development, Figure 12
presents a plot of both the RMP and IR of Sprague-Dawley Purkinje neurons for the different 5-day
age groups. As can be seen, there is a large hyperpolarization of the membrane potential between
P10-14 and P15-19. The IR declines more gradually, but a large portion of this decrease also occurs
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FIGURE 10. Bar graph comparing the resting membrane potential of Purkinje neurons in
cerebellar slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats measured using
intracellular recording techniques. Values are plotted as mean ± S.E.M. There were no significant
differences among the animal strains for any age group (p<0.05). Sample sizes can be found in the
accompanying table (Table 4).
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Postnatal
Age (Days)

10-14

15-19

20-24

25-29

30+

15+

-49.7 ± 1.1
(46)

-54.2 ± 1.6
(32)

-57.3 ±
1.3
(30)

-58.7 ±
1.5
(28)

-57.9 ± 0.8
(86)

-57.2 ± 0.6
(176)

GEPR-NE

-51.0 ± 1.9
(15)

-55.4 ± 2.2
(13)

-58.0 ±
2.2
(10)

-58.8 ±
1.7
(11)

-57.7 ± 2.1
(8)

-57.3 ± 1.0
(42)

GEPR-3

-50.1 ± 1.4
(12)

-54.9 ± 1.6
(13)

-59.1 ±
1.8
(10)

-57.4 ±
2.8
(6)

-57.0 ± 3.0
(3)

-56.9 ± 1.1
(32)

-48.9 ± 1.4
(22)

-53.9 ± 1.7
(20)

SpragueDawley

-56.8 ±
-58.1 ±
-57.0 ± 0.9 -56.6 ± 0.6
1.4
1.8
(64)
(126)
GEPR-9
(24)
(18)
TABLE 4. Resting membrane potential (mV) of Purkinje neurons in cerebellar slices from
Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats at various postnatal ages. Data are
presented as mean ± S.E.M. Number in parentheses indicates the number of cells averaged. See
text for comparison of mean values.
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Sprague-Dawley
GEPR-NE
GEPR-3
GEPR-9
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FIGURE 11. Bar graph comparing the input resistance of Purkinje neurons in cerebellar slices
from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats measured using intracellular
recording techniques. Values are plotted as mean ± S.E.M. There were no significant differences
among the animal strains for any age group (p<0.05). Sample sizes can be found in the
accompanying table (Table 5).
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Postnatal Age
(Days)

10-14

15-19

20-24

25-29

30+

15+

SpragueDawley

11.2 ± 0.2
(46)

10.0 ± 0.3
(32)

9.9 ± 0.3
(30)

9.7 ± 0.3
(28)

9.4 ± 0.1
(86)

9.6 ± 0.1
(176)

GEPR-NE

11.1 ± 0.4
(15)

9.5 ± 0.5
(13)

9.5 ± 0.6
(10)

9.6 ± 0.5
(11)

9.3 ± 0.4
(8)

9.5 ± 0.2
(42)

GEPR-3

11.6 ± 0.6
(12)

9.9 ± 0.5
(13)

9.7 ± 0.3
(10)

9.8 ± 0.7
(6)

8.7 ± 1.5
(3)

9.7 ± 0.3
(32)

11.0 ± 0.3 9.6 ± 0.3
9.6 ± 0.4
9.6 ± 0.4
9.2 ± 0.2
9.4 ± 0.1
(22)
(20)
(24)
(18)
(64)
(126)
TABLE 5. Input resistance (M ) of Purkinje neurons in cerebellar slices from Sprague-Dawley,
GEPR-NE, GEPR-3, and GEPR-9 rats at various postnatal ages. Data are presented as mean ±
S.E.M. Number in parentheses indicates the number of cells averaged. See text for comparison of
mean values.
GEPR-9
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Resting Membrane Potential (mV)
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FIGURE 12. Plots of the resting membrane potential (~) and input resistance (>) for Purkinje
neurons in cerebellar slices from Sprague-Dawley rats at various postnatal ages as determined using
intracellular recording techniques. Means are plotted ± S.E.M. Both the mean resting membrane
potential and input resistance of Purkinje neurons from animals 10-14 days postnatal are
significantly different from all other age groups as indicated by the asteriks (*). Sample size for
both plots are (number of cells): P10-14 (46); P15-19 (32); P20-24 (30); P25-29 (28); P30+ (86).
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between P10-14 and P15-19. Curves constructed for the other animal strains (not shown) display
similar characteristics.
B. The Effects of Ouabain in Sprague-Dawley Rats
Although, as expected, there were no differences in the basic electrical membrane properties
between animal strains (see above), the developmental hyperpolarization of the Purkinje neuron
membrane was of interest, especially since it coincided with the period of time when the GEPRs
become seizure prone (see section IIB). In an attempt to better understand the nature of this
hyperpolarization, the effects of ouabain on the membrane characteristics of Purkinje neurons in
slices of the Sprague-Dawley cerebellum were examined for various age groups. Ouabain inhibits
the Na+,K+-pump, leading to a depolarization of the membrane potential, and, thus, by applying
saturating concentrations of ouabain it is possible to estimate the contribution of the pump to RMP
(Thomas, 1972; Urquilla et al., 1978). The role of the Na+,K+-pump was the focus of these
investigations due to the critical role which it plays in determining resting membrane potential (see
section I).
In these experiments, ouabain (1 mM) was applied to Sprague-Dawley Purkinje neurons in
cerebellar slices via superfusion and the effects on RMP and IR were measured. An example of the
effects of a typical ouabain application is illustrated in Figure 13. Figure 13 presents the membrane
response of a Purkinje neuron from a 22 day old Sprague-Dawley rat to 1 mM ouabain showing a
depolarization of the membrane potential (24 mV) and a slight decrease in input resistance (2.1
M ) as determined from the periodic injection of 3nA current pulses via the recording electrode.
As typical of the membrane responses to this concentration of ouabain, this cell did not return to
RMP during the course of the experimental observation.
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FIGURE 13. A trace of the membrane response of a Purkinje neuron in a cerebellar slice from a
P22 Sprague-Dawley rat to ouabain superfusion illustrates the depolarizing effects of ouabain on
the membrane potential. Downward traces reflect the membrane response to injected current (3
nA). Arrow indicates the time of addition of ouabain to the superfusion fluid. Due to the long
lasting effects of ouabain this cell did not return to resting membrane potential upon removal of
ouabain during the course of the experimental observation.
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28
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10-14
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25-29

30+
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FIGURE 14. Plot of the depolarizing effects of superfusing ouabain (1 mM) on the resting
membrane potential of Purkinje neurons in cerebellar slices from Sprague-Dawley rats as
determined using intracellular recording techniques. Results are plotted as mean ± S.E.M. The
asterik (*) denotes a significantly reduced depolarizing effect of ouabain compared to all other age
groups (p<0.005). The double-asterik (**) denotes a significant difference from all other age groups
except the 20-24 age group (p<0.005). The sample size for each age group are (number of cells):
P10-14 (7); P15-19 (9); P20-24 (9); P25-29 (8); P30+ (15).

-94-

Age (days)

10-14

15-19

20-24

25-29

30+

Depolarization (mV)

19.7 ± 1.8*

23.9 ± 0.5**

26.0 ± 0.6

26.5 ± 0.7

26.8 ± 0.3

Final Membrane
Potential (mV)

-29.1 ± 2.2

-30.5 ± 3.5

-31.8 ± 2.7

-31.9 ± 0.9

-31.4 ± 1.7

n=7 (4)
n=9 (6)
n=9 (5)
n=8 (5)
n=15 (7)
Sample Size†
TABLE 6. Effects of superfusing ouabain (1mM) on the resting membrane potential (RMP) of
Purkinje neurons in cerebellar slices from Sprague-Dawley rats of various postnatal ages determined
using intracellular recording techniques. Means are reported ± S.E.M. *Denotes significant
difference from all other age groups (p<0.005). **Denotes significant difference from 10-14, 25-29,
and 30+ age groups (p<0.005). †Indicates number of cells from (number of animals). There were
no significant differences between the final membrane potentials after ouabain (1 mM) application
(p<0.005).
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The results of superfusion of 1 mM ouabain onto Purkinje neurons of Sprague-Dawley rats
of various ages are presented in Figure 14 and Table 6. Figure 14 presents a plot of the magnitude
of the depolarization induced by ouabain superfusion with respect to age. As can be seen, there is
a statistically significant increase (p<0.005) in the magnitude of depolarization with increasing
animal age indicating an increase in the contribution of the Na+,K+-pump to RMP with
development. As noted for Figure 13, the application of ouabain typically led to a slight decrease
of the IR of Purkinje neurons (mean = 3.9 ± 0.9) but there was no statistically significant agedependent effect of ouabain on IR (p>0.005). Illustrated in Table 6 are the values used to construct
Figure 14 (magnitude of ouabain-induced depolarization) as well as the mean final membrane
potential of neurons after obtaining maximal depolarization. Interestingly, these final membrane
potentials were quite similar irrespective of age and were not significantly different from each other
(p<0.005).
The remaining experiments described below were concerned primarily with the agonist
sensitivity of Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats. As these studies represent
the primary focus of this manuscript, no further experiments were conducted concerning the
developmental hyperpolarization of Purkinje neurons. However, due to the possible impact of this
hyperpolarization on membrane responses to other agonists, the results described in succeeding
sections are divided into those obtained from animals less than 15 days of age (P10-14) and those
15 days of age or older (P15+).

C. Intracellular Comparison of Sprague-Dawley and GEPR-NE Purkinje Neurons
For a control group of animals, the studies presented in this manuscript employed normal
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Sprague-Dawley rats. However, there is a genetic control strain of GEPR animals (GEPR-NEs)
which were derived from Sprague-Dawley stock. Thus, it was pertinent to compare membrane
responses from Sprague-Dawley and GEPR-NE rats to ensure that no differences exist. If, in fact,
no differences existed between Sprague-Dawley and GEPR-NE Purkinje neurons, the data obtained
from Sprague-Dawley animals could be considered a valid source of control data with which to
compare similar data obtained from GEPR-9 and GEPR-3 animals. In addition, similarities between
the GEPR-NE and Sprague-Dawley animals would provide further evidence that any changes
subsequently observed for seizure-prone animals was a possible contributor to the epileptic nature
of these animals. On the other hand, common differences of epileptic (GEPR-3 and GEPR-9) and
non-epileptic (GEPR-NE) compared to Sprague-Dawley animals would not likely be involved in
seizure predisposition due to the absence of seizure susceptibility in the GEPR-NEs.
In order to compare the GEPR-NE and Sprague-Dawley rats, the membrane responses to
various drugs and neurotransmitters were measured using intracellular recording techniques. The
first step of these studies was to compare the effects of single concentrations of drug on the
membrane potential of Purkinje neurons. The effects of GABA receptor agonists (muscimol,
GABA, and baclofen) as well as the GABAA-receptor antagonist, bicuculline, on the membrane
potential are presented in Table 7 for P10-14 and P15+ animals. Both GABA (10 µM) and the
GABAA-selective agonist, muscimol (1 µM), induced prominent hyperpolarizations of the Purkinje
neuron membrane which were not statistically different between animals for either age group
(p<0.05). Furthermore, these hyperpolarizations were antagonized by bicuculline (30 µM), which
had no effect on the membrane potential when given alone. Baclofen, a GABAB-receptor agonist,
also had very little effect on the membrane potential at a concentration of 10 µM.
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Sprague-Dawley
(P10-14)4

GEPR-NE
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-NE
(P15+)

Muscimol (1µM)§

-11.3 ± 0.4
(17)+

-10.8 ± 0.6
(6)

-11.6 ± 0.2
(78)

-11.3 ± 0.3
(8)

Muscimol (1µM) +
Bicuculline (10µM)

-0.3 ± .2
(3)

0.5 ±0.6
(6)

-0.1 ± 0.3
(9)

-0.1 ± 0.5
(6)

GABA (10µM)§

-11.7 ± 0.7
(5)

-10.3 ± 0.7
(6)

-11.1 ± 0.2
(14)

-11.6 ± 0.3
(12)

GABA (10µM) +
Bicuculline (10µM)

-0.1 ± 1.1
(3)

0.7 ± 0.5
(5)

-1.2 ± 0.3
(4)

0.8 ± 0.4
(8)

Bicuculline (30µM)

0.6 ± 0.4
(3)

0.1 ± 0.5
(4)

1.0 ± 0.5
(6)

-0.1 ± 0.5
(6)

-1.6 ± 0.2
-0.3 ± 0.6
-0.9 ± 0.2
1.0 ± 0.4
(3)
(6)
(6)
(6)
TABLE 7. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-NE rats induced by various GABA-receptor agonists and antagonists
as determined using intracellular recording techniques. §Indicates that only hyperpolarizing
responses to these GABAA-receptor agonists were included in the mean values. Means are reported
± S.E.M. There were no significant differences between the responses for a given drug (or
combination of drugs) for identical age groups between the two animal strains (p<0.05). +Indicates
sample size (number of cells). 4Indicates that the group includes only Purkinje neurons from
animals between the ages of 10 and 14 days postnatal. LIndicates that the group includes only
Purkinje neurons from animals 15 days postnatal or older.
Baclofen (10µM)
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As noted in the legend to Table 7, the mean effects for GABA and muscimol on the
membrane potential presented reflect only hyperpolarizing responses which were obtained. An
unexpected outcome of these experiments was occasional depolarizing effects of these agonists
when applied to Purkinje neurons from animals less than 15 days of age. These depolarizations,
which were quite variable in amplitude, occurred for six Sprague-Dawley and three GEPR-NE
Purkinje neurons and led to mean depolarizations of 6.0±1.1mV and 4.6±1.6 mV, respectively,
when both GABA and muscimol responses are pooled. Since both the mean ampltitude and relative
occurrence (21% of Sprague-Dawley and 23% of GEPR-NE Purkinje neurons) of these
depolarizations were similar between animals, they were not investigated further.
Table 8 presents the mean membrane depolarizing effects of the excitatory neurotransmitters,
glutamate and aspartate, at a concentration of 10 µM in young (P10-14) and old (P15+) animals
determined using intracellular recording techniques. As for the GABA receptor ligands, there were
no significant differences between the two animal strains for either age group in response to these
depolarizing agonists (p<0.05). The Purkinje neurons from younger animals responded differently
from those obtained from older animals in both rat strains. In the case of aspartate and glutamate
this was in the form of a slight but significant increase in the depolarizing effect of these agonists
in the older animals (p<0.05).
The next step in comparing the Sprague-Dawley and GEPR-NE animals was to determine
concentration-response curves to agonists of the major neurotransmitter receptors for Purkinje
neurons from animals 15 days and older (P15+). Concentration-response curves were constructed
by superfusing single, increasing concentrations of drug while allowing recovery to RMP between
applications as described in the methods (section VI). The responses to each of these agonists are
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Glutamate (10µM)

Sprague-Dawley
(P10-14)4

GEPR-NE
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-NE
(P15+)

12.8 ± 0.3
(7)+

12.9 ± 0.6
(5)

16.7 ± 0.2
(9)

16.3 ± 0.3
(8)

10.8 ± 0.4
11.6 ± 0.6
13.6 ± 0.2
13.2 ± 0.4
(4)
(5)
(9)
(7)
TABLE 8. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-NE rats induced by excitatory agonists as determined using intracellular
recording techniques. Means are reported ± S.E.M. There were no significant differences between
the responses for either agonist for identical age groups between the two animal strains (p<0.05).
+
Indicates the sample size (number of cells). 4Indicates that the group includes only Purkinje
neurons from animals between the ages of 10 and 14 days postnatal. LIndicates that the group
includes only Purkinje neurons from animals 15 days postnatal or older.
Aspartate (10µM)
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relatively rapid and, thus, drug application time was typically one minute or less.

Full

concentration-response curves to GABA, muscimol, glutamate, and aspartate are depicted in Figures
15 through 18. In each case, the membrane response (hyperpolarization for GABA and muscimol;
depolarization for glutamate and aspartate) was normalized to the maximum response obtained with
Sprague-Dawley Purkinje neurons, such that differences in maximal responses would still be evident
by examining the concentration-response curve. Curves were fit by non-linear regression analysis
using SigmaPlot software (Jandel Scientific), and the subsequent best fit estimations of EC50 values
are reported.
Figure 15 is the concentration-response curve generated from the superfusion of GABA at
various concentrations (0.1-300 µM). Maximal hyperpolarizing responses, of approximately 15 mV
in magnitude, were similar for both Sprague-Dawley and GEPR-NE rats. The geometric mean EC50
values for Sprague-Dawley and GEPR-NE Purkinje neurons were 6.6 ± 0.7 µM and 6.1 ± 0.6 µM,
respectively. Likewise, the concentration-response curves to muscimol superfusion (Figure 16)
yielded similar curves for both Sprague-Dawley and GEPR-NE animals, with EC50 values of 0.61
± 0.05 µM and 0.70 ± 0.05 µM, respectively, and maximal hyperpolarizations of approximately 15
mV in magnitude.
Concentration-response curves for the excitatory neurotransmitters, glutamate and aspartate,
are depicted in Figures 17 and 18, respectively. Again, a high degree of similarity between the
curves for Purkinje neurons from both animal strains is evident. For both GEPR-NE and SpragueDawley rats, glutamate and aspartate induced maximal depolarizations of approximately 17-18 mV,
with glutamate doing so at a slightly lower concentration. Glutamate EC50 values were 3.3 ± 0.3
µM and 3.0 ± 0.2 µM, whereas aspartate EC50 values were 6.3 ± 0.6 µM and 7.2 ± 0.6 µM for
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FIGURE 15. Concentration-response curves of Purkinje neurons to superfusion of GABA.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal hyperpolarization for Purkinje neurons from Sprague-Dawley and GEPRNE rats (p>0.05). Data are presented as mean ± S.E.M.
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FIGURE 16. Concentration-response curves of Purkinje neurons to superfusion of muscimol.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal hyperpolarization for Purkinje neurons from Sprague-Dawley and GEPRNE rats (p>0.05). Data are presented as mean ± S.E.M.
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FIGURE 17. Concentration-response curves of Purkinje neurons to superfusion of glutamate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-NE
rats (p>0.05). Data are presented as mean ± S.E.M.
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FIGURE 18. Concentration-response curves of Purkinje neurons to superfusion of aspartate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-NE
rats (p>0.05). Data are presented as mean ± S.E.M.
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Sprague-Dawley and GEPR-NE Purkinje neurons, respectively.
D. Intracellular Comparison of Sprague-Dawley and GEPR-9 Purkinje Neurons
Having found no differences in agonist responsiveness between the genetically-epilepsy
prone rat control strain (GEPR-NE) and Sprague-Dawley rats, the next group of experiments to be
performed was a comparison of GEPR-9 rats, the most severely seizure-prone strain, to SpragueDawley rats in order to determine if the subsensitivity to GABAA-receptor activation observed in
situ (Gould, 1991, 1995) was demonstrable in the in vitro model employed in the present studies
and, if so, to determine the degree of this subsensitivity. In addition, further clues as to the
mechanism of the decreased responsiveness were also sought. To accomplish these tasks,
experiments similar to those just described above were employed utilizing intracellular recording
techniques in vermal cerbellar slices of Sprague-Dawley and GEPR-9 rats. It should be noted that
the data provided for neurons in the Sprague-Dawley strain presented in this section are the same
data as those presented in the previous section for comparisons to the GEPR-NE.
The initial experiments performed examined the effect of single concentrations of various
drugs and neurotransmitters on the membrane polarization of Purkinje neurons in cerebellar slices.
The effects of various GABA receptor agonists (GABA, muscimol, and baclofen) and antagonists
(bicuculline and picrotoxin) on Purkinje neurons from P10-14 and P15+ Sprague-Dawley and
GEPR-9 rats are listed in Table 9. In response to both 1 µM muscimol and 10 µM GABA, Purkinje
neurons from GEPR-9 rats displayed a significantly reduced hyperpolarization, irrespective of age
(p<0.05). The effects of both agonists were blocked by either bicuculline (30 µM) and/or picrotoxin
(10 µM) indicating that GABA and muscimol were exerting their effects via GABAA-receptor
activation. In addition, bicuculline (30 µM) was without significant effect when superfused alone.
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Sprague-Dawley
(P10-14)4

GEPR-9
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-9
(P15+)

Muscimol (1µM)§

-11.3 ± 0.4*
(17)+

-5.0 ± 0.5*
(11)

-11.6 ± 0.2**
(78)

-5.2 ± 0.2**
(69)

Muscimol (1µM) +
Bicuculline (10µM)

-0.3 ± .2
(3)

0.2 ±0.3
(3)

-0.1 ± 0.3
(9)

0.1 ± 0.2
(7)

GABA (10µM)§

-11.7 ± 0.7*
(5)

-3.7 ± 0.4*
(7)

-11.1 ± 0.2**
(14)

-4.8 ± 0.2**
(12)

GABA (10µM) +
Bicuculline (10µM)

-0.1 ± 1.1
(3)

0.1 ± 0.7
(6)

-1.2 ± 0.3
(4)

-0.2 ± 0.3
(5)

GABA (10µM) +
Picrotoxin (10µM)

0.3 ± 0.3
(3)

0.9 ± 0.4
(4)

1.3 ± 0.5
(3)

-0.1 ± 0.2
(5)

Bicuculline (30µM)

0.6 ± 0.4
(3)

-0.7 ± 0.3
(4)

1.0 ± 0.5
(6)

0.2 ± 0.2
(8)

-1.6 ± 0.2*
1.3 ± 0.2*
-0.9 ± 0.2
0.3 ± 0.2
(3)
(4)
(6)
(11)
TABLE 9. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-9 rats induced by various GABA-receptor agonists and antagonists as
determined using intracellular recording techniques. §Indicates that only hyperpolarizing responses
to these GABAA-receptor agonists were included in the mean values. Means are reported ± S.E.M.
*Denotes a significantly different response between the two animal strains for the indicated agonist
during the 10-14 day postnatal age period (p<0.05). **Denotes a significantly different response
between the two animal strains for the indicated agonist during the 15 day and older postnal age
period (p<0.05). +Indicates sample size (number of cells). 4Indicates that the group includes only
Purkinje neurons from animals between the ages of 10 and 14 days postnatal. LIndicates that the
group includes only Purkinje neurons from animals 15 days postnatal or older.
Baclofen (10µM)
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Baclofen (10 µM), a GABAB-selective agonist, had minimal effects on Purkinje neurons from either
animal strain. Though minimal, these effects were significantly different for animals 10-14 days
of age (P10-14), inducing a slight hyperpolarization in Sprague-Dawley Purkinje neurons and a
slight net depolarization in GEPR-9 Purkinje neurons.
As stated when comparing Sprague-Dawley and GEPR-NE Purkinje neurons, this table only
includes hyperpolarizing responses to muscimol and GABA for animals in the P10-14 age group.
Again, the depolarizing responses in the young animals were not further investigated as they were
a minority of the neurons investigated (21% for Sprague-Dawley, 31% for GEPR-9). However, it
should be noted that the depolarizing responses to muscimol in P10-14 animals were significantly
decreased for GEPR-9 Purkinje neurons compared to Sprague-Dawley neurons, with mean
depolarizations of 2.1 ± 0.4 mV and 6.0 ± 1.1 mV, respectively. There were not enough
depolarizing responses to GABA to make statistical comparisons.
These studies next focused on excitatory neurotransmission by examining the depolarizing
effects of single concentrations of glutamate (10 µM), aspartate (10 µM), and N-methyl-D-aspartate
(NMDA; 10 µM). As can be seen in Table 10, unlike the responses to GABA and muscimol, the
responses to all three of these agonists, though varying with age, were never significantly different
when comparing the two animal strains at equivalent ages (p>0.05). Once again, a significant
increase in the effects of glutamate and aspartate were observed in the older (P15+) animals
(p<0.05), but these shifts in responsiveness were equivalent for both groups of animals.
Unexpectedly, the depolarizing responses to NMDA (10 µM) had the exact opposite trend, that is,
they were significantly decreased in the older animals (P15+). Examining these responses over a
more precise time course further indicated that, whereas, glutamate and aspartate had large increases
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Sprague-Dawley
(P10-14)4

GEPR-9
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-9
(P15+)

Glutamate (10µM)

12.8 ± 0.3
(7)+

12.6 ± 0.4
(6)

16.7 ± 0.2
(9)

16.2 ± 0.2
(12)

Aspartate (10µM)

10.8 ± 0.4
(4)

11.7 ± 0.5
(7)

13.6 ± 0.2
(9)

13.1 ± 0.2
(12)

5.5 ± 0.3
4.8 ± 0.4
2.2 ± 0.4
3.0 ± 0.3
(8)
(6)
(17)
(12)
TABLE 10. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-9 rats induced by excitatory agonists as determined using intracellular
recording techniques. Means are reported ± S.E.M. There were no significant differences between
the responses for any of the agonists for identical age groups between the two animal strains
(p<0.05). +Indicates the sample size (number of cells). 4Indicates that the group includes only
Purkinje neurons from animals between the ages of 10 and 14 days postnatal. LIndicates that the
group includes only Purkinje neurons from animals 15 days postnatal or older.
NMDA (10µM)
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in response in P15-19 vs. P10-14 animals (Sprague-Dawley, GEPR-NE, and GEPR-9), the decrease
in response to NMDA was quite gradual, slowly decreasing with age (data not shown).
Having demonstrated single concentrations at which GEPR-9 Purkinje neurons displayed
reduced responses to both GABA and muscimol, the next step was to complete full concentration
response curves in 15 day and older animals (P15+; as described above and in section VI) to better
determine the nature and magnitude of this decreased responsiveness.

All responses were

normalized to the maximal response obtained in Sprague-Dawley neurons. Figure 19 contains
concentration-response curves to GABA for both Sprague-Dawley and GEPR-9 Purkinje neurons.
Though the magnitude of the maximal responses to GABA were not significantly different between
Sprague-Dawley and GEPR-9 Purkinje neurons (p>0.05; -14.5 ± 0.9 mV and -15.2 ± 1.1 mV,
respectively), there was a distinct shift to the right of the concentration-response curve. Analysis
of the best fit curves via non-linear regression analysis provided estimates of the GABA geometric
mean EC50 values and were 6.6 ± 0.7 µM and 20.6 ± 1.5 µM for Sprague-Dawley and GEPR-9
Purkinje neurons, respectively. These EC50 values were significantly different (p<0.05) and revealed
an approximate 3.1-fold rightward shift of the GABA concentration-response curve for GEPR-9
compared to Sprague-Dawley Purkinje neurons.
When concentration-response curves for muscimol were constructed for these two animal
strains (Figure 20), similar results were seen. The maximal responses were, again, not statistically
different (p>0.05; -15.1 ± 0.7 mV for Sprague-Dawley; -14.2 ± 0.6 mV for GEPR-9), while there
was a significant shift in the overall concentration-response curve. Muscimol geometric mean EC50
values obtained from the best fit parameters of these curves were estimated as 0.61 ± 0.05 µM for
Sprague-Dawley neurons and 1.8 ± 0.2 µM for GEPR-9 neurons, yielding an approximate 3.0-fold
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FIGURE 19. Concentration-response curves of Purkinje neurons to superfusion of GABA.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There was no statistically significant difference in the maximal hyperpolarization
for Purkinje neurons from Sprague-Dawley and GEPR-9 rats (p>0.05). The estimated geometric
mean EC50 for GEPR-9 Purkinje neurons was shifted approximately 3-fold to the right of that for
Sprague-Dawley Purkinje neurons. Data are presented as mean ± S.E.M.
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FIGURE 20. Concentration-response curves of Purkinje neurons to superfusion of muscimol.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There was no statistically significant difference in the maximal hyperpolarization
for Purkinje neurons from Sprague-Dawley and GEPR-9 rats (p>0.05). The estimated geometric
mean EC50 for GEPR-9 Purkinje neurons was shifted approximately 3-fold to the right of that for
Sprague-Dawley Purkinje neurons. Data are presented as mean ± S.E.M.
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shift of the concentration response curve.
To ensure that there were no differences in the responsiveness of GEPR-9 Purkinje neurons
to glutamate or aspartate compared to Sprague-Dawley rats which were not revealed by the single
concentration comparisons (such as a change in maximal response), concentration-response curves
to these excitatory amino acids were also constructed and are depicted as Figures 21 and 22,
respectively. As for the GEPR-NE Purkinje neurons, there were no significant differences in either
the maximal responses obtained or in the geometric mean EC50 values for glutamate or aspartate in
GEPR-9 Purkinje neurons compared to Sprague-Dawley neurons (p>0.05).

Maximal

depolarizations of 17-18 mV were obtained in both animal strains to glutamate and aspartate.
Geometric mean EC50 values for GEPR-9 Purkinje neurons were 3.3 ± 0.3 µM for glutamate and
6.5 ± 0.7 µM for aspartate and were similar to those obtained for Sprague-Dawley Purkinje neurons
(glutamate, 3.2 ± 0.3 µM; aspartate 6.3 ± 0.6 µM).
In an attempt to further elucidate the possible mechanism of this apparent selective
subsensitivity of GEPR-9 Purkinje neurons to GABAA-receptor activation, the next set of
experiments surveyed the effects of two modulators of the GABAA-receptor complex,
norepinephrine and diazepam, on Purkinje neurons from P15+ aged animals. In order to conduct
these experiments, GABA concentrations near the EC 50 value for each animal (and thus
equieffective) were chosen, and these were 7 and 20 µM for Sprague-Dawley and GEPR-9 strains,
respectively. Norepinephrine (500 µM) or diazepam (100 µM) was then superfused for 1 minute
and the effects on membrane potential were measured. After a 5 minute recovery period, the
appropriate estimated EC50 concentration of GABA was superfused for 1 minute and the effects on
membrane potential were measured. Following another 5 minute recovery period, the combination
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FIGURE 21. Concentration-response curves of Purkinje neurons to superfusion of glutamate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-9
rats (p>0.05). Data are presented as mean ± S.E.M.
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FIGURE 22. Concentration-response curves of Purkinje neurons to superfusion of aspartate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-9
rats (p>0.05). Data are presented as mean ± S.E.M.
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of GABA and modulator (norepinephrine or diazepam) was superfused for 1 minute and the
subsequent membrane polarization effects measured. The results of these experiments are detailed
in Table 11.
As can be seen in Table 11, both norepinephrine and diazepam induced small
hyperpolarizations when given alone to Purkinje neurons from both animal strains and these
membrane potential changes were not significantly different between animal strains (p<0.05).
Importantly, the concentrations of GABA chosen (7 µM, Sprague-Dawley; 20 µM, GEPR-9) did
produce statistically equivalent membrane hyperpolarizations of about half maximal responses as
determined during concentration-response curve construction. When combinations of either
GABA+norepinephrine or GABA+diazepam were applied, potentiated hyperpolarizations of roughly
equivalent magnitude were observed for Purkinje neurons from either animal strain. Furthermore,
the differences in the magnitude of the combination drug treatment and the GABA treatment were
also not statistically different between animal strains (p<0.05).
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Sprague-Dawley

GEPR-9

-2.5 ± 0.3

-2.4 ± 0.3

GABAA

-7.5 ± 0.3

-6.9 ± 0.3

GABA +
Norepinephrine (500µM)B

-13.5 ± 0.3

-12.7 ± 0.6

Difference (B-A)

-6.0 ± 0.2
(6)+

-5.8 ± 0.3
(5)

Sprague-Dawley

GEPR-9

-1.4 ± 0.3

-1.1 ± 0.3

GABAC

-8.4 ± 0.4

-7.6 ± 0.3

GABA +
Diazepam (100µM)D

-13.3 ± 0.6

-13.0 ± 0.3

Norepinephrine (500µM)
‡
‡

Diazepam (100µM)
‡
‡

-4.9 ± 0.5
-5.4 ± 0.5
(6)
(6)
TABLE 11. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-9 rats induced by GABA and/or modulators of the GABAA-receptor
as determined using intracellular recording techniques. Drugs were superfused sequentially for 1
minute at 5 minute intervals. ‡Concentrations of GABA used for each animal strain were chose to
approximate the EC50 concentrations as reported in the text (Sprague-Dawley, 7 µM; GEPR-9, 20
µM). Means are reported ± S.E.M. There were no significantly different responses to drug
superfusion between the two animal strains nor were the changes in response (for GABA vs. GABA
+ modulator) significantly different (p<0.05). All animals used for these experiments were postnatal
day 15 or older. +Indicates sample size (number of cells).
Difference (D-C)
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E. Intracellular comparison of Sprague-Dawley and GEPR-3 Purkinje Neurons
Having observed an approximate 3-fold subsensitivity of GEPR-9 Purkinje neurons to
GABAA-receptor activation compared to Sprague-Dawley Purkinje neurons, the next set of
experiments were similarly designed to investigate possible deficits in the GEPR-3, a moderately
seizure-prone animal model. Thus, as with both the GEPR-NE and GEPR-9, these studies began
by evaluating the responses of Purkinje neurons from GEPR-3 animals to single concentrations of
drugs and comparing these effects to those observed for Sprague-Dawley Purkinje neurons. Once
again, it should be noted that the data presented in this section for Sprague-Dawley Purkinje
neurons have been previously presented in the preceding paragraphs.
The first set of experiments, looking at GABA receptor activation and blockade, employed
the same concentrations of agonist as used previously. The results of these experiments are
presented in Table 12. As can be seen in this table, the ability of both muscimol (1 µM) and GABA
(10 µM) to evoke hyperpolarizations of GEPR-3 Purkinje neurons was slightly, but significantly
reduced (p<0.05) for both young (P10-14) and older (P15+) animals.

As expected these

hyperpolarizations were antagonized by bicuculline (30 µM) in both animal strains and bicuculline
alone, at this concentration, had no significant effect on the membrane potential in either animal
strain. Represented in this table are only the hyperpolarizing responses to GABA and muscimol.
However, for GEPR-3 Purkinje neurons, only 1 cell (7% of total) depolarized in the presence of
GABA or muscimol (compared to 21% for Sprague-Dawley).
Similar to the results observed for GEPR-9 Purkinje neurons, baclofen (10 µM) induced a
slight depolarization of P10-14 GEPR-3 Purkinje neurons which was great enough to be statistically
different from the minor hyperpolarization in response to baclofen for Sprague-Dawley Purkinje
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Sprague-Dawley
(P10-14)4

GEPR-3
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-3
(P15+)

Muscimol (1µM)§

-11.3 ± 0.4*
(17)+

-8.5 ± 0.4*
(7)

-11.6 ± 0.2**
(78)

-9.6 ± 0.3**
(14)

Muscimol (1µM) +
Bicuculline (10µM)

-0.3 ± .2
(3)

0.5 ±0.8
(4)

-0.1 ± 0.3
(9)

0.4 ± 0.9
(5)

GABA (10µM)§

-11.7 ± 0.7*
(5)

-9.1 ± 0.4*
(5)

-11.1 ± 0.2**
(14)

-10.1 ± 0.3**
(15)

GABA (10µM) +
Bicuculline (10µM)

-0.1 ± 1.1
(3)

1.0 ± 0.6
(5)

-1.2 ± 0.3
(4)

0.6 ± 0.5
(5)

Bicuculline (30µM)

0.6 ± 0.4
(3)

0.1 ± 0.5
(4)

1.0 ± 0.5
(6)

-0.1 ± 0.5
(6)

-1.6 ± 0.2*
1.1 ± 0.6*
-0.9 ± 0.8
1.2 ± 0.6
(3)
(4)
(6)
(4)
TABLE 12. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-3 rats induced by various GABA-receptor agonists and antagonists as
determined using intracellular recording techniques. §Indicates that only hyperpolarizing responses
to these GABAA-receptor agonists were included in the mean values. Means are reported ± S.E.M.
*Denotes a significantly different response between the two animal strains for the indicated agonist
during the 10-14 day postnatal age period (p<0.05). **Denotes a significantly different response
between the two animal strains for the indicated agonist during the 15 day and older postnal age
period (p<0.05). +Indicates sample size (number of cells). 4Indicates that the group includes only
Purkinje neurons from animals between the ages of 10 and 14 days postnatal. LIndicates that the
group includes only Purkinje neurons from animals 15 days postnatal or older.
Baclofen (10µM)
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neurons (p<0.05). Presented in Table 13 are the single concentration responses of Purkinje neurons
from GEPR-3 and Sprague-Dawley animals for the excitatory agonists, glutamate (10 µM) and
aspartate (10 µM). As expected and as seen for GEPR-9 Purkinje neurons, there was no statistically
significant difference between the responses of Purkinje neurons from GEPR-3 and Sprague-Dawley
rats to either of these agonists for either age group (p>0.05) and the increase in responsiveness to
both agonists increased with age in a similar manner.
To further evaluate the responsiveness of GEPR-3 Purkinje neurons to GABA, muscimol,
glutamate, and aspartate, concentration-response curves were constructed for animals 15 days and
older (P15+) and compared to those obtained from Sprague-Dawley Purkinje neurons. Figure 23
is a comparison of the GABA concentration-response curves. As can be seen in Figure 23, quite
a different alteration in responsiveness to GABA was evident for GEPR-3 Purkinje neurons
compared to Sprague-Dawley neurons than was observed for GEPR-9 neurons. Rather than the
parallel rightward shift of the concentration-response curve which was observed for GEPR-9
neurons, GEPR-3 Purkinje neurons displayed a significantly decreased maximal response (-12.4 ±
0.5 mV) when compared to Sprague-Dawley Purkinje neurons (-14.9 ± 0.9 mV) without displaying
a significantly different geometric mean EC50 concentration (p>0.05). When approximated using
non-linear regression analysis of the concentration-response curves, the GABA geometric mean
EC50 values for Sprague-Dawley and GEPR-3 Purkinje neurons were -6.6 ± 0.7 µM and -6.4 ± 0.7
µM, respectively.
When concentration-response curves to muscimol were constructed (Figure 24) a similar
pattern was observed. While the maximal hyperpolarization induced by muscimol for GEPR-3
Purkinje neurons (-13.2 ± 0.6 mV) was significantly less than the maximal hyperpolarization
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Glutamate (10µM)

Sprague-Dawley
(P10-14)4

GEPR-3
(P10-14)

Sprague-Dawley
(P15+)L

GEPR-3
(P15+)

12.8 ± 0.3
(7)+

12.2 ± 0.7
(5)

16.7 ± 0.2
(9)

16.3 ± 0.4
(8)

10.8 ± 0.4
10.9 ± 0.6
13.6 ± 0.2
13.3 ± 0.4
(4)
(4)
(9)
(6)
TABLE 13. Changes in membrane potential of Purkinje neurons in vermal cerebellar slices from
Sprague-Dawley and GEPR-3 rats induced by excitatory agonists as determined using intracellular
recording techniques. Means are reported ± S.E.M. There were no significant differences between
the responses for either agonist for identical age groups between the two animal strains (p<0.05).
+
Indicates the sample size (number of cells). 4Indicates that the group includes only Purkinje
neurons from animals between the ages of 10 and 14 days postnatal. LIndicates that the group
includes only Purkinje neurons from animals 15 days postnatal or older.
Aspartate (10µM)
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FIGURE 23. Concentration-response curves of Purkinje neurons to superfusion of GABA.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There was no statistically significant difference in the estimated geometric mean
EC50 for Purkinje neurons from Sprague-Dawley and GEPR-3 rats (p>0.05). The responses of
GEPR-3 Purkinje neurons were significantly reduced compared to those from Sprague-Dawley
Purkinje neurons at concentrations of 10 µM and above (p<0.05). Data are presented as the mean
± S.E.M.

-122-

% Sprague-Dawley Max

100

Sprague-Dawley
GEPR-3

80

60

40

20

0
-8

-7

-6

-5

-4

log [Muscimol]

FIGURE 24. Concentration-response curves of Purkinje neurons to superfusion of muscimol.
Hyperpolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There was no statistically significant difference in the estimated geometric mean
EC50 for Purkinje neurons from Sprague-Dawley and GEPR-3 rats (p>0.05). The responses of
GEPR-3 Purkinje neurons were significantly reduced compared to those from Sprague-Dawley
Purkinje neurons at concentrations of 1 µM and above (p<0.05). Data are presented as the mean
± S.E.M.
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observed for Sprague-Dawley Purkinje neurons (-15.1 ± 0.7 mV; p<0.05), the estimated geometric
mean EC50 values were not significantly different (p>0.05).

The geometric mean EC50

concentrations of muscimol were 0.61 ± 0.05 µM and 0.75 ± 0.07 µM for Sprague-Dawley and
GEPR-3 Purkinje neurons, respectively.
The concentration-response curves for glutamate (Figure 25) and aspartate (Figure 26)
revealed similar maximal depolarizations of the membrane potential as well as similar EC50 values
when GEPR-3 and Sprague-Dawley Purkinje neurons were compared. Both agents induced
approximately a 17-18 mV maximal depolarization of the neuronal membrane for cells from both
animal strains. Using non-linear regression analysis to estimate geometric mean EC50s gave values
that were not statistically different between animal strains (p>0.05). These values for glutamate
were 3.2 ± 0.3 µM (Sprague-Dawley) and 2.9 ± 0.3 µM (GEPR-3). For aspartate, the geometric
mean EC50 estimations were 6.3 ± 0.6 µM (Sprague-Dawley) and 5.3 ± 0.5 µM (GEPR-3).
As a summary of the results obtained from the construction of concentration-response curve
for GABA, muscimol, glutamate, and aspartate in Sprague-Dawley, GEPR-NE, GEPR-3, and
GEPR-9 animals, Table 14 lists geometric mean EC50 values as well as the relative shifts of the
EC50/concentration-response curve. The magnitude of the shift simply represents the EC50 value of
the appropriate test group divided by the corresponding EC50 value estimated for Sprague-Dawley
Purkinje neurons. This value is given as a discrete number without a standard error or confidence
interval and is meant to represent an approximate shift of the concentration-response curve.

-124-

% Sprague-Dawley Max

100

Sprague-Dawley
GEPR-3

80

60

40

20

0
-7

-6

-5

-4

log [glutamate]

FIGURE 25. Concentration-response curves of Purkinje neurons to superfusion of glutamate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-3
rats (p>0.05). Data are presented as mean ± S.E.M.

-125-

% Sprague-Dawley Max

100

Sprague-Dawley
GEPR-3

80

60

40

20

0
-7

-6

-5

-4

-3

log [aspartate]

FIGURE 26. Concentration-response curves of Purkinje neurons to superfusion of aspartate.
Depolarizing responses are normalized to the percent of the maximal Sprague-Dawley Purkinje
neuron response. There were no statistically significant differences in the estimated geometric mean
EC50 (see text) or maximal depolarization for Purkinje neurons from Sprague-Dawley and GEPR-3
rats (p>0.05). Data are presented as mean ± S.E.M.
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Sprague-Dawley

GEPR-NE

GEPR-3

GEPR-9

Aspartate (µM)

6.3 ± 0.6
(6)

7.2 ± 0.6
(5)
*1.14

5.4 ± 0.5
(5)
*0.85

6.5 ± 0.7
(6)
*1.03

Glutamate (µM)

3.2 ± 0.3
(7)

3.0 ± 0.2
(5)
*0.94

2.9 ± 0.3
(5)
*0.91

3.3 ± 0.3
(6)
*1.03

GABA (µM)

6.6 ± 0.7
(7)

6.1 ± 0.6
(6)
*0.92

6.4 ± 0.7
(6)
*0.97

#

20.6 ± 1.5
(8)
*3.12

#
1.93 ± 0.17
0.70 ± 0.05
0.76 ± 0.07
(9)
Muscimol (µM)
(6)
(7)
*3.16
*1.14
*1.25
TABLE 14. Geometric mean EC50 values ± S.E.M. (in µM) determined from concentrationresponse curves (see text) for membrane polarization effects of various agonist using intracellular
recording techniques in Purkinje neurons. Number in parentheses indicates the number cells.
*Indicates relative magnitude of geometric mean values compared to Sprague-Dawley control
animals as an indicator of the shift in the concentration-response curve (e.g., 1=no shift). #Indicates
a statistically significant difference/shift of this EC50 value for GEPR-9 rats to both GABA and
muscimol compared to all other groups (p<0.05).

0.61 ± 0.05
(8)
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F. Comparison of GABA Responses Using the Whole-Cell Patch-Clamp Technique
The next phase of these studies was to investigate GABAA-receptor activation using the
whole-cell patch-clamp technique. This technique allowed for a more direct and precise comparison
of receptor activation between animal strains. In these studies, P15+ Sprague-Dawley, GEPR-3, and
GEPR-9 animals were investigated. One technique used to make comparisons was to construct
concentration-response curves for the peak (IP) and steady-state (ISS) whole-cell currents activated
by GABA superfusion at a holding potential (VH) of -60 mV, near the mean RMP determined for
P15+ Purkinje neurons in the earlier intracellular studies (see Table 4). The second technique
employed was to voltage-clamp the membrane potential at various potentials and measure the peak
current induced by a saturating concentration of GABA (1mM). These results were then used to
construct mean I/V curves for each animal strain (see section VI).
As mentioned in the methods (section VI), prior to voltage -clamping, RMP and IR values
were briefly estimated upon initially achieving the whole-cell configuration. The mean RMP and
IR values from these estimations are provided in Table 15. Though the RMP values obtained via
the whole-cell patch-clamp technique were quite similar to the mean values obtained using
intracellular techniques (Table 4), the mean IR values were dramatically increased compared to
those obtained via intracellular recording (Table 5). Similar to the results obtained via intracellular
recording, neither the RMP nor the IR were significantly different between animal strains (p>0.05).
The first series of experiments examined the whole-cell conductance properties of Purkinje
neurons voltage-clamped at a holding potential of -60 mV.

After superfusing multiple

concentrations of GABA for several neurons, mean concentration-response curves for whole cell
conductance were constructed. Figure 27 presents concentration-response curves constructed for
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Sprague-Dawley

GEPR-3

GEPR-9

Resting Membrane
Potential (mV)

-61.2 ± 1.4

-62.6 ± 1.6

-58.6 ± 2.6

Input Resistance
(M )

454 ± 22

491 ± 13

445 ± 22

Number of Cells
17
18
14
TABLE 15. Resting membrane potential (mV) and input resistance (M ) of Purkinje neurons in
cerebellar slices immediately following attainment of whole cell configuration of the patch-clamp
technique. There were no statistically significant differences between animal strains (p<0.05).
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Sprague-Dawley, GEPR-3, and GEPR-9 Purkinje neuron peak current (IP) amplitudes. Also
included as an inset to Figure 27 is the plot to determine the Hill coefficient (log-log plot of IP ÷
(Imax-IP) vs. [GABA]). Similar to concentration-response curves obtained via intracellular recording,
the GEPR-9 response curve was shifted rightward without a significant decrease in maximal
response (IP). Unlike the concentration-response curves obtained for GEPR-3 Purkinje neurons
there was no decrease in maximal response when whole-cell peak currents were measured. The
estimated geometric mean EC50 values for the whole-cell concentration response curves were 9.1
± 0.6 µM (Sprague-Dawley), 9.2 ± 0.9 µM (GEPR-3), and 18.2 ± 1.1 µM (GEPR-9), indicating no
shift and a 2-fold rightward shift of the concentration response curves of GEPR-3 and GEPR-9
Purkinje neurons compared to Sprague-Dawley, respectively. The Hill coefficients are represented
in Figure27 as the slopes of the corresponding inset plot. These values were 1.78 (Sprague-Dawley),
1.48 (GEPR-3), and 1.67 (GEPR-9).
Since concentrations of GABA near the EC50 concentration and higher typically caused a
marked level of desensitization with prolonged exposure, concentration-response curves were also
constructed to compare the steady-state (ISS) currents as a function of the higher GABA
concentrations (10 µM-100 µM) employed. These plots can be found in Figure 28. The results of
this analysis revealed that, though GEPR-9 and Sprague-Dawley Purkinje neurons had statistically
equivalent ISS levels at each of these concentrations, GEPR-3 Purkinje neurons displayed
significantly reduced ISS levels compared to Sprague-Dawley Purkinje neurons at both 30 and 100
µM GABA (p<0.05).
The next set of experiments examined the conductance characteristics of Purkinje neurons
at various holding potentials (VH) at a concentration of GABA (1 mM) which gave maximal peak
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Figure 27. Concentration response curves of the mean neuron peak current amplitudes of
Purkinje neurons to superfusion of GABA. Inset represents the Hill plot of concentration
response data.
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Figure 28. Mean concentration response curve of Purkinje neurons to superfusion of higher
concentrations of GABA depicting the steady state current. Note that GEPR-3 neurons
showed reduced steady state current.
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currents in all three animal strains. The mean I/V curves constructed from these experiments are
plotted in Figure 29. Though standard error bars are not included for the plots in this curve for
presentation purposes, it can be seen that Purkinje neurons from all three animal strains displayed
similar peak current characteristics for 1 mM GABA, not differing in IP level at any VH.
Furthermore, the reversal potentials of Purkinje neurons were similar for all three animal strains at
a potential near zero. At a VH of 0 mV, the closest holding potential to the reversal potential, the
current amplitudes of each animal strain were 74 ± 34 pA (Sprague-Dawley), 66 ± 28 pA (GEPR-3),
and 14 ± 24 pA (GEPR-9).
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Figure 29. Mean I/V curves of Purkinje neurons exposed to 1mM GABA held at various
membrane potentials.
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G. Comparison of GABA Responses in Single-Channel Outside-Out Patches
As a final examination of the response characteristics of Purkinje neurons to GABAAreceptor activation, single channel characteristics were studied using the outside-out patch-clamp
technique. The aim of these experiments was to compare the basic conductance properties of single
GABAA-receptor channels from Sprague-Dawley, GEPR-3, and GEPR-9 Purkinje neurons to
determine whether single channel conductance amplitudes were different between animal strains.
Specifically, neuronal steady-state conductances (ISS) were compared with regard to the magnitude
of the single channel conductance states, mean open times, and mean closed times in response to
applications of 100 µM GABA.
These experiments identified two conductance states of the GABA A-receptor, one of
approximately 28 pS (1.70pA current at VH of -60 mV) and another of approximately 21 pS (1.26
pA current at VH of -60 mV). Examples of these two different conductance states are shown in
Figure 9 (section VI). A histogram plot depicting these separate conductance states for GEPR-9
Purkinje neurons is presented in Figure 30. The histogram plots the amplitude of detected open
events versus the frequency with which each of these amplitudes was detected into 0.02 pA bins.
These conductance states were highly consistent between patches from not only single Purkinje
neurons, but also patches from Purkinje neurons from all three animal strains. The larger
conductance level accounted for approximately 95% of the total current observed in these patches,
with only rare openings to the 21 pS “subconductance” level.
Using the Fetchan analysis program of the pClamp software package (Axon Instruments),
the observed total number of openings, mean open durations, and mean closed durations for the
main conductance level (28 pS) at ISS in response to 100 µM GABA were determined and are
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presented in Table 16. Mean observed times are listed as no manipulation of the data was
performed in order to account for missed open and closed events. Figure 31 presents histograms
of open durations for each animal strain, illustrating the similar distribution of open durations
between Purkinje neurons from each strain. A statistical comparison of the mean open and closed
durations revealed no differences between Purkinje neurons from these three animal strains.
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Sprague-Dawley

GEPR-3

GEPR-9

Mean open duration
(msec)

4.20 ± 0.11

3.90 ± 0.34

4.16 ± 0.15

Mean closed duration
(msec)

81.7 ± 2.8

89.1 ± 5.4

85.6 ± 3.6

Number of Openings
2472
1351
1822
TABLE 16. Mean open durations (msec) and closed durations (msec) obtained from single-channel
recordings of Purkinje neurons from Sprague-Dawley, GEPR-3, and GEPR-9 animals. The number
of events represents to total pooled events for each given animal. Data are presented as mean ±
S.E.M. There were no significant differences in mean open or closed duration when comapring any
of the three animal strains (p>0.05).
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FIGURE 30. Histogram plot of the amplitude of detected open events for GEPR-9 Purkinje
neurons. Amplitudes are binned in 0.02 pA increments. Amplitudes include all open events for
GEPR-9 Purkinje neurons (n=1822).
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FIGURE 31. Histogram plots of open durations for Sprague-Dawley, GEPR-3, and GEPR-9
Purkinje neurons upon application of 100 µM GABA. Open durations are plotted in 0.5 msec bins
and plotted as normalized frequency.
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VIII. Discussion
The regulation of cellular responsiveness plays a prominent role in how neurons of the
mammalian central nervous system communicate with one another, and thus, improper regulation
of responsiveness represents a potential form of pathology of the nervous system. Many forms of
epilepsy represent just such pathological conditions in that neurons are hyperexcitable (i.e., too
responsive to excitatory drive or unresponsive to inhibitory input). To study the mechanisms by
which this hyperexcitability develops in epilepsy, many investigators have chosen to examine
genetic animal models of epilepsy since many of these models share important traits with human
forms of epilepsy (Jobe et al., 1991). In the present studies, Purkinje neurons of the cerebellum of
genetically epilepsy-prone rats (GEPRs) were studied electrophysiologically in an attempt to
ascertain a general mechanism which may account for the seizure susceptibility of these animals.
The GEPR-9, the most severely seizure-prone of the GEPRs, is an animal model which
appears to have numerous central nervous system abnormalities. The most prominently investigated
and documented of these abnormalities are the alterations in serotonergic and noradrenergic
signaling systems. In the mammalian brain, these neurotransmitter systems are rather diffuse and
appear to serve primarily to modulate the activity of other signaling systems (Cooper et al., 1991).
Though some investigators have claimed that “epileptic predispositions in GEPRs is partially caused
by noradrenergic and serotonergic deficits” (Jobe et al., 1991) based upon the observations that
there are numerous deficits in these systems and that experimentally inducing further deficits
increases seizure susceptibility, a causal role for these systems has never been shown, only a
correlative role. Furthermore, lesions of the locus coeruleus (Anselmo-Franci et al., 1997), the
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major noradrenergic nucleus in the mammalian brain, or of the raphe nuclei (Jacobs and Fornal,
1995), the major serotonergic nuclei of the mammalian brain, do not appear to increase seizure
susceptibility in otherwise normal animals. Similarly, measurement of fos-like-immunoreactivity
in the locus coeruleus following audiogenic seizures in the GEPR-9 indicates that the locus
coeruleus activity in the GEPR-9 is equivalent to that of control rats (Eells et al., 1997). These
latter observations, combined with the ability of noradrenergic and serotonergic systems to enhance
both inhibitory and excitatory neurotransmission (Cooper et al., 1991), suggest that other factors
are likely to be involved in the seizure-predisposition of these animals.
To this end, some excesses in excitatory transmission utilizing glutamate and aspartate have
been noted in the GEPR-9 (Jobe et al., 1991). However, deficiencies of the inhibitory GABAergic
system appear to be more plentiful and uniform throughout the GEPR-9 brain. As the major
inhibitory neurotransmitter in the mammalian central nervous system, GABA stands to play a
pivotal role in determining the general state of excitability of the brain. Although excess numbers
of GABAergic terminals have been noted in a few areas, a deficient level of GABAergic
transmission has been observed in all areas of the GEPR brain studied (see review by Jobe et al.,
1991).
In addition to the GEPR-9, there are two other GEPR strains, the GEPR-NE and the GEPR3. The GEPR-NEs serve as a genetic control for GEPR-3 and GEPR-9 animals in that they do not
exhibit any heightened level of seizure-predisposition compared to the Sprague-Dawley animals
from which they and the GEPR-3/9s were derived (Jobe et al., 1993a). Having a genetic control
such as the GEPR-NE provides a valuable tool for the investigation of factors which may contribute
to the seizure-prone state of the GEPR-3 and GEPR-9 animals. Simply put, differences from normal
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Sprague-Dawley animals which are common to both seizure-prone GEPRs (3s and 9s) and nonseizure-prone GEPR-NEs are not likely to represent differences which contribute to the epileptic
state of the seizure-prone GEPRs. Thus, the GEPR-NE serves as a powerful means by which to
discriminate between deficits that may be contributory to the seizure-prone state of GEPR-3s and
9s and those which likely are not involved in this predisposition.
The GEPR-3 animals present moderate seizure severity upon audiogenic stimulation (Jobe
et al., 1991). Due to this fact, more subtle or less profound differences are commonly assumed to
be present in these animals (as compared to GEPR-9s) and, thus, these animals have not been nearly
as thoroughly investigated as the GEPR-9s (Jobe et al., 1991). The only consistent finding in the
GEPR-3s is that they are not simply “milder” versions of the GEPR-9. That is, they do not directly
exhibit intermediate levels of deficits which have been found in the GEPR-9. For example, the
response of GEPR-3 animals to anti-epileptic drugs compared to GEPR-9s is erratic. Though
certain agents are equally effective in both animals (e.g., clonazepam, phenobarbital), others are
more effective in the GEPR-3 (e.g., valproate, loreclezole), and still others are less effective (e.g.,
phenytoin, carbamazepine; Dailey et al., 1996). These findings emphasize the point that epilepsy
is a group of related, yet distinct, neurological diseases with neuronal hyperexcitability as their
common, underlying cause. The ability to gain advances in the treatment of these diseases will
derive from the concerted efforts of investigating and understanding its various forms.
Based primarily upon the information available for the GEPR-9s, the present studies
investigated the GABAergic system of the GEPR strains in a region of the brain well suited for such
studies, the cerebellum. The cerebellum is an excellent model system for studying GABAergic
neurotransmission, especially in the rat, for a number of reasons (see review by Wisden et al.,
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1996), including:
1) It is a structure which has been conserved throughout evolution (Ito, 1984),
2) It has a well documented development (see section III),
3) It is readily accessible,
4) Individual neuronal populations can be identified, and
5) GABA-receptor expression for most cell types has been intricately detailed (see section
IV)
Studies by Gould et al. (1991, 1995) utilizing extracellular recording techniques in situ,
indicated that GEPR-9 Purkinje neurons are specifically subsensitive to GABAA-receptor activation.
Since such a specific subsensitivity would indicate either an alteration in receptor number/density
or in single chloride channel characteristics (see section IA), these investigators also chose to
measure radioligand binding sites for [3H]-muscimol and [3H]-flunitrazepam, both of which bind
the GABAA- receptor complex, in cerebellar homogenates from GEPR-9 and control animals (Gould
et al., 1995). These studies indicated that such binding sites were not quantitatively different
between GEPR-9 and control rats. Based upon the findings of these authors, the present studies
have focused on the general hypothesis that the GABA subsensitivity in Purkinje neurons of the
GEPR-9 is due to a decreased ability to conduct chloride ions upon activation of GABAA-receptors.
However, in order to more fully investigate this possibility, recording techniques offering greater
precision and providing the ability to record from cell somata needed to be employed, namely,
intracellular and patch-clamp recording from in vitro cerebellar slices to allow greater examination
of activity at the cellular level.
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A. Purkinje Neurons in Cerebellar Slices Obtained from Sprague-Dawley, GEPR-NE, GEPR-3,
and GEPR-9 Animals Have Equivalent Basic Electrical Membrane Properties
In order to start investigating possible GABAergic deficits in the GEPR cerebellum, it was
first important to be sure that such a deficit existed in the recording model chosen. Once
preliminary studies had shown this to be the case for GEPR-9s (see section VIIID for greater detail),
the first goal was to test two similar hypotheses. One was that the resting membrane potential
(RMP) and input resistance (IR) of Purkinje neurons from GEPR and control animals would be
similar in the adult animals that previous investigators had studied (Gould et al., 1991, 1995). The
second hypothesis was that these properties would also be similar at younger ages (near 15 days of
age) both prior to the development of seizure-susceptibility and shortly thereafter. If this latter
hypothesis was true, it would permit the use of these younger animals in later experiments focused
on cellular mechanisms, since these are better suited for studying slices from immature animals.
The results of these experiments can be see in Tables 4 and 5, as well as Figures 10 and 11.
In every age group examined, there was never a difference in RMP or IR among the four
animal strains even though there were parallel developmental changes in these properties for each.
Such developmental changes common to all strains are discussed in section VIIIB. Though RMPs
and IRs for Purkinje neurons have been rarely reported in the literature for normal rats and not at
all for the GEPRs, the values obtained in the present experiments are quantitatively similar to
previous studies which have measured and reported these values. Using whole-cell patch clamp
recording techniques, Puia et al. (1994) reported a mean RMP for cerebellar Purkinje neurons of
adult rats of -61 mV. The small discrepancy between these values and the ones obtained in the
present study (-57 to -58 mV) may be attributable to the different techniques used to obtain them.
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One of the disadvantages that the intracellular recording technique presents is that impalement of
a cell with a sharp electrode essentially creates a hole in the membrane. By doing so, a voltageindependent conductance is created that is not ion selective, with a reversal potential of
approximately 0 mV (Hagiwara and Jaffe, 1979). This may result in an unavoidable disruption of
the “true” RMP and thus yield a slight depolarization of the membrane potential. However, using
careful technique and permitting time for repolarization can help to minimize this effect and allow
meaningful comparisons to be made. Since the values obtained in these experiments are fairly close
to those values obtained using the less invasive technique of whole-cell patch clamping both later
in these studies (see Results, Table 15), as well as by others (Puia et al., 1994), they are likely to
adequately represent an accurate estimation of the true RMP of Purkinje neurons in cerebellar slices.
The IRs determined in the present studies are also similar to published values for Purkinje
neurons obtained using intracellular recording. As with RMP, the leakage current due to cell
impalement appears to alter the IR obtained using intracellular recording as compared to patch
clamp techniques. In cerebellar slices, intracellular recordings have yielded a mean IR of 6 M
(Crepel and Delhaye-Bouchaud, 1979), whereas a mean of 167 M was reported in studies using
patch clamp recording (Llano et al., 1991), and a mean of around 450 M was found in the present
study (see Table 15) using similar techniques. Such a discrepancy casts doubt as to how well IRs
obtained with intracellular recording represent and relate to those which might be found in vivo.
However, if one assumes that the effect of the leakage current created is approximately the same
over a large population of cells and since changes in IR can be detected during drug exposure, these
values may still serve as valuable qualitative tools in determining changes in IR, and thus the
possible involvement of changes in ion conductance during such drug exposures. In conclusion,
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though the values of the electrical membrane properties measured in the present experiments may
not perfectly reflect in vivo values, they are similar to values reported by other investigators for
similar preparations and lend further support to the proposition that RMP and IR are not
significantly different between Purkinje neurons from Sprague-Dawley, GEPR-NE, GEPR-3, and
GEPR-9 rats. Thus, any differences in agonist sensitivity are unlikely to be the result of a general
change in the excitability of Purkinje neurons as is strongly supported by the pharmacological data
(see below).

B. Developmental Changes in Cellular Responsiveness of Purkinje Neurons
The primary task undertaken in the present studies was to use intracellular recording
techniques to investigate the cellular responsiveness of Purkinje neurons in vermal cerebellar slices.
These experiments employed the superfusion of drugs while measuring changes in membrane
polarization as the pharmacological response. In order to discuss the results of these experiments
in an organized and logical manner, the results obtained from Sprague-Dawley control animals will
first be focused upon, followed by a comparison to the results obtained from the other animals
strains in section VIIID.
Before embarking on the discussion of the pharmacological responsiveness of Purkinje
neurons, however, a brief discussion of the developmental findings (common to all animal strains)
is pertinent. As noted in VIIIA, during the course of comparing the resting membrane potential
(RMP) and input resistance (IR) of Purkinje neurons from Sprague-Dawley and GEPR rats of
various ages, an unexpected developmental change in these properties became apparent in each
animal strain. As seen in Figures 10, 11, and 12 as well as Tables 4 and 5, there is a significant
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hyperpolarization of the membrane potential and significant decrease in IR from animals aged 15
days postnatal and older compared to animals 10-14 days of age. Attempts to determine if these
changes had been previously reported in the literature were unsuccessful. However, pieces of
various studies do lend support to the idea that this change is a true alteration and not the effect of
the experimental model system used (i.e., the in vitro slice method).
Mariani and Changeux (1981a) determined RMP using intracellular recording methods for
30 Purkinje neurons from normal rats which yielded a mean of -51 mV. The neurons were from
animals of various ages (P5-9, n=4; P10-15, n=21; and P16+, n=5) which makes interpretation a
little more difficult. However, the RMP is decreased compared to the P15+ animals reported here
and the RMP for Purkinje neurons from adult animals reported by Crepel et al. (1982), and are
similar to the values obtained in the present experiments for P10-14 aged animals. Furthermore,
it would appear that most of the Purkinje neurons in the Mariani and Changeux (1981a) study came
from animals less than 15 days of age, though the exact number is not reported. The study also
reported input resistances for Purkinje neurons from rats age P5-11 (10.7 M ) and P13-15 (7.3
M ). Thus, there is also precedence for a developmental decrease in IR as well. Other than these
studies, the literature appears to be devoid of data on the basic electrical membrane properties of
Purkinje neurons of the developing rat cerebellum.
Since this hyperpolarization of the Purkinje neuron membrane potential happened to
coincide with the postnatal age at which GEPRs become seizure-prone, some basic steps were taken
in order to gain a better understanding of the mechanism by which it may be occuring. To this end,
the experiments described in VIB, employing the superfusion of ouabain onto Purkinje neurons
from Sprague-Dawley rats of various postnatal ages, were performed. The Na+,K+-pump was used
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as an initial target for these investigations due to its prominent role in determining the membrane
potential (see section I) and the fact that some relatively simple experiments could be performed to
gain a resonably rapid understanding of this process.
If regulation of the activity of the sodium-pump was involved in the developmental
hyperpolarization of Purkinje neurons, it was expected that saturating concentrations (1mM) of the
pump-inhibitor, ouabain, would have a more prominent effect on the membrane potential in animals
older than 15 days compared to P10-14 animals. The results of these experiments (see Figure 14
and Table 6) revealed that ouabain did have an increased effect on the membrane potential of
Purkinje neurons from older animals, coincident with the developmental hyperpolarization of these
neurons. In addition, as detailed in Table 6, the final membrane potential after ouabain exposure
was statistically equivalent for all age groups (p>0.05). These findings are thus solid evidence for
an increased Na+,K+-pump activity underlying the developmental hyperpolarization of Purkinje
neurons around postnatal age 15 (P15).
In light of the observations that Purkinje neuron membranes became hyperpolarized during
development and that the magnitude of ouabain-induced depolarizations of the membrane increased
during development, other members of the laboratory performed radioligand binding studies using
[3H]-ouabain in cerebellar homogenates to determine if binding sites for this ligand were increased
in P15+ Sprague-Dawley animals compared to P10-14 animals. The results of these studies
indicated an approximate 2-fold increase in the Bmax (maximal binding) and no significant change
in the KD for ouabain binding (Taylor et al., 1998). Similarly, studies by Atterwill et al. (1985)
noted a 4-fold increase in Na+,K+-ATPase activity in rats age P22 versus rats age P11. The findings
from these studies along with those of the present study suggest that there is a developmental
-148-

increase in the number of Na+,K+-pump sites, the level of Na+,K+-ATPase activity, and the
contribution of this activity to the RMP.
Another developmental difference seen in each animal strain was in the pharmacological
responsiveness of Purkinje neurons to various agonists. As noted in Tables 7, 9, and 12, there were
occasional (approximately 20-25% overall) depolarizing responses to GABA and/or muscimol for
Purkinje neurons from P10-14 animals of each strain tested. Although no evidence of such findings
was discovered in the literature, there are a number of instances where evidence has revealed that
GABAA-receptor activation leads to depolarizing responses transiently during the developmental
period of a variety of other neurons (Ben-Ari et al., 1989; Cherubini et al., 1990; Conner et al.,
1987; Janigro and Schwartzkroin, 1988; Wu et al., 1992; Yuste and Katz, 1991). In general, these
depolarizing responses have been found to be the result of changes in intracellular chloride ion
concentration, though some authors have proposed a role for bicarbonate ion in this process (Staley
et al., 1995).
Young animals (P10-14) from each strain also displayed a decreased responsiveness to
aspartate and glutamate (see Tables 8, 10, and 13). In contrast, NMDA was more effective in
depolarizing Purkinje neurons from young Sprague-Dawley and GEPR-9 animals (the only animal
strains for which NMDA was examined; see Table 10). Though these results were not initially
expected, precedence for these findings were found in the literature. Dupont et al. (1987), studying
the postnatal development of sensitivity in the rat cerebellum, found both increases in response to
aspartate and glutamate with animal age as well as a similar decrease in responsiveness to NMDA.
Though each of these previously mentioned developmental alterations in Purkinje neuron
responsiveness represent interesting findings, they do, in fact, deviate from the primary focus of the
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present study. For this reason, the remaining discussion will focus upon the experimental results
obtained from animals 15 days and older. Thus, all data discussed below will be assumed to be
from the P15+ population of animals unless otherwise specified.

C. Cellular Responsiveness of Sprague-Dawley Purkinje Neurons to Various Agonists
This discussion will focus upon the control results obtained from Sprague-Dawley Purkinje
neurons using intracellular recording techniques in cerebellar slices. As alluded to in section VIIIA,
there have not been many studies reporting the results of intracellular recording of Purkinje neurons
in slices. However, there have been enough studies using similar techniques to make meaningful
comparisons to the results obtained in the present study. Itier et al. (1996), studying acutely
dissociated Purkinje neurons, found that GABA induced inward currents in a concentrationdependent manner with an EC50 of approximately 4 µM, which is very similar to the value of 6.6
µM obtained in the present study for GABA-induced hyperpolarizations (see Figures 15, 19, and
23 and Table 14).
Although approximate EC50 values for muscimol in similar experiments have not been found
in the literature, inferences can be made from studies which have employed iontophoretic
application of both GABA and muscimol. A study of dissociated Purkinje neurons from normal rats
by Cheun and Yeh (1992) found that approximately three times more current was evoked by
iontophoretically applied muscimol compared to similar levels of application of GABA. Although
this value is a bit lower than the nine- to ten-fold difference seen in the present experiments, two
important differences between the comparisons should be noted. The first is that muscimol-evoked
responses in the study by Cheun and Yeh (1992) were near maximal currents and thus may
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underestimate the difference in the effectiveness of these two compounds to elicit a response, since
comparisons made at either end of a concentration-response curve may not accurately reflect
comparisons made from the linear portion of the curve. Secondly, there is less likelihood of GABA
uptake playing a role in dissociated cells as compared to in slices. Since muscimol is not
susceptible to uptake by GABA transporters whereas GABA is, for equal concentrations of applied
drug, more muscimol may reach the biophase than will GABA and thus a slight overestimation of
the difference in effectiveness of these two compounds may result from studies done in slices.
Another important finding in Sprague-Dawley Purkinje neurons, which was also found for
the other animal strains, was that there was very little, if any, GABAB-receptor activity in these
slices. This was confirmed by two findings during the single concentration studies. The first was
that both picrotoxin and bicuculline, GABAA-receptor selective antagonists, fully blocked the effects
of either GABA or muscimol when applied concomitantly (see Tables 7, 9, or 12). This indicated
that GABA, in addition to muscimol, was exerting its effects solely via GABAA-receptor activation.
Also, neither bicuculline nor picrotoxin had significant membrane polarization effects when applied
alone (again, see Tables 7, 9, or 12), which also indicated a lack of basal GABAergic tone in these
cerebellar slices for Purkinje neurons. In addition, baclofen, a GABAB-receptor selective agonist,
was without significant effect in these preparations (see Table 7, 9, or 12). The GABAB-receptor,
a G-protein coupled receptor that regulates Ca++ and/or K+ conductance (Cherubini and North,
1984; Deisz and Lux, 1985; Desarmenien et al., 1984; Gähwiler and Brown, 1985; Inoue et al.,
1985a,b), has been found in the cerebellum with the highest concentrations being in the molecular
layer (Bowery et al., 1987) which contains the Purkinje neuron dendrites (see section IIIA).
However, previous studies have shown little effect of GABAB-receptor activation on Purkinje
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neuron activity (Parfitt et al. 1990; Cheun and Yeh, 1992). Thus, in agreement with other studies,
it can be concluded from the results of these experiments that the primary effects of GABA
neurotransmission are mediated via the GABAA-receptor for Purkinje neurons of the rat cerebellum.
The effects of the excitatory amino acids, glutamate and aspartate (as well as NMDA), were
also as expected for Sprague-Dawley Purkinje neurons. In response to glutamate or aspartate,
depolarizations of the membrane potential were accompanied by a decrease in the IR, indicating a
direct effect on the Purkinje neurons via increased ion conductance. Although EC 50 values for these
agonists on Purkinje neurons in cerebellar slices were not found in the literature, Dupont et al.
(1987) found that glutamate was approximately twice as potent as aspartate and Crepel et al. (1982),
using iontophoretic application of drugs, reported the ratio of IC50 values (glutamate/aspartate) to
be approximately 1.45 for Purkinje neurons from normal rats. These values are very similar to the
ratio of EC50 values found in the present study (1.97; see Table 14). In addition, the maximal
depolarizations reported for both agonists by Crepel et al. (1982) were approximately 18 mV in
amplitude, as was found in the present study.
NMDA did not have as clear an effect on Purkinje neurons as glutamate and aspartate in the
present study. The effect of NMDA on input resistance was quite variable, with only 10 of 17
(59%) Sprague-Dawley Purkinje neurons responding with a decrease in IR. Furthermore, NMDA
yielded only minor depolarizations (mean = 2.2 ± 0.4) when applied to Sprague-Dawley Purkinje
neurons. These variable effects on IR and relatively minor depolarizations are, however, consistent
with previous studies which studied adult rat Purkinje neuron responses to NMDA (Dupont et al.,
1987; Garthwaite and Beaumont, 1989; Crepel et al., 1982).
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D. Comparison of the Responsiveness of Purkinje Neurons from GEPR-NE, GEPR-3, and
GEPR-9 Animals to that of Sprague-Dawley Purkinje Neurons
The primary hypothesis to be tested was that Purkinje neurons in cerebellar slices from the
GEPR-9 would display subsensitivity to the neurotransmitter GABA and that this subsensitivity is
specifically mediated via the GABAA-receptor subtype. In addition, it was hypothesized that GEPRNE Purkinje neurons would display no differences in responsiveness compared to Sprague-Dawley
Purkinje neurons. No firm hypotheses were made concerning the cellular responsiveness of GEPR3 Purkinje neurons due to the lack of available data concerning these animals. However, it was
hypothesized that their cellular responsiveness would be different from both control animals
(Sprague-Dawley and GEPR-NE) and GEPR-9 animals. This was based upon the fact that (1) they
display a different seizure-prone state than both of these populations of animals (see section II) and
(2) the seizure-prone state is believed to be highly dependent upon the level of cellular
responsiveness (see sections I and II). Thus, differing seizure-prone states would likely be due to
different levels of altered responsiveness.
The first portion of these studies relied upon the application of single doses of drug via
superfusion to Purkinje neurons in cerebellar slices. The drugs used in each of these studies
included: GABA (10 µM), muscimol (1 µM), bicuculline (10 and 30 µM), baclofen (10 µM),
glutamate (10 µM), and aspartate (10 µM). In addition, picrotoxin (10 µM), norepinephrine (500
µM), and diazepam (100 µM) were also employed in the study of GEPR-9 Purkinje neurons. The
results from norepinephrine and diazepam applications on GEPR-9 Purkinje neurons (Table 11) will
be discussed at the end of this section. The results of these single-concentration studies can be
found in Tables 7/8(GEPR-NE), 9/10 (GEPR-9), and 12/13 (GEPR-3).
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These results were in agreement with our initial hypotheses. First, there were no differences
unveiled when comparing GEPR-NE Purkinje neurons to those of Sprague-Dawley animals to any
of the agonists used. Secondly, GEPR-9 Purkinje neurons of adult (P15+) animals were selectively
subsensitive to the effects of GABA and muscimol, the effects of which could be blocked by
bicuculline and/or picrotoxin, indicating a specific subsensitivity of GEPR-9 Purkinje neurons to
GABAA-receptor activation. Thirdly, GEPR-3 Purkinje neurons displayed a selectively subsensitive
response to GABA and muscimol when compared to Sprague-Dawley Purkinje neurons. In
addition, though not directly compared in the results section, if GEPR-3 and GEPR-9
hyperpolarizing responses in P15+ animals are compared, they, too, are found to be significantly
different at the concentrations of GABA (10 µM) and muscimol (1 µM) employed (p<0.05). Thus,
the key findings of these experiments were (for the single concentrations of agonists and antagonists
employed, compared to Sprague-Dawley rats):
1) GEPR-NE Purkinje neurons display an equivalent level of pharmacological
responsiveness to both excitatory and inhibitory endogenous neurotransmitter
receptor activation,
2) GEPR-9 Purkinje neurons display a robustly diminished response to GABAA-receptor
activation without displaying similar alterations in their responsiveness to excitatory
neurotransmitters,
3) GEPR-3 Purkinje neurons display a slightly diminished response to GABAA-receptor
activation without displaying similar alterations in their responsiveness to excitatory
neurotransmitters, and
4) GEPR-3 and GEPR-9 Purkinje neurons differ selectively in their response to GABAA-154-

receptor activation.
The next step in this study was to more thoroughly investigate the responsiveness of Purkinje
neurons from these animal strains by comparing complete concentration response curves. Doing
so allowed for a more precise description and better understanding of the neuronal deficits in the
seizure prone animals. Also, it was important to construct these curves to ensure that the
concentrations of drugs used had not simply obscured the ability to discriminate actual differences
which existed. When comparing the curves constructed to GABA, muscimol, glutamate, and
aspartate for GEPR-NE and Sprague-Dawley animals (Figures 15 through 18, respectively), it is
clear that the responsiveness of Purkinje neurons from these two animal strains is quite similar. No
statistically significant differences were found in either the maximal membrane polarization
responses or EC50 values for any of these agonists.
When these same comparisons are made for GEPR-9 and GEPR-3 Purkinje neurons, some
discernable differences do become evident. For both GEPR-9 and GEPR-3 Purkinje neurons, the
maximal responses and EC50 values in response to aspartate and glutamate were equivalent to those
of Sprague-Dawley Purkinje neurons, as was expected (Figures 21, 22, 25, and 26 and Table14).
This was not the case for GABA and muscimol concentration-response curves. For the GEPR-9s,
both of these curves demonstrated similar phenomena (Figures 19 and 20 and Table 14). GEPR-9
Purkinje neurons had the same maximal hyperpolarization as those from Sprague-Dawley rats;
however, it took increased quantities of agonist to obtain these responses. In addition, the estimated
geometric mean EC50 concentrations for GABA and muscimol for GEPR-9 Purkinje neurons were
both approximately 3-fold greater than the corresponding concentrations for Sprague-Dawley
Purkinje neurons. Thus, the responses obtained from the GEPR-9 display a classical rightward shift
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of the concentration-response curve without a change in maximal response, indicating a specific
subsensitivity of these Purkinje neurons to GABAA-receptor activation.
The GABA and muscimol concentration-response curves obtained for GEPR-3 Purkinje
neurons (Figures 23 and 24) implied a different form of subsensitive response of these neurons to
GABAA-receptor activation. In this case, the EC50 concentrations were not significantly shifted to
the right, but the maximal obtainable hyperpolarization was decreased by approximately 10-15%
for both agonists. In fact, for all concentrations of muscimol $1 µM and concentrations of GABA

$10 µM , the mean hyperpolarizing responses for GEPR-3 Purkinje neurons were decreased. The
results of these studies further support the conclusions drawn from the single-concentration studies
and emphasize that the subsensitivity of GEPR-9 Purkinje neurons exists over the entire response
range, whereas the subsensitive responses of GEPR-3 Purkinje neurons occur only at the higher
concentrations of agonist.
In an attempt to gain further insight into the nature of the GEPR-9 Purkinje neurons
subsensitivity to GABAA-receptor activation, we next examined the effects of modulators of the
GABAA-receptor on Purkinje neurons in cerebellar slices. As discussed in section IV, two such
modulators are diazepam, a benzodiazepine, and norepinephrine. It was thought that if either of
these modulators displayed an altered level of activity in the GEPR-9 then valuable clues could be
obtained regarding the exact cellular mechanism of the subsensitivity to GABAA-receptor activation
in these animals due to the fact that the actions of these modulatory agonists are highly dependent
upon subunit composition of the receptor and the existing level of GABAergic activity. In order to
make these comparisons, approximate EC50 concentrations of GABA were used for each animal in
an attempt to create an equal “starting point” for receptor modulation. The responses to these
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concentrations of GABA were then compared to responses of GABA in the presence of either
norepinephrine or diazepam (see Table 14). Though it was hypothesized that differences might
likely exist for the modulatory actions of these compounds, no such differences were found. The
responses to norepinephrine (500 µM), diazepam (100 µM), and combinations of each of these
drugs with GABA were not significantly different between GEPR-9 and Sprague-Dawley Purkinje
neurons.

E. Comparison of GEPR-9, GEPR-3, and Sprague-Dawley Purkinje Neuron Whole-Cell and
Single-Channel Conductance Responses to GABA
Having found a decreased membrane polarization response to GABA in both the GEPR-9
and the GEPR-3, the next step was to look at macroscopic chloride conductance. Presumably, since
the membrane hyperpolarization in response to GABA was decreased for a given GABA
concentration (or at high concentrations for the GEPR-3), the chloride conductance response would
also be subsensitive to GABA. Thus, the aim of the whole-cell patch-clamp studies was two-fold.
First, concentration response-curves for GABA-activation of macroscopic chloride conductance
were constructed with the hypothesis that these response curves would be similar in nature to the
membrane hyperpolarization concentration-response curves.
For the GEPR-9, the peak current amplitude (IP) response curve (Figure 27) revealed just
that. Again, a parallel rightward shift of this curve with no significant change in the maximal peak
current (Imax) was obtained. Although the shift in EC50 was not quite as large as that for the
intracellular response curves (2-fold and 3-fold, respectively), it was significant (p<0.05). IPresponse curves for GEPR-3s, however, did not reveal the same pattern as did the curves obtained
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via intracellular recording. In this case (Figure 27), there was no change in EC50 or maximal peak
current response. However, plots to determine the Hill coefficient (Figure 27, inset), revealed values
of 1.78 (Sprague-Dawley), 1.67 (GEPR-9), and 1.48 (GEPR-3), indicating a possible decrease in
the positive co-operativity between GABA molecules in activating chloride conductance.
When concentration-response curves for steady-state current (ISS) were constructed for
GABA concentrations which yielded a significant desensitization of the conductance response
(Figure 28), it was found that GEPR-3 Purkinje neurons had a significantly decreased ISS (p<0.05)
at GABA concentrations $30 µM. Though ISS was less for GEPR-9 Purkinje neurons as well, it was
not a statistically significant decrease (p>0.05). Thus, at concentrations roughly corresponding to
GABA concentrations which produced significantly less hyperpolarization in the GEPR-3 ($10
µM), there was a decreased steady-state current (e.g., increased level of receptor desensitization).
The other aim of these whole-cell current studies was to determine if there was a shift in the
reversal potential for the chloride conductance by constructing I/V curves to a saturating
concentration of GABA (1 mM; Figure 29). Such a shift in reversal potential could indicate that
reduced macroscopic current responses were due to a decreased driving force for chloride ions.
However, when these curves were constructed for holding potentials (VH) between -80 mV and +20
mV (at 20 mV steps), very similar chloride reversal potentials near 0 mV were observed. Thus, in
accordance with the general hypothesis of the present study, whole cell chloride current amplitudes
were subsensitive to GABAA-receptor activation in the GEPR-9. Furthermore, this subsensitivity
is likely due to the activation of the receptor rather than merely a change in the driving potential for
chloride ions. Although whole-cell currents recorded from GEPR-3 Purkinje neurons did not reveal
quite as clear an answer, it does appear that their decreased responsiveness at high concentrations
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of GABA is based upon a greater level of desensitization of the receptor without a change in peak
current response (IP).
As a final step to gain additional understanding of the mechanism of GABA subsensitivity
in the GEPR, single-channel currents were examined to determine if conductance amplitudes of
these currents were diminished.

As revealed in Table 16, the single-channel conductance

amplitudes in response to 10 µM GABA were not significantly different between animal strains
(p>0.05) and were consistent with previous reports of single-channel chloride conductance levels
(Hamill et al., 1983; Sakmann et al., 1983; Macdonald and Olsen, 1994). Furthermore, mean open
and closed times were similar between animal strains.

Thus, the mechanisms for GABA

subsensitivity in Purkinje neurons of the GEPR-9 and increased current desensitization for the
GEPR-3 do not appear to rely upon a decrease in the ability of single GABAA-receptor channels to
conduct chloride ions upon activation by ligand.

F. Conclusions
In general, it can be clearly stated that the data obtained in the present study strongly support
the hypothesis that a specific subsensitivity to GABAA-receptor activation exists for Purkinje
neurons of the GEPR-9 compared to those of control animals. Furthermore, it can be concluded that
this subsensitivity to GABA is due to a decreased macroscopic chloride conductance in these
neurons which is due to activation of the receptor-channel by GABA, rather than a shift in the
driving force for chloride ions. In addition, it can be concluded that single-channel conductance
amplitude is not the underlying mechanism for this decreased whole-cell conductance.
Though it was beyond the scope of the present study to more thoroughly investigate the
-159-

single-channel properties of these animals, it appears that such studies will ultimately be required
before the molecular mechanism for GABA subsensitivity in the GEPR-9s is detailed. Such studies
will need to examine the ability of the GABA/GABAA-receptor interaction to activate chloride
conductance as it appears that the decreased whole-cell conductance must rely on the ability of
GABA to open the channel rather than the conductance of the channel once opened. This is
supported by the findings that peak whole-cell current (IP) is decreased in the GEPR-9 without a
concomitant decrease in single channel current amplitude.
For GEPR-3 Purkinje neurons, the primary conclusion is that they display a subsensitivy to
high concentrations of GABA which is likely due an increased level of receptor desensitization but
not due to a difference in single-channel conductance amplitude. In addition, it is possible that
decreased co-operativity between the two GABA molecules required for maximal receptor activation
may be present for Purkinje neurons of the GEPR-3. Thus, for the GEPR-3 as well, it appears that
the underlying cellular mechanisms rely upon the GABA/GABAA-receptor interaction rather than
chloride conductance, per se. Future studies to delineate the exact molecular mechanisms
underlying these two different forms of GABA subsensitivity in the GEPR-9 and GEPR-3 will need
to focus on the subunit composition of the GABAA-receptors in these animals as it is these subunits
which determine the manner in which receptors interact with GABA. Preliminarily, it can be stated
that these studies will need to focus on the

and

subunits of the receptor since these subunits

appear to comprise the GABA binding sites and, thus, influence the GABA interaction with the
receptor.
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